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Abstract
Many processes must occur in sequence to ensure the successful healing of a
bone fracture. At the fracture gap, healing progresses through endochondral
bone formation. A cartilage matrix bridges the fracture gap and provides sta-
bility. This cartilage matrix is subsequently replaced with a bony matrix and
clinically healing is considered complete when the gap has been fully bridged
by bone tissue. Distal to the fracture site new bone is being formed through
a different process, intramembranous bone formation. During intramembra-
nous bone formation, new bone forms directly without a precursor cartilage
matrix. In fracture healing intramembranous bone occurs in regions of high
mechanical stability. Histological observations reveal that the new intramem-
branous bone appears in the early stages of fracture healing and has a woven
appearance.
During intramembranous bone formation many complex cellular and chemical
interactions take place. In this thesis we examine some of these interactions,
and use them to build mathematical models to describe some of the processes
that are taking place. In particular we investigate the regulation of the cellular
differentiation of progenitor cells to become osteoblasts, and the mineralisation
of new bone tissue as they occur during intramembranous bone formation.
Before new bone can form, osteoblast progenitor cells present in the callus
must differentiate to become osteoblasts, the bone forming cells. This process
is regulated by many different proteins present during the fracture healing
process. Members of the bone morphogenetic protein (BMP) family are known
to enhance the differentiation of progenitor cells to osteoblasts. However the
known BMP antagonist noggin reduces the effectiveness of the BMPs. We
build a model for the differentiation of progenitors to osteoblast due to the
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effects of BMP and noggin. We demonstrate that the model can be reduced to
a model for just BMP and noggin. This reduced model has a form that gives
rise to Turing patterns. We demonstrate that the pattern forming ability of the
model is conserved when the full model is considered, and that the temporal
and spatial appearance of the patterning seems consistent with histological
observations. We also consider the effects of a BMP source on one of the
boundaries. This gives rise to a moving front of pattern formation, which
moves at a speed much greater than the expected growth rate of the callus.
We further extend this model to include a moving boundary to represent the
growth of the callus. We show that the growth rate of the callus has an effect
on the final appearance of the pattern and on the transient structures that
are observed as the patterns evolve.
We also build a model for the mineralisation of the new bone tissue. Os-
teoblasts produce new bone tissue by first producing a collagen matrix and
then regulating the deposition of mineral onto the matrix, a process referred
to as mineralisation. The removal of the mineralisation inhibitor pyrophos-
phate (PPi) is seen as a key requirement for mineralisation to occur. This is
facilitated by osteoblasts by the production of an enzyme, tissue non-specific
alkaline phosphatase (TNAP). The removal of PPi by TNAP also increases
the local concentration of phosphate (Pi), an important component of bone
mineral. We start with a kinetic model for TNAP, PPi and Pi. This model
qualitatively matches results seen in cell mineralisation assays. We further
take these kinetics and use them to build a model that includes the movement
of the mineralisation front. Using this we demonstrate the effect that varying
parameters and boundary conditions have on the speed of mineralisation.
iv
Statement of Original Authorship
The work contained in this thesis has not been previously submitted to meet
requirements for an award at this or any other higher education institution. To
the best of my knowledge and belief, the thesis contains no material previously
published or written by another person except where due reference is made.
Louise Manitzky
Signature:
Date:
v
5/11/14
QUT Verified Signature

Acknowledgements
There are many people who need to be thanked for their help during the last
four years leading to the completion of this thesis. Firstly to my supervisor
Graeme. Thanks for your patience, support, reassurance and guidance along
the way. To my associate supervisor Troy, thanks for your advice towards the
end.
Thanks to my family, particularly my parents for their love and support.
Thanks Dad for proof reading and picking up all the misplaced commas.
To my fellow PhD students, thanks for all the fun times and for reminding me
I’m not the only person crazy enough to go down this path. To my outside
friends for providing welcome distractions. In particular I want to thank Mel,
Nors, and Connie, who got me through when times were tough.
Finally thanks (I think) to Alan Williams, who planted the seed that I should
do a PhD many years ago, and then once I had enrolled never failed to remind
me that a PhD equals suffering.
vii

Contents
Keywords i
Abstract iii
Statement of Original Authorship v
Acknowledgements vii
1 Introduction 1
1.1 Overview . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
1.2 Aims and Objectives . . . . . . . . . . . . . . . . . . . . . . 6
1.3 Outline of Thesis . . . . . . . . . . . . . . . . . . . . . . . . 8
2 Background Information and Literature Review 11
2.1 Overview of Relevant Biology . . . . . . . . . . . . . . . . . 12
2.2 Existing Mathematical Models for Fracture Healing . . . . 15
2.3 Mathematical Models of Bone Mineralisation . . . . . . . . 20
2.4 Turing Patterns in Models of Bone Growth . . . . . . . . . 22
2.5 Summary . . . . . . . . . . . . . . . . . . . . . . . . . . . . 29
3 A Regulatory Model for Osteoblast Progenitor Differen-
tiation 31
3.1 The Role of BMP and Noggin in Inducing Cellular Differ-
entiation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 32
3.2 Model Formation . . . . . . . . . . . . . . . . . . . . . . . . 34
3.3 Fast Time Scales . . . . . . . . . . . . . . . . . . . . . . . . 42
3.4 Full System . . . . . . . . . . . . . . . . . . . . . . . . . . . 51
3.5 Summary . . . . . . . . . . . . . . . . . . . . . . . . . . . . 57
ix
Contents
4 Cellular Differentiation in a Growing Domain 59
4.1 Determining the Wave Speed of Cellular Differentiation . . 60
4.2 Extension to Growing Domain . . . . . . . . . . . . . . . . 70
4.3 Summary . . . . . . . . . . . . . . . . . . . . . . . . . . . . 75
5 A Mathematical Model for the Mineralisation of New
Bone Tissue 79
5.1 Mineralisation of Bone Tissue . . . . . . . . . . . . . . . . . 80
5.2 A Model for Mineralisation . . . . . . . . . . . . . . . . . . 84
5.3 Kinetic Equations . . . . . . . . . . . . . . . . . . . . . . . 86
5.4 Parameter Values for Kinetic Model . . . . . . . . . . . . . 88
5.5 Rescaling the Kinetic Equations . . . . . . . . . . . . . . . . 90
5.6 Determining the Unknown Parameters . . . . . . . . . . . . 91
5.7 Results and Discussion . . . . . . . . . . . . . . . . . . . . . 97
5.8 Extension to Moving Boundary . . . . . . . . . . . . . . . . 101
5.9 Summary . . . . . . . . . . . . . . . . . . . . . . . . . . . . 120
6 Summary and Future Directions 123
6.1 Summary . . . . . . . . . . . . . . . . . . . . . . . . . . . . 124
6.2 Future Work . . . . . . . . . . . . . . . . . . . . . . . . . . 127
Appendices 131
A An Overview of Bone Biology 133
A.1 Bone Function . . . . . . . . . . . . . . . . . . . . . . . . . 133
A.2 Bone Classification . . . . . . . . . . . . . . . . . . . . . . . 133
A.3 Bone Structure . . . . . . . . . . . . . . . . . . . . . . . . . 134
A.4 Mechanism of Bone Formation . . . . . . . . . . . . . . . . 139
B Introduction to Turing pattern formation 141
B.1 Diffusion Driven Instability . . . . . . . . . . . . . . . . . . 141
B.2 Turing Mechanisms . . . . . . . . . . . . . . . . . . . . . . . 142
B.3 Conditions for Diffusion Driven Instability . . . . . . . . . . 143
B.4 Finite Domains . . . . . . . . . . . . . . . . . . . . . . . . . 148
C Numerical Methods 151
C.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . 151
C.2 Finite Volume Method . . . . . . . . . . . . . . . . . . . . . 152
x
Contents
C.3 Finite Volume Method in Two Dimensions . . . . . . . . . . 158
C.4 Simulations on a Growing or Shrinking Domain: A Rescal-
ing Approach . . . . . . . . . . . . . . . . . . . . . . . . . . 160
Glossary 169
Bibliography 171
xi
List of Tables
3.1 Table of parameter values used for the cellular differentiation
model . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 40
5.1 Table of parameters for mineralisation model. . . . . . . . . . . 88
5.2 Table of additional parameters for mineralisation model . . . . 97
5.3 Table of additional parameters for the extended mineralisation
model. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 106
B.1 Conditions for diffusion driven instability. . . . . . . . . . . . . 147
xii
List of Figures
1.1 Histological section showing new intramembranous bone forma-
tion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3
1.2 Schematic demonstrating the growth of a fracture callus . . . . 4
1.3 Simplified schematic of the region of the fracture callus where
intramembranous bone formation is occurring . . . . . . . . . . 5
2.1 Difference between activator-inhibitor and activator-substrate
systems . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 24
2.2 3D plot of complex spatio-temporal behaviour in the model
from Courtin et al. (1995) . . . . . . . . . . . . . . . . . . . . . 27
3.1 Schematic of the regulation of progenitor cell differentiation to
osteoblasts by BMP and noggin . . . . . . . . . . . . . . . . . . 35
3.2 Concentration profiles of BMP and noggin as the solutions to
the reduced fast time cellular differentiation model . . . . . . . 44
3.3 Demonstration of the stability of the solutions to the reduced
fast time cellular differentiation model . . . . . . . . . . . . . . 45
3.4 Parameter space for the reduced fast time cellular differentia-
tion model . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 48
3.5 Effect of P¯0 on the potential patterning frequencies . . . . . . . 50
3.6 Concentration and cell population profiles from the full cellular
differentiation model on a 1D domain . . . . . . . . . . . . . . 52
3.7 Continued on next page. . . . . . . . . . . . . . . . . . . . . . . 54
3.6 Concentration and cell population profiles for BMP and os-
teoblasts on a 2D domain . . . . . . . . . . . . . . . . . . . . . 55
3.7 Histological section of an ovine osteotomy 2 weeks post surgery 56
xiii
List of Figures
4.1 Schematic of the domain used to determine wave-speed of dif-
ferentiation front . . . . . . . . . . . . . . . . . . . . . . . . . . 60
4.2 Concentration of BMP and cell density of the osteoblasts demon-
strating movement of the differentiation front in 1D . . . . . . 64
4.3 Concentration of BMP and cell density of the osteoblasts demon-
strating movement of the differentiation front . . . . . . . . . . 66
4.4 Space-time evolution along the line y = 0.1 cm for BMP and
osteoblasts, showing the propagation of the differentiation front 67
4.5 Schematic of the domain with a BMP source on the top half of
the left boundary. . . . . . . . . . . . . . . . . . . . . . . . . . 68
4.6 Concentration of BMP and cell density of the osteoblasts with
a source of BMP across half the left boundary . . . . . . . . . . 69
4.7 Histological section showing new intramembranous bone forma-
tion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 70
4.8 Schematic of the domain when a moving boundary is included 71
4.9 Concentration of BMP and cell density of the osteoblasts with
a moving boundary . . . . . . . . . . . . . . . . . . . . . . . . . 73
4.10 Illustration of the transient stripe-like structures that evolve
when a moving boundary is included. . . . . . . . . . . . . . . 74
4.11 Concentration of BMP and cell density of the osteoblasts with
a fast moving boundary . . . . . . . . . . . . . . . . . . . . . . 76
5.1 Illustration of the relationship of PPi and TNAP . . . . . . . . 86
5.2 Phase plane for the reduced mineralisation model with β¯ = 0 . 93
5.3 Parameter space for α¯ and η¯ . . . . . . . . . . . . . . . . . . . 94
5.4 Phase plane for the reduced mineralisation model with β¯ 6= 0 . 95
5.5 Parameter space for β¯ . . . . . . . . . . . . . . . . . . . . . . . 96
5.6 Results for the mineralisation kinetic model with β¯ = 0 . . . . 97
5.7 Comparison of experimental results for TNAP expression with
simulation results for TNAP concentration . . . . . . . . . . . 100
5.8 Results for the mineralisation kinetic model with β¯ 6= 0 . . . . 101
5.9 Schematic of domain for mineralisation model . . . . . . . . . . 102
5.10 Results for the extended mineralisation model including the
mineralisation front . . . . . . . . . . . . . . . . . . . . . . . . 110
5.11 Position and velocity of the mineralisation front . . . . . . . . . 111
5.12 Velocity of the mineralisation front for increasing values of λ . 114
xiv
List of Figures
5.13 Velocity of the mineralisation front for decreasing values of IM 115
5.14 Velocity of the mineralisation front showing effect of both in-
creasing λ and decreasing IM . . . . . . . . . . . . . . . . . . . 115
5.15 Results for the movement of the mineralisation front for a do-
main of width 0.1 cm . . . . . . . . . . . . . . . . . . . . . . . . 117
5.16 Results for the movement of the mineralisation front for a do-
main of width 0.02 cm . . . . . . . . . . . . . . . . . . . . . . . 118
5.17 Effect of parameter σ on the mineralisation rate . . . . . . . . 119
A.2 Transverse section through cortical bone showing the osteon
structure . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 136
B.1 Example of diffusion driven instability . . . . . . . . . . . . . . 142
B.2 Effect of diffusion coefficient on |M | and Reλ . . . . . . . . . . 147
C.1 Diagram of node distribution for a 1D problem . . . . . . . . . 153
C.2 Diagram of an interior node, demonstrating the notations used
in for finite volume discretisation . . . . . . . . . . . . . . . . . 154
C.3 Diagram of demonstrating the notation used for flux limiting . 156
C.4 Diagram illustrating the notation used for boundary nodes . . 157
C.5 Schematic of a rectangular grip over a 2D domain . . . . . . . 158
C.6 Diagram of a typical control volume in 2D demonstrating the
notation. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 159
xv

1Introduction
1.1 Overview
Bone is unique among the tissues of the body in that at the conclusion of
successful healing the new tissue is identical to the old tissue in form and
function. However within a clinical setting successful healing within a timely
fashion does not always occur, leading to a delayed union. Of greater concern
is that occasionally healing ceases altogether before completion leading to a
non-union of the fracture. This non-union can be painful as well as physically
disabling for a patient. The rate of non-union varies with different bones and
is influenced by a range of factors but is generally estimated to be around
5–10%. There is a significant financial cost to treat non-unions (Tosounidis
et al. 2009) and the standard approach to treatment is surgical intervention
(Antonova et al. 2013, Kanakaris & Giannoudis 2007).
Traditionally the surgical intervention is aimed at stabilising the fracture site
and often a bone graft is used to further induce bone formation (Antonova
et al. 2013, Schoelles et al. 2005). Due to potential complications during
the bone graft procedure alternative approaches have been developed. One
alternative is the use of collagen sponges containing BMP-2 or -7. More recent
research has been conducted into the use of bone scaffolds. A commonly
researched scaffold material is a calcium-phosphate compound similar to bone
mineral. Methods researched to increase the ability of these scaffolds to induce
bone formation include seeding with stem cells and implantation of growth
factors such as BMP (Bose et al. 2012).
Stability of the fracture site is undoubtedly an important factor in ensuring
successful healing. However the roles played by growth factors and other
signalling molecules cannot be overlooked, particularly as their potential role
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in clinical settings increases. Whilst much is known about the actions of
growth factors and other signalling molecules in the regulation of fracture
healing there are still many gaps in the knowledge. In particular from a clinical
point of view it is difficult to determine the optimal timing and dosage of
application of a growth factor to ensure successful bone growth. Mathematical
modelling can help to fill the gaps in the biological knowledge. These models
act as another tool to help interpret experimental results or test hypothesises,
these models may even raise new questions or give rise to a new hypothesis
that can help guide experimental research (Pivonka & Dunstan 2012, Geris
et al. 2010).
1.1.1 Intramembranous Bone Formation
Fracture healing is achieved through a complex series of events. The current
generally accepted interpretation of bone healing considers a number of phases.
The first phase is dominated by the inflammation response to the initial injury.
The next stage is the reparative phase. During this stage two separate types
of bone formation, intramembranous where new bone is formed directly and
endochondral where bone formation is preceded by cartilage growth, occur to
form a callus which bridges the fracture gap. Once the gap has been bridged
with bony material the final remodelling phase begins. In the remodelling
stage the callus is resorbed and the bone is restored to its original structure
(Prendergast & van der Meulen 2001).
Generally, at the fracture gap, new bone is formed through endochondral
bone formation. Here the fracture gap may first be bridged by a cartilaginous
tissue which provides increased stabilisation. The cartilage is then converted
to mineralised bone through a concerted process involving osteoblasts (bone
forming cells) and chondrocytes (cartilage cells). At the periphery of the callus
however new bone forms through a different mechanism.
Intramembranous bone formation (or intramembranous ossification) is when
bone is formed directly without an intermediary cartilage matrix. In fracture
healing it occurs during the early stages of repair and is typically associated
with the new bone that forms in the regions some distance from the fracture
gap, at the periphery of the callus. These regions are characterised as having
high mechanical stability with little interfragmentary movement and deforma-
tion of tissue. Indeed, intramembranous bone formation has been shown to
2
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Image removed due to copyright.
Please see Schell et al. (2006) Figure
3.
Figure 1.1: Histological section showing new intramembranous bone formation. The section
is from a sheep, taken two weeks after a tibial osteotomy (Schell et al. 2006).
The black rectangular regions are the pre-existing cortical bone, the irregularly
patterned black material in the regions adjacent to the cortical bone is the new
intramembranous bone. The white region is bone marrow and the pink regions
are fibrous tissue.
be independent of overall fracture gap stability (Epari et al. 2006).
As intramembranous bone formation occurs in areas of high mechanical sta-
bility, it makes an ideal starting point for building a mathematical model to
investigate bioregulatory effects on fracture healing. Also of interest is the spe-
cific structure that is apparent in newly formed intramembranous bone. This
is illustrated in Figure 1.1 which shows a histological slice taken 2 weeks follow-
ing a sheep osteotomy. Here the black rectangular regions are the pre-existing
cortical bone, and the white region that they surround is the bone marrow.
The new intramembranous bone can be seen adjacent to the pre-existing cor-
tical bone, due to its appearance this new bone is sometimes referred to as
spongy or woven bone. We note that there is a significant difference in the
amount of bone formation on either side of the callus and that this may in
part be due to spatial heterogeneities in the soft tissue surrounding the bone
(Epari et al. 2006). Looking at the intramembranous bone on the left of the
callus, we see that the new bone is not completely random in its appearance.
Near the fracture gap the spicules of bone growth appear aligned perpendic-
ular to the cortical bone surface, whereas the near the cortical bone surface
the growth appears to be aligned with the bone surface.
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(a)
(b) (c) (d)
Figure 1.2: Schematic demonstrating the growth of a fracture callus. (a) represents a long
section of a typical long bone with a mid shaft fracture. (b), (c) and (d) represent
the growth of the callus in the region indicated in (a). The white area is existing
cortical bone, the light blue is the region where cell proliferation is occurring,
the green is the region of cellular differentiation and the dark blue is where new
bone formation has occurred. As the callus grows the region of interest also
changes shape.
1.1.2 Mathematical Modelling For Fracture Healing
Traditionally mathematical models of fracture healing have focused on the
mechanical forces throughout the fracture callus. More recently models have
been developed that consider bioregulatory factors. Even more recently these
two approaches have been combined in the form of hybrid models. These
models all work on a callus scale. They have success at predicting regions
where intramembranous or endochondral formation will occur and in some
cases model the new bone formation using simple relationships. However none
of these models focus on the processes that are occurring during intramem-
branous bone formation in specific detail (for a more detailed review of the
existing models of fracture healing please see Chapter 2).
Instead we take a different tack in building a model for fracture healing. We
look specifically at intramembranous bone formation as it is occurring during
callus formation, with the aim of adding to the knowledge of the effect of
growth factors and other bioregulatory factors on fracture healing.
Intramembranous bone formation occurs during the early stages of fracture
repair and at the periphery of the callus. A schematic of the stages in this pro-
cess is illustrated in Figure 1.2. As the bone is fractured the periosteum, the
4
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Figure 1.3: Simplified schematic of the region of the fracture callus where intramembranous
bone formation is occurring. We consider the callus to be composed of three
regions, the proliferative region where the stem cells from the periosteum are
proliferating, a differentiation region where the stem cells differentiate to become
osteoblasts, and a mineralisation region where the new bone is being formed.
Legend: CB - cortical bone, M - zone of mineralisation, D - zone of cellular
differentiation, Pr - zone of proliferation, P - periosteum.
membranous material that surrounds the bone, is also damaged. This triggers
a response from the stem cells in the periosteum which begin to proliferate,
with the subsequent increase in tissue volume driving the periosteum away
from the cortical bone. In response to signals from growth factors these stem
cells begin to differentiate to become osteoblasts, the bone forming cells. As
pools of differentiated osteoblasts start to emerge the cells begin to operate
to produce the new intramembranous bone. As the new bone is produced it
also contributes to the callus growth.
We can further simplify this view and consider the callus region to be split
into three separate regions, a proliferative region, a differentiation region and
a mineralisation region. By dividing the callus into three distinct regions we
can also consider the growth of the callus as the movement of three distinct
fronts, the periosteum at the absolute boundary of the callus, a second front
between the proliferating cells and the differentiating cells and a third front
representing the formation of mineralised bone tissue. We illustrate these re-
gions in Figure 1.3, here we have also assumed a further abstracted fracture
geometry. The left side of the picture is the cortical bone and the right edge
is the periosteum. At the onset of the fracture healing process the cells in
the periosteum begin proliferating driving the periosteum away from the bone
surface. Close to the bone surface the stem cells begin to differentiate to be-
come osteoblasts, whilst those near the periosteum are still proliferating. As
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the population of osteoblasts becomes established these cells then begin to
produce the new bone tissue. The new bone further displaces the differenti-
ating cells, driving the front of differentiation to the right, which further acts
to drive the periosteum to the right.
1.2 Aims and Objectives
Currently there are aspects of the cellular and molecular interactions that oc-
cur during intramembranous bone formation (and fracture healing in general)
that are not particularly well understood. Intramembranous bone formation
takes place in areas of high mechanical stability making it ideal for investi-
gating the cellular and molecular processes that are occurring. By building
mathematical models that focus on the bio-regulatory mechanisms we aim to
improve on the current knowledge of the involvement of growth factors and
cells during healing.
Within this thesis we are aiming to build models to investigate bio-regulatory
effects on intramembranous bone formation during fracture healing. Specifi-
cally we consider secondary healing of a mid-shaft long bone fracture. However
we note that the models, or at the very least the insights gained from them,
could be applied to other aspects of bone formation.
We focus our attention on two separate processes that must occur in order
for intramembranous bone to form. These are the cellular differentiation of
stem cells to osteoblasts that can form new bone, and the regulation of new
bone formation by osteoblasts. The mathematical modelling of these processes
gives rise to two key objectives, these are described below.
Cellular Differentiation The first objective is to develop a model that
describes the cellular differentiation that occurs as a precursor to new
intramembranous bone being formed. We hypothesise that the struc-
tural appearance of new intramembranous bone is a result of a spatially
heterogeneous distribution of osteoblast cells, and that this distribution
is due to a chemical pre-pattern. We focus the model on describing the
relationship between the relevant cells and growth factors known to be
present in the callus and implicated in the differentiation process. This
model represents the processes that are occurring in the differentiation
zone of our simplified view of the callus region.
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As a first step to the completion of this objective we build a model
for cellular differentiation of stem cells into osteoblasts as driven by a
chemical pattern developed due to the interactions of BMP and noggin.
The underlying kinetics between BMP and noggin can be reduced to a
standard Turing pattern model, which creates an avenue for analysis of
the patterning potential of the underlying model.
Having developed the base model, we aim to extend it to a more accurate
representation of the callus which includes callus growth as illustrated
in Figure 1.3 (however with no explicit inclusion of mineralisation the
differentiation zone in effect reaches to the cortical bone surface). Our
goal is to investigate the effect that domain growth has on the evolution
of pattern in the cell differentiation.
Mineralisation The second objective is to build a model that describes
the mineralisation of new bone tissue, a process that takes place in the
mineralisation zone of our schematic of the callus. In many models of
bone formation, the production of new bone is simply modelled as being
proportional to the osteoblast population. We aim to build a model
that investigates some additional regulatory effects on the production of
new bone tissue. Bone tissue is comprised of a collagen matrix which
has been mineralised. We focus building a model that examines the
regulation of the mineralisation of the collagen matrix.
In particular the relationship between alkaline phosphatase and py-
rophosphate has been identified as being key to the regulation of miner-
alisation. We build a mathematical model to investigate this relationship
and the effect it has on the formation of new bone mineral.
The completion of these key objectives will give rise to two models that de-
scribe aspects of intramembranous bone formation. These models are novel
mathematical interpretations of the current knowledge of factors affecting frac-
ture healing. Thus it is hoped that these models will contribute to the current
knowledge of bioregulatory processes that are occurring during fracture heal-
ing.
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1.3 Outline of Thesis
In this section we present an outline of the content of the remainder of the
thesis.
Chapter 2 – Background Information and Literature Review
Here we provide an overview of the current knowledge of the biology of
fracture healing, as well as a review of the current mathematical models
that exist for fracture healing. We also review other models for bone
formation that are not directly related to fracture healing but still model
processes that are similar to that which occurs during fracture repair.
Chapter 3 – A Regulatory Model for Osteoblast Progenitor Differ-
entiation
In this chapter we present a model for the cellular differentiation of stem
cells, present in the periosteum, to osteoblasts. We look at the role of two
chemical species BMP and noggin in inducing this differentiation. These
chemical species act in tandem to produce a chemical pre-pattern that
then defines the pattern of cell differentiation seen across the domain.
We reduce the relationship between BMP and noggin to a standard
Turing pattern model, which allows for analysis of the pattern forming
potential of the model. We also present simulations of the full model for
both one and two dimensional domains.
Chapter 4 – Cellular Differentiation in a Growing Domain
Here we extend the model for cellular differentiation to more reasonably
represent the callus. At first we investigate the effect of more realistic
boundary conditions on the ability of our model to produce patterning in
the cell species. We then simulate our model on a growing domain, and
examine the effect that this has on the cellular differentiation process.
Chapter 5 – A Mathematical Model for the Mineralisation of New
Bone Tissue
In this chapter we build a new model for the mineralisation that occurs
as new bone forms, that examines the influence of the mineralisation in-
hibitor pyrophosphate. We begin by examining the relationship between
alkaline phosphatase and pyrophosphate, and building a kinetic model
8
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for this relationship. We then extend the model to a one dimensional
domain and consider spatial effects. In this model we explicitly model
the movement of the mineralisation front, caused by the deposition of
new mineral. We then examine the effects of varying parameters on the
speed of movement of this front.
Chapter 6 – Summary and Future Directions
We finish the thesis by providing a summary and discussion of the work
presented. We also indicate some future directions to further improve
upon the models presented in this thesis.
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Review
It is difficult to observe fracture healing as it is occurring in an individual.
X-rays and other imaging procedures can be used to view the growth of the
callus over time, however observing the behaviour of cells and growth factors is
a much more difficult task. Histological slices can be taken and examined but
these observations are a 2D slice of a 3D callus taken at a single time point.
Thus it can be difficult to observe changes in cell populations or growth factor
expression over time and space. Mathematical modelling can be used to gain
insights into these processes that are difficult or impossible to observed.
Many mathematical models for fracture healing have been developed. Tra-
ditionally these were based on the theory that mechanical forces, related to
the stability of the fracture site, was the key regulating factor for successful
fracture healing. As more evidence came to light about the role of growth
factors in regulating fracture healing, a new series of bio-regulatory models
were built. More recently hybrid models which consider both mechanical and
biological factors have been developed.
In this chapter we provide a review of the existing models of fracture healing.
We also examine some other models of bone formation that are not directly
related to fracture healing, as it is likely that similar processes play a role
across all types of bone formation. As part of this review we identify the
contrasts between our methodology and existing models. We also identify
aspects of the existing models that support our methodology.
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2.1 Overview of Relevant Biology
We start with an overview of the the relevant biology underlying fracture
healing and intramembranous bone formation. Particular attention is paid to
the driving factors for the differentiation of stem cells to osteoblasts and the
biology of new bone tissue formation. A more detailed description of some of
the biology of bone is provided in Appendix A.
2.1.1 Fracture Healing
Classically fracture healing is described as occurring along two pathways, pri-
mary or secondary healing. Primary healing can only occur when the fracture
gap is very small and stable. Under these circumstances the bone can regener-
ate through osteonal remodelling without a callus forming. Clinically primary
healing is observed when rigid fixation techniques, such as compression plat-
ing, are used. The more common form of healing is secondary healing. Here
the bone heals with the formation of a callus that bridges the fracture gap
(Einhorn 1998, Prendergast & van der Meulen 2001). Both colloquially and in
the literature the term fracture healing without specification can be assumed
to refer to secondary healing and this practice is followed in this thesis.
Bone fracture healing is typically described as occurring in three phases, the
reactive, reparative and remodelling phases. Each phase consists of distinct
biological processes, however the timing of these phases may overlap.
The reactive phase is the body’s initial response to a fracture. When a fracture
occurs the tissue surrounding the bone is also damaged. The reactive phase
is mostly the response of the soft tissue to the injury. As with all soft tissue
injuries the first response is inflammation, which results in the formation of
a haematoma at the fracture site. As part of this inflammation the cells
required for healing, including mesenchymal stem cells (MSC)s, accumulate
at the fracture site . There are many sources of MSCs but the largest source
is believed to be the periosteum, a membrane material that covers the outside
of the bone (Gerstenfeld et al. 2003). It is debatable whether the cells of the
periosteum are true MSCs or more specialised osteoblast progenitor cells. In
this thesis we generally use the term osteoblast progenitor cells to refer to cells
specifically from the periosteum whereas we use MSC when talking about the
general fracture healing process.
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The reparative phase is when the new bone is created. There are two processes
of bone formation, intramembranous and endochondral, that occur simultane-
ously to create a callus surrounding the fracture site. Intramembranous bone
formation occurs at the periphery of the callus, in areas of high mechanical
stability (Epari et al. 2006). The MSCs differentiate to become osteoblasts,
the bone forming cells, which immediately start to form the woven intramem-
branous bone. Around the fracture gap a endochondral ossification occurs.
This region is very mechanically unstable. The MSCs differentiate to become
chondrocytes (cartilage cells) which begin to form cartilage. Eventually the
cartilage bridges the fracture gap providing an increase in mechanical sta-
bility. The cartilage bridge can then be mineralised and turned into bone
by osteoblasts. This phase is considered complete when the fracture gap is
completely bridged by bone (Prendergast & van der Meulen 2001).
The final phase is remodelling. During this phase the original structure of the
bone is restored. The unorganised bone that was created during the reparative
phase is resorbed and new lamellar bone is laid down by the osteoblasts. This
process is quite gradual and can take up to a year depending on the animal
species (Doblare´ et al. 2004).
Intramembranous Bone Formation
Intramembranous bone formation occurs during the reparative phase of bone
healing. It occurs at the periphery of the fracture callus in areas of high me-
chanical stability (Schindeler et al. 2008). When the bone is fractured, the
periosteum is also damaged. In response to this, MSCs from the periosteum
proliferate and push the periosteum further away from the bone. These MSCs
then differentiate to become osteoblasts. The osteoblasts are responsible for
secreting the collagen and minerals which will form the new bone. The new
bone starts to grow as a series of spicules, these eventually become intercon-
nected and give the bone a woven appearance The osteoblasts continue to lay
mineralised bone until the pores in the woven bone are filled (Jee 2001).
A study conducted on sheep (Epari et al. 2006) showed that early intramem-
branous bone formation was the same regardless of the level of external sta-
bilisation that was applied to the fracture. The authors suggested that this
indicates that intramembranous bone formation, at least in the early stages
of healing, is independent of mechanical conditions. In this study there was
13
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a difference in the amount of bone formation on the lateral and medial sides
of the callus. The authors suggested that this disparity was due to a dif-
ference in the amount of soft tissue surrounding the bone which affects the
biological capacity for healing. However a more recent examination of the
same results hypothesises that the difference in bone formation was instead
due to the different levels of mechanical stability of either side of the callus
which resulted from the method of stabilisation of the fracture gap (Epari
et al. 2013). Whilst mechanical factors could be affecting the extent of bone
formation that occurs, it is widely assumed in mathematical models of frac-
ture healing that intramembranous bone formation can only occur in regions
of high mechanical stability, see for example (Go´mez-Benito et al. 2005, Ament
& Hofer 2000, Claes & Heigele 1999).
Focussing instead on bioregulatory factors influencing intramembranous bone
formation during fracture healing we see that there are several different growth
factors and inhibitors believed to affect this process. The bone morphogenetic
family of proteins (BMP) is believed to control the differentiation of MSCs
into osteoblasts (bone forming cells) or chondrocytes (cartilage cells). BMPs
are produced by a wide variety of cell types including MSCs and osteoblasts
(Bostrom 1998, Onishi et al. 1998, Spector et al. 2001) In the regions where
intramembranous bone formation occurs it appears that BMP 2 and BMP 4
are activating the differentiation of MSCs into osteoblasts (Barnes et al. 1999).
The effect of the BMPs is inhibited by several molecules including noggin and
gremlin (Tsiridis et al. 2007).
Noggin inhibits BMP by binding with it (Zimmerman et al. 1996), which
renders the BMP unable to bind with its receptors on cells. Thus the presence
of noggin will reduce the effect of BMP on cell functions. Noggin and BMP
have been shown to be present in the same areas of the callus (Yoshimura et al.
2001). Noggin is expressed by cells of an osteoblastic lineage with expression
increasing as the cells mature (Abe et al. 2000, Wan et al. 2007). There is
also evidence that the presence of BMP augments the expression of noggin
by osteoblasts (Gazzerro et al. 1998, Krause et al. 2011). This has led to the
belief that the interaction between BMP and noggin plays an important role in
regulation of bone formation during fracture healing. More specifically excess
noggin has been shown in vivo to reduce the amount of intramembranous bone
formation in adult rats (Aspenberg et al. 2001).
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Once the osteoblasts are present they begin to produce the new bone tissue.
This process begins with the production of a collagen matrix. Some of these
osteoblasts become embedded in the collagen and differentiate to become os-
teocytes. The osteocytes and osteoblasts then work in tandem to regulate the
deposition of mineral onto the collagen matrix (Franz-Odendaal et al. 2006).
This is a complex process that is not well understood.. The new bone mineral
is typically described as an impure form of hydroxyapatite (Ca5(PO4)3(OH)).
Many growth factors and other chemicals present in the interstitial fluid are
thought to influence the the production of collagen and its subsequent min-
eralisation, including members of the BMP family (Cho et al. 2002, Barnes
et al. 1999). Other proteins that affect mineralisation include osteopontin,
osteonectin and osteocalcin (Hirakawa et al. 1994, Einhorn 1998, Thompson
et al. 2002).
One key requirement for the deposition of mineral is removal of mineralisation
inhibitor pyrophosphate (PPi). PPi is produced as a by-product of cellular res-
piration and hence is present throughout the body (Fleisch & Bisaz 1962, Rus-
sell et al. 1971). Osteoblasts produce a protein alkaline phosphatase (TNAP),
which cleaves PPi. The presence of TNAP and hence the removal of PPi is
known to be critical in allowing mineralisation of new bone tissue to occur
(Murshed et al. 2005).
Another factor that affects the mineralisation process is the amount of vas-
cularisation that has occurred. Angiogenisis, the process by which new blood
vessels are created, is regulated during fracture healing by vascular-endothelial
growth factor (VEGF). VEGF is expressed by osteoblasts, and the rate of ex-
pression is stimulated by the presence of BMPs (Tsiridis et al. 2007). The
inhibition of VEGF has been shown to slow the process of intramembranous
bone formation (Street et al. 2002).
2.2 Existing Mathematical Models for Fracture
Healing
There exists many mathematical models for fracture healing. Traditionally
these models are mechanoregulatory, that is they are based on the assump-
tion that cell differentiation during fracture healing occurs as a response to
mechanical stimulus. More recently, as the effect of growth factors during
15
2 Background Information and Literature Review
fracture healing becomes more clear, new bioregulatory models have been
developed where cell differentiation is assumed to be driven by growth factor
concentrations. There also exists hybrid models which consider both mechano-
and bioregulatory effects.
In the following section we provide a brief review of the existing mathemat-
ical models. We acknowledge that there exists a number of review papers
on mathematical modelling of fracture healing including, (Geris et al. 2009,
Isaksson 2012, Boccaccio et al. 2011), and direct the interested reader towards
them.
2.2.1 Mechanoregulatory Models
Mechanoregulatory models assume that fracture healing is driven entirely by
mechanical stimuli, such as the stresses and strains placed on the bone or
interstitial fluid flow. These models are usually solved computationally using
a finite element framework. Generally these models are only solved at discrete
time points, i.e. 1 week, 2 weeks, 3 weeks and at a given time point a fracture
geometry is assumed. This means that in many of these models the temporal
evolution of the callus is unable to be observed.
Pauwels (1980) first proposed that tissue differentiation was stimulated by
physical deformation of the MSCs. Pauwels proposed that exposure to shear
stress changed the shape of MSCs and caused differentiation into fibroblasts,
whereas hydrostatic pressure changed the volume and caused differentiation
into chondrocytes. A combination of both sheer and hydrostatic pressure
resulted in fibrocartilage. This theory also predicted the need for a stable
mechanical environment for bone formation to occur. The concepts of Pauwels
theory of tissue differentiation have guided many computational models of
fracture healing, some of which are discussed below.
Another early theory proposed for mechanoregulation of tissue differentiation
is interfragmentary strain theory (Perren 1979). When a fracture is loaded
the fragments displace relative to each other. If the original fracture gap
width is L and the gap changes width by ∆L when loading is applied then
the longitudinal interfragmentary strain is given by
IFS =
∆L
L
. (2.1)
Interfragmentary strain theory states that tissue can only be formed in the
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fracture gap if that tissue type is capable of withstanding the interfragmentary
strain without rupturing. Granulation tissue has the highest strain tolerance
followed by cartilage and lowest is bone. Thus if the gap has high interfrag-
mentary strain cartilage cannot form until granulation tissue has formed and
stabilised the gap. Similarly bone cannot form until the cartilage has further
stabilised the gap.
The first computational models of fracture healing were proposed by Carter
et al. (1988). Based on the concepts of Pauwels’ theory they proposed that
MSC differentiation was decided by the local strain history. Using a finite
element model they calculated the load history at each point of the fracture
callus. Based on the calculated load history they hypothesised a series of
tissue differentiation rules. Using these rules they were able to qualitatively
match their results to histological results.
Claes & Heigele (1999) proposed that ossification could only occur along the
surface of existing bone and that the magnitude of local stress and strain
determined whether intramembranous or endochondral ossification occurred.
A finite element analysis was conducted at different stages during the fracture
healing process to calculate local stress and strain. By comparing these results
to histology from animal fracture models they were able to quantify the levels
of stress and strain required for different types of tissue formation to occur.
A different approach which was based on interfragmentary strain theory was
used by Gardner et al. (2000). They created a finite element model using
geometry from a left tibial fracture in a human patient. They calibrated
the model by measuring the forces applied to the leg when the patient was
standing and adjusting the model parameters until the force distributions were
matched. Using the calibrated model they found the stresses throughout the
callus when a walking load was applied. This allowed them to identify regions
where callus breakdown was likely to occur due to high levels of stress which
the new tissue was unable to withstand.
The previous models discussed were only evaluated at a few discrete time steps.
This meant that the temporal evolution of the callus could not be observed.
This problem was addressed by Lacroix & Prendergast (2002). They used a
series of tissue differentiation rules based on tissue shear strain and interstitial
fluid flow as proposed by Prendergast et al. (1997). Using these rules they
were able to create a model for fracture healing that was able to track the
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temporal evolution of the callus. Given an initial callus size they were able
to use their model to predict the resorption of the callus. However one issue
with this model is that it does not predict the resorption of the callus within
the medullary cavity. A behaviour which is physiologically unrealistic.
An variation of this model was presented in Isaksson et al. (2008). In this
model they used the same tissue differentiation rules from Prendergast et al.
(1997), however they explicitly modelled the different cell species and their
production of new tissue. This model did not include the resorption of the
callus so it can not be said whether the inclusion of the differing cell species
removed the physiologically unrealistic behaviour observed in Lacroix & Pren-
dergast (2002).
Another model to address temporal evolution was proposed by Ament & Hofer
(2000) in the form of a fuzzy logic model. They developed a series of fuzzy rules
based on strain energy density, which they calculated from a finite element
model. They also tried to incorporate some of the biology of bone healing in
the model by assuming that ossification could only occur next to an existing
bone surface. They modelled this by including an osteogenic factor, which they
defined as the spatial gradient of the amount of bone tissue. Regions where
this factor was high were considered to be lying on the surface of existing
bone and ossification could occur. Using this model they were able to predict
both the growth of the callus during the early stages of healing as well as the
resorption of the callus during the later stages.
2.2.2 Bioregulatory Models
For the most part biological effects are ignored in the above models. In par-
ticular the effect of growth factors on tissue differentiation has not been ad-
dressed. Their is now plenty of research that suggests that growth factors
have a large effect on initiating and regulating cell differentiation, migration
and proliferation. This has led to the development of a series of bioregulatory
models.
Bailo´n-Plaza & van der Meulen (2001) proposed the first model for fracture
healing that had no dependence on mechanical conditions. Instead they cre-
ated a 2D continuum model based on cell density, extracellular matrix density
and growth factor distribution. They considered two generic growth factors,
one chondrogenic and the other osteogenic. The chondrogenic growth factor
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produced by chondrocytes, with an initial source at the fracture gap. The
osteogenic growth factor was produced by osteoblasts, with an initial source
along the existing bone removed from the fracture gap. The model was solved
on a static 2D domain so was not able to track the growth of the callus over
time. This model has been corroborated by Geris et al. (2006) who com-
pared simulated results to experimental results obtained from tibial fractures
in mice.
The model has been further extended in different ways. Geris et al. (2008)
included the effects of angiogenesis on the healing process. This provided a
quantitative improvement on the model by Bailo´n-Plaza & van der Meulen
(2001), by more accurately predicting the fractional amount of different tissue
types in the callus.
2.2.3 Hybrid Models
There has also been a series of hybrid models which consider both mechano-
and bioregulatory effects. In these models the rates at which biological pro-
cesses occur, such as cell differentiation or proliferation, is affected by the local
mechanical conditions.
An example of this is an extension of the Bailo´n-Plaza & van der Meulen
(2001) model to include mechanical influences on fracture healing (Bailo´n-
Plaza & van der Meulen 2003). In this modified model the authors used
a finite element model to calculate the local mechanical strain present in the
callus. The parameters of the original model controlling cell differentiation and
tissue production were modified to instead become functions of the calculated
strain. By doing this the authors were able to observe the effect that different
loading conditions had on the formation of new tissue in the callus.
Another hybrid model was presented in Go´mez-Benito et al. (2005) which
allowed the authors to observe callus growth. They considered the rates of
cellular proliferation and differentiation and of tissue production to be reg-
ulated by the local stresses and strains as calculated from a finite element
model, however they did not include effects of growth factors. They assumed
that callus growth occurred due to cell proliferation and hypertrophy of chon-
drocytes and used these assumptions to incorporate callus growth into the
model.
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The use of bioregulatory models for fracture healing is a useful tool to gain
insights into the effects of growth factors on new bone formation. This is of
particular interest as new clinical approaches to treatment of bone non-union
have emerged using these growth factors. We note that all of the bioregula-
tory models focus on the entire callus. This is a complex domain where many
differing processes are occurring in different spatial and temporal locations.
These models are quite successful at providing an overall view of the develop-
ment of new tissue in the callus over time. However by focusing on the entire
callus they are unable to provide detailed analysis of or insight into the factors
controlling specific aspects of fracture healing. We also note that none of the
existing bioregulatory models model the growth of the callus over time.
We aim to use a methodology that is in contrast to these existing models.
Instead of taking an overall callus view we focus on building models that
provide insight into the effect of growth factors and other molecules on specific
processes that occur during intramembranous bone formation. We investigate
two processes, cellular differentiation and mineralisation.
In the existing bioregulatory models cell differentiation is controlled in re-
sponse to a single osteogenic or chondrogenic growth factor. We also consider
a model where cellular differentiation is controlled by a osteogenic growth fac-
tor BMP but we also consider the influence of the BMP inhibitor noggin on
the cellular differentiation. Additionally we consider the effect that a growing
domain has on the appearance of the differentiation.
We also focus on the processes that regulate new bone tissue formation, specifi-
cally the mineralisation. In the existing models bone tissue formation is simply
a function of osteoblast cell population. We would like to provide additional
insight into the regulatory processes that occur. In particular the effect of
the presence of PPi and TNAP on this process. Mineralisation has also been
considered in other bone formation contexts and we review these models in
the following section.
2.3 Mathematical Models of Bone Mineralisation
A common approach used in the bioregulatory models of fracture healing de-
scribed above is to model the rate of formation of new mineralised bone tissue
as being proportional to the osteoblast population density. This approach fails
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to identify any external regulatory factors that affect the formation and min-
eralisation of bone. However there does exist other models of bone formation
which examine some of these regulating factors.
Several models have been built to examine the behaviour of the bone multi-
cellular unit (BMU) during bone remodelling. In bone remodelling a group of
cells referred to as the BMU travels along the bone and replaces the old bone
with new bone. At the head of the group are osteoclasts that dissolve the old
bone, leaving a hollow channel. Trailing these is a population of osteoblasts,
which replace the bone, filling in the channel. This process gives rise to the os-
teon structure observed in cortical bone. Like the models of fracture healing in
these models the rate of bone formation is taken as simply being proportional
to the osteoblast cell density (Ryser et al. 2009, Pivonka et al. 2008). In more
recent models this has been taken a step further and geometric considerations
have been taken into account with the rate of bone formation decreasing as
the radius of the channel decreases (Buenzli et al. 2011).
Other models that deal with bone formation include those built for the osseoin-
tegration of implants into bone. In this case the new bone forms intramem-
branously and similarities can be drawn between the bone formed surrounding
the implants and the woven bone observable in fracture healing (Davies 2003).
In one of these models (Moreo et al. 2009) they model tissue formation using
volume fractions and consider the new bone formation to be proportional to
the number of osteoblasts as well as dependent on two unspecified growth
factors.
A more interesting approach to modelling implant osseointegration was pre-
sented in Prokharau et al. (2012). They considered the domain to consist
of two separate regions, one filled with bone tissue the other soft tissue, and
explicitly model the boundary between the two using the level set method.
As new bone is deposited onto the existing bone the region of bone tissue
grows. However, like many of the other models discussed, they model new
bone deposition as proportional to the osteoblast cell density with no other
regulatory factors considered. Another interesting aspect of this model is that
it models the degree of cellular maturity as an extra dimension of the model,
with only fully mature osteoblasts capable of producing new bone. In this
article the authors only solved the system on a 1D domain, however the inclu-
sion of an extra dimension for cellular maturity could introduce complexities
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in the numerics when solving the system in a 2D or 3D domain. This is in
addition to the increased complexity of implementing the level set method in
higher dimensions.
Another differing model for bone formation is presented in Carlier et al. (2011),
where they give a model for bone formation on a calcium-phosphate scaffold.
Using a reduced version of the bioregulatory model of Geris et al. (2008) as a
starting point they also included the effect of calcium concentration on mineral
deposition. In this model they only considered the temporal changes in the
modelled species, however the authors indicate that this is an area under
future investigation.
Whilst none of these models are explicitly related to intramembranous bone
formation during fracture healing there are concepts and ideas that can be
applied to this context. In particular the modelling of the mineralisation front
explicitly as in (Prokharau et al. 2012) and the dependence of new mineral for-
mation on mineral concentration as in (Carlier et al. 2011) are ideas that war-
rant further investigation. We also note that none of these models investigate
the effect of the regulatory loop between TNAP and PPi on mineralisation.
2.4 Turing Patterns in Models of Bone Growth
During intramembranous bone formation there appears to be some pattern
in the structure of the newly formed bone. As indicated in the literature
(Tsiridis et al. 2007, Barnes et al. 1999) intramembranous bone formation
during fracture healing is influenced by growth factor concentrations. It is
therefore possible that the patterning apparent in new intramembranous bone
is due to an underlying chemical pre-pattern
The emergence of pattern or form in an organism is termed morphogenesis.
The earliest attempt at providing a mathematical description of morphogen-
esis was done by Turing (1952) in his seminal paper ‘The chemical basis of
morphogenesis’. Turing proposed that morphogenesis was the result of cells
responding to chemical stimuli. These chemical species, termed morphogens,
were free to diffuse and react across the domain. When there are 2 or more
morphogens, a variety of behaviours can arise. Of most interest in morpho-
genesis is the evolution of a stable spatial pattern from an (almost) spatially
homogeneous initial state. Turing described the conditions under which this
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and other states would arise. One essential element that was identified by Tur-
ing was that for stable patterns to evolve the interacting morphogens must
both be diffusing at different rates. The idea that diffusion is required for
spatial patterning to occur is counter intuitive as diffusion is usually seen as
a smoothing process.
Turing patterns are well studied and have been used for many different ap-
plications. Analysis has been conducted on standard Turing patterns and
many variations on this type of model. Some of these variations include the
effect of spatially nonuniform parameters (Maini et al. 1992, Page et al. 2003)
and the evolution of pattern on a growing domain (Crampin et al. 2002).
Additionally this Turing models have been used to model many different bi-
ological phenomena. Perhaps the most famous example is of modelling an-
imal coat patterns, here Turing models have been able to reproduce pat-
terns that resemble the stripes on a tiger or the spots on a leopard (Koch &
Meinhardt 1994, Murray 2003). Other well studied examples include stripe
formation in zebrafish (Kondo & Asai 1995) and the regular spatial distribu-
tion of feather buds in a developing chick (Jung et al. 1998).
Whilst it is easy to write down a model of pattern formation, and for this to
qualitatively match expected patterns in biology it is much harder to exper-
imentally verify that the pattern is indeed due to the mechanism described
by Turing. The complexity of biological systems means that morphogens are
difficult to identify and measure. There are also other mechanisms by which
morphogenesis can occur and it can be difficult to distinguish which mecha-
nism gave rise to the observed structure.
An exciting, recent breakthrough in this area was made by Economou et al.
(2012). They were able to demonstrate that in a developing mice embryo the
patterning of the rugal (the ridges on the top of the mouth) matched that
predicted by a Turing model, and importantly could not have been explained
by any other known pattern formation process.
2.4.1 Local Self Enhancement, Long Range Inhibition
Following on from Turing’s work, two other important properties were iden-
tified as required for the evolution of a temporally stable spatial pattern.
Gierer & Meinhardt (1972) and independently Segel & Jackson (1972) both
demonstrated that for stable spatial patterns to evolve there must be local self
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Figure 2.1: Schematic diagrams and typical solutions for activator-inhibitor and activator-
substrate systems. (a), (b) are for an activator-inhibitor system where the
self-activating A also activates the production of the inhibitor I. (a) Shows a
schematic of this behaviour and (b) the qualitative behaviour of the solution for
an activator-inhibitor system. (c),(d) are for a activator-substrate system where
the self - activating A consumes the substrate S.
enhancement and long range inhibition. Local self enhancement means that
any small perturbations in the concentration of an activator are amplified. In
the absence of an inhibitory substance then this amplification would spread
across the entire domain. For patterns to arise a fast diffusing antagonist must
exist. This antagonist acts over a much wider range then the activator and
whilst it is not strong enough to suppress the original spike it will suppress
any activator spikes from evolving in the neighbourhood of the original spike.
In a two species system there are two ways that local self activation and long
range inhibition can occur. An activator-inhibitor system or an activator-
substrate system. These systems have differing underlying mechanisms and
have qualitatively different results. Figure 2.1 provides an illustration of the
different systems along with an example of their qualitative results.
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In what is classically known as an activator-inhibitor system the activator self
activates and induces the production of the inhibitor. The inhibitor however
inhibits the production of the activator. Patterns evolve because an area
of high activator concentration induces a high production of inhibitor. The
inhibitor acts over a wider range than the activator and hence suppresses
activator production in the local neighbourhood of the region of high activator.
In these systems we see patterns arise where the activator and inhibitor are
in phase with one another.
Long range inhibition can be achieved in another fashion typically described as
a activator-substrate or positive-feedback system. Here rather then inhibiting
the activator, the “inhibitor” is a substrate that is required for the production
of the activator. As the activator is produced the substrate is consumed. The
inhibition exists because as the amount of substrate available decreases so
does the rate at which new activator can be formed. In these systems the
resultant patterns have the activator and substrate 180◦ out of phase.
2.4.2 Use of Turing Patterns for Bone Growth Modelling
Recently Turing models have been developed for different aspects of bone
growth. Whilst none of these models focus on intramembranous bone for-
mation, they do provide some evidence that Turing models can be used to
describe some of the patterns that arise during bone growth.
Courtin et al. (1995) created a Turing instability type model for bone mineral
metabolism based on a previously derived compartment model for calcium
metabolism (Staub et al. 1988). This original compartment model was devel-
oped to capture the cyclical circadian nature of calcium concentration in the
blood plasma. Two of the components accounted for this cyclic behaviour and
a new reduced system consisting of just these two species was created. This
reduced system is given in non-dimensional form by
∂Y
∂t
= ∇2Y + γ((k + Y 2)X − (1 + k2)Y ), (2.2)
∂X
∂t
= D∇2X + γ(A− (k1 + k + Y 2)X + k2Y ). (2.3)
The variables X and Y are proposed by the authors to represent diffusible min-
eral precursors amalgams of calcium and phosphate. The parameters A, k, k1
and k2 are all positive rate constants which were determined as part of the
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original compartment model. The parameter D > 1 represents the ratio of
the diffusion coefficients of X and Y .
For suitably large values of D, the resultant stable patterns are similar to
those exhibited by other Turing pattern forming systems. As D increases the
patterns formed transform from hexagonal to striped and return to an inverse
hexagonal pattern.
One interesting aspect of the model is that for the given parameters, in the ab-
sence of diffusion the kinetics do not give rise to a stable steady state. Instead
the steady sate is unstable and is surrounded by an associated stable limit
cycle. This limit cycle means that for small (or no) diffusion coefficients the
behaviour will be a temporally oscillating spatially homogeneous steady state.
As D increases the behaviour in the solutions transitions from the temporally
oscillating yet spatially homogeneous to become temporally steady and spa-
tially heterogeneous. In this transition zone the numerical solutions exhibited
complex spatio-temporal behaviour. When this behaviour was plotted in 3D
by including time as the third dimension the results resembled the structure
of new woven bone as shown in Figure 2.2. This complex behaviour was fur-
ther explored by the authors in a later paper (Courtin et al. 1997). Here the
authors used a circular domain, which gave a cylindrical 3D image in order to
more accurately represent a growing embryonic long bone.
Within the context of bone formation, the paper interprets X and Y as pre-
crystalline calcium-phosphate associations. These associations are free to dif-
fuse throughout the bone extracellular fluid where calcium and phosphate is
super saturated. However a more detailed physical interpretation of these
species is lacking. The link between the patterning in these species and the
resultant bone pattern is hypothesised to be that the difference in chemical
species could result in differences in the rates at which mineral is deposited.
They propose that this effect could either be a direct or indirect response to
the concentration levels, as it is known that cell species respond to the levels
of ionic species.
A different use for Turing models was to identify the location of secondary
ossification centres (Garzo´n-Alvarado et al. 2009b). This is a process that
occurs during developmental bone growth. When endochondral ossification
occurs in a new bone it starts in the middle of the shaft and advances to-
wards the heads. Postnatally as this ossification front approaches the head
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Image removed due to copyright.
Please see Courtin et al. (1995)
Figure 4.
Figure 2.2: 3D plot of complex spatio-temporal behaviour. Here time is used as the third
dimension and the 2D images found are combined to form a structure that
resembles woven bone (Courtin et al. 1995).
a secondary ossification centre is formed in the head. The authors modelled
this by considering cell differentiation of chondrocytes to be driven due to the
concentrations of parathyroid hormone-related peptide (PTHrP) and Indian
hedgehog (Ihh). They used Schnackenberg kinetics to model the relationship
between PTHrP and Ihh. This model was able to identify regions where sec-
ondary ossification was likely to occur for different animals based on bone
head shape.
A similar model from the same authors was used to model long bone growth
(Garzo´n-Alvarado et al. 2009a). This model had more complicated cellular
dynamics but the underlying reaction kinetics of PTHrH and Ihh were the
same. This model was used to simulate the growth of a long bone during fetal
development, due to endochondral ossification. Due to the similarities between
these models and the next model to be discussed (Garzo´n-Alvarado 2013) we
provide only a detailed review of the next model as it specifically relates to
intramembranous bone formation.
Another model proposed by Garzo´n-Alvarado (2013) is for the formation of
primary ossification centres in the membranous neurocranium (part of the
embryonic skull). The primary ossification centres are where the first sites of
ossification occur during the embryonic development of what will become the
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flat bones of the skull. These flat bones form via intramembranous ossification.
The authors identify BMP-2 and noggin as the key regulators of the differen-
tiation of MSCs to osteoblasts. Based on this they propose a model for the
differentiation of osteoblasts as a process regulated by BMP concentrations,
where BMP is itself regulated by its interactions with noggin.
The model used in the paper is described below. They assume that BMP and
noggin have a relationship capable of producing Turing patterns and hence
model their interactions using the well known Schnackenberg kinetics. Little
justification is provided for this choice of kinetics. Additionally Schnackenberg
kinetics are of the type activator-substrate, which seems at odds with the
descriptions of BMP-noggin interactions found in the biological literature.
The equations for BMP and noggin are given by
∂SB
∂t
= C(α1 − µSB + γ0S2BSN ) +DB∇2SB, (2.4)
∂SN
∂t
= C(α2 − γ0S2BSN ) +DN∇2SN , (2.5)
Here SB and SN are the concentrations of BMP and noggin respectively, C is
a constant representing the concentration of MSCs, α1, α2, µ, γ0 are positive
rate constants and DB and DN are the diffusion coefficients for BMP and
noggin.
The paper also provides an equation for the change in osteoblast concentration
due to cellular differentiation. However no simulation results or discussion is
provided for this equation, nor are any parameters provided. The model
assumes that cell differentiation is dependent on both the BMP concentration
and the maturity of cells, with only the more mature cells able to differentiate.
The cell maturation is implemented in the model as a spatial effect, with cells
closer to boundary of the domain representing the Rostral crest assumed to
be more mature then cells further away. This equation for the cells is given
by
∂c0
∂t
= η
SnB
SnB + S
n
T
T ra
T ra + t
r
f(xrel), (2.6)
where c0 is the cell concentration of osteoblasts, η is a rate constant, ST is a
threshold value for BMP, Ta is the time required to perform the differentiation
and tr is the time limit of action of the BMP-2.The function f(xrel) is used
to define the cell maturation as a function of the distance of a point to the
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boundary of the domain, labelled xrel. It is defined as
f(xrel) =
1 xrel ≤ r,0 xrel > r. (2.7)
The equations for BMP and noggin are simulated on the surface of a partial
curved ellipsoidal shape, with the spatial dimensions determined from exper-
imental measurements. Several questions arise from the parameters used in
these simulations. Firstly, the parameters reported as being used in the sim-
ulations for DB and DN are incapable of giving Turing patterns. Some of
the parameters for the model were able to be determined from sources in the
literature, however, like in many other mathematical models of biological phe-
nomenon, this was not possible for all parameters. In this case the authors
chose their parameters such that suitable patterns emerged. A consequence of
this is that the pattern forming process has a characteristic time of 65 weeks.
Clearly this value is unrealistic given that the biological process examined here
is the development of the embryonic skull.
Our approach to building a model for the cellular differentiation bears some
resemblance to the model presented in Garzo´n-Alvarado (2013), however there
are some key differences between the models which address some of the afore-
mentioned problems with the model in Garzo´n-Alvarado (2013). Firstly there
is a difference in the kinetics used in the two models. In our model we build
the kinetics based on the behaviour of the cells and growth factors described
in the literature, as opposed to Garzo´n-Alvarado (2013) where the kinetics
used did not seem appropriate given the biological context. Another feature
of our work presented in this document is that we consider the effect of a
growing domain on the pattern forming ability of the model. This is impor-
tant as during the early stages of fracture healing, the callus grows larger and
it is possible that this callus growth is influencing the pattern formation that
occurs.
2.5 Summary
There is strong evidence that intramembranous bone formation is influenced
by bioregulatory factors such as growth factor concentration. Despite this
most traditional models of fracture healing tend to focus on healing as driven
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by mechanical factors. There does exist some bioregulatory models of fracture
healing. These models are phenomenological and act on the entire callus
scale. As such they do not provide much insight into specific processes that
are occurring during intramembranous bone formation or how these processes
give rise to the structure of the new bone that is observed.
Instead we take the approach of building mathematical models that aim to
provide a more mechanistic understanding of specific processes that occur
during intramembranous bone formation. We focus of two processes, cellu-
lar differentiation and mineralisation of new bone tissue. The differentiation
of stem cells to osteoblasts is controlled by the presence of various growth
factors, which can either increase or decrease the differentiation rate. These
growth factors establish a chemical pre-pattern which then drives the cellular
differentiation
Turing like models have had some success when applied to other aspects of
bone growth and healing. We propose that a Turing like model can be used to
establish a chemical pre-pattern which then drives the cellular differentiation
and mineralisation processes. This will be the basis of a new model for cellular
differentiation as it occurs during intramembranous bone formation in fracture
healing.
We also aim to build a model for mineralisation of new bone tissue. Typically
models of fracture healing consider the production of bone matrix to simply
be a function of the osteoblast population, with no regulation by other growth
factors or molecules. We have identified a regulatory effect of PPi and TNAP
on bone mineralisation that is well established in the literature. However this
regulatory effect has not yet been applied to a mathematical model of new
bone formation in any context. Thus we aim to build a model that investigates
this effect.
30
3A Regulatory Model for Osteoblast
Progenitor Differentiation
One of the first processes that must occur during the intramembranous bone
formation component of fracture healing is the differentiation of osteoblast
progenitors, present in the expanded periosteum, into mature osteoblasts that
can create mineralised bone. Many existing mathematical models of frac-
ture healing propose that this differentiation is regulated by the amount of
mechanical stress or strain that is experienced by the cells (see for example
Lacroix & Prendergast (2002) or Claes & Heigele (1999)) or as a response to
a single chemical species present in the tissue, in and around the fracture site
(Bailo´n-Plaza & van der Meulen 2001, Geris et al. 2006). These models all
focus on the entire fracture callus and demonstrate varying levels of success
at predicting regions in which intramembranous bone formation will occur.
Within the context of intramembranous bone formation we are particularly
interested in the semi-regular pattern that often appears in the newly formed
bone. None of the classical models of fracture healing provide any insight
into how the structure of new intramembranous bone arises. As a first ap-
proach to constructing a model to reproduce this structure we present here
a model that gives rise to a non-uniform distribution of osteoblasts. Whilst
not demonstrated explicitly in this chapter it is expected that regions where a
high concentration of osteoblasts exist will become focal points for new bone
formation. The expectation is then that as time evolves this non-uniform dis-
tribution of nodes of bone formation will give rise to the structure observed
in new intramembranous bone.
In our model we take the approach of considering the differentiation of the
osteoblast progenitors to osteoblasts to be driven by two interacting chemical
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species, bone morphogenetic protein (BMP) known to promote cellular differ-
entiation and its inhibitor, noggin. This approach is similar to that presented
in Garzo´n-Alvarado (2013), however there is a key difference in the underly-
ing reaction diffusion relationship between BMP and noggin. In their paper
Garzo´n-Alvarado (2013) assume that BMP and noggin have an activator-
substrate type of relationship and use the well studied Schnackenberg kinetics
to describe this. The use of these kinetics seems a poor choice when compared
to the current understanding of the interactions of BMP and noggin described
in the biological literature (see (Krause et al. 2011) for example). Furthermore
the authors do not provide any reasoning for the biological relevance of the
chosen kinetics. In contrast as we build a model in which all of the terms are
biologically relevant. This leads to a system where the underlying relationship
between BMP and noggin is of the activator-inhibitor type.
3.1 The Role of BMP and Noggin in Inducing
Cellular Differentiation
During fracture healing most intramembranous bone is formed in regions of
high mechanical stability, directly between the periosteum and the existing
bone. The progenitor cells present in the periosteum proliferate and differen-
tiate to become mature osteoblasts capable of producing bone tissue. Members
of the BMP family have been shown to induce this differentiation.
Much research has been conducted on the role of BMP in regulating this
differentiation process. BMPs were first identified for the role they play in
inducing new bone formation (Urist 1965, Wozney et al. 1988) but it has since
been shown that they play a role in the development and function of other
organs in the body (Chen et al. 2004). Of the many different BMPs only
some induce differentiation of cells to osteoblasts. BMPs 2, 4, 6 and 9 have
been shown to have the strongest effect on inducing osteoblastic differentiation
(Cheng et al. 2003). However of these only BMP 2 and 4 are located within
intramembranous bone (Krause et al. 2011). Also of importance is that both
BMP 2 and 4 have been shown to have a short range of activity (Jones et al.
1996, Ohkawara et al. 2002).
BMP 2 and 4 have both been shown to be expressed during fracture healing
by cells across the osteoblastic linage, from periosteum derived osteoblast
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precursors, to mature matrix producing osteoblasts (Bostrom 1998, Onishi
et al. 1998, Spector et al. 2001). Additionally BMPs are also found within the
extracellular matrix of bone tissue (Yang et al. 1990). It is believed that when
the bone is damaged during fracture healing BMPs are released, subsequently
initiating the response of the cells present in the periosteum (Barnes et al.
1999, Tsiridis et al. 2007).
Like all biological signalling systems, many other proteins can influence the
effect that BMPs have on cellular differentiation. Some proteins like Sonic
Hedgehog (SHH) have a positive effect on BMP signalling (Warzecha et al.
2013), whereas others can inhibit its signalling ability. These BMP inhibitors
can interfere with the signalling on several levels. At the extracellular level,
proteins like noggin, gremlin and chordin can all bind with BMP molecules pre-
venting them from interacting with cell receptors (Zimmerman et al. 1996, Hsu
et al. 1998, Piccolo et al. 1996). At a receptor level, BMP is inhibited by
BAMBI (BMP and activin membrane bound inhibitor). BAMBI is a pseu-
doreceptor located on the cell membrane. To BMPs located in the extracel-
lular space it appears as a normal cell receptor, however it lacks any intracel-
lular component so the BMP signalling pathway is interrupted (Onichtchouk
et al. 1999). Finally BMP can also be inhibited at an intracellular level. These
intracellular proteins interfere with the signalling pathway within the cell and
includes some smads and Smurf (smad ubiquitin regulatory factor) (Dimitriou
et al. 2006, Balemans & Hul 2002).
The BMP inhibitor noggin has been shown to reduce intramembranous bone
formation (Aspenberg et al. 2001, Krause et al. 2011). Noggin was first dis-
covered in the frog species xenopus and is so named because embryos in
which excess noggin synthesis was induced developed large heads (Smith &
Harland 1992). Noggin is an extracellular inhibitor and it inhibits BMP by
binding with it, preventing the BMP from binding with receptors on the cell
(Zimmerman et al. 1996). By doing this, noggin reduces the effect of BMP
present in the system. In osteoblasts, noggin production is induced by BMP
(Gazzerro et al. 1998). This natural feedback loop, where BMP induces noggin
which reduces the amount of BMP, is believed to be an important regulatory
mechanism for bone growth. There is histological evidence that BMP and
noggin are colocalised during fracture healing (Yoshimura et al. 2001). Ad-
ditionally noggin has been shown to have a long spatial range of inhibition
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(Jones & Smith 1998).
The above description provides good evidence that the interactions between
BMP and noggin could be modelled using a activator-inhibitor type of reaction
kinetics. Here BMP induces the production of noggin by osteoblasts but the
presence of noggin reduces the amount of BMP expressed by the osteoblasts.
We also note that a key requirement for Turing pattern formation, as described
in the preceding chapter, the presence of a long range inhibitor and a short
range activator, is met by both BMP and noggin (Jones & Smith 1998, Jones
et al. 1996, Ohkawara et al. 2002)
3.2 Model Formation
We illustrate the previous description of the roles of BMP and noggin on the
regulation of cellular differentiation as a schematic in Figure 3.1. Here we
consider four key components of the cellular differentiation process, two cell
species defined as progenitor cells and osteoblasts and the two proteins BMP
and noggin. At this point it should be mentioned that cellular differentiation
is not a discrete process, that is, a cell is not one type in one moment and
a different type the next. Instead the classification of different cell types is
murky, and there is no set definition for the boundaries for where one cell stage
ends and another begins. In our model we consider the cellular populations
as distinct, as is done in other models of fracture healing (Bailo´n-Plaza &
van der Meulen 2003, Geris et al. 2006). In our classification of relevant cell
types we use the terms progenitor cells and osteoblasts to distinguish the cell
populations. The term progenitor refers to cells derived from the periosteum.
These cells are free to proliferate and are not expressing any of the markers
of osteoblastic differentiation such as alkaline phosphatase (ALP). The cells
referred to as osteoblasts in this model could perhaps be better described as
pre-osteoblasts, at the very least they are not fully mature osteoblasts. These
are cells that are showing signs of osteoblastic differentiation such as increased
expression of ALP, however they are not producing mineralised matrix.
The key feature of the coupled cell and regulatory process to be considered
here is that the progenitor cells differentiate to become osteoblasts, where the
rate of differentiation is increased by the presence of BMP and reduced by the
presence of noggin. We embed this feature into a mathematical model con-
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Figure 3.1: Schematic of the regulation of progenitor cell differentiation to osteoblasts by
BMP and noggin. Solid lines represent a transformation, or production, dashed
lines represent a regulatory effect on the rate of transformation or production.
Differentiation of progenitor cells to osteoblasts increases (+) in the presence of
BMP and is reduced (−) in the presence of noggin. BMP is produced by both
progenitors and osteoblasts, and has an autocatalytic effect on its production
by the latter. Noggin is produced by osteoblasts and the production rate is
upregulated by the presence of BMP.
structed as a system of partial differential equations describing the interaction
and dispersion of progenitor cells (P (x, t)), osteoblast cells (O(x, t)), BMP 2
or BMP 4 (B(x, t)) and noggin (N(x, t)).
The proliferation of the progenitor cell population is modelled as a logistic
growth behaviour. Both progenitors and osteoblasts influence the proliferation
rate and as cell numbers increase the rate of proliferation decreases. The
progenitor cells differentiate to become osteoblasts, the rate at which this
occurs is increased in the presence of BMP and decreased in the presence of
noggin (see Figure 3.1). We note that we do not consider the effect of the
limited lifespan of the progenitor cells as in humans the average lifespan of
progenitor cells is much greater than the time span observed in our simulations
(Stenderup et al. 2003). From this we write the following equation for the rate
of change of the progenitor cells,
∂P
∂t
= λ1P (1− λ2P − λ3O)− ζBP
+N
+DP∇2P, (3.1)
where all of the parameters λ1, λ2, λ3, ζ,  and DP are assumed to be positive
and constant. We can introduce new parameters, ξ = λ1/λ2 which represents
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the intrinsic growth rate of the progenitor cell population, and Pc = 1/λ2
which represents the carrying capacity. We then rewrite the equation as
∂P
∂t
= ξP
(
Pc − P − λ3
λ2
O
)
− ζBP
+N
+DP∇2P. (3.2)
We assume that all progenitor cells are the same size and similarly that all
osteoblasts are that same size, meaning that we can equally think of the car-
rying capacity as a number or density. We then make the further assumption
that osteoblasts and progenitor cells are of the same size as each other, which
implies that λ3 ≈ λ2 and our equation reduces to
∂P
∂t
= ξP (Pc − P −O)− ζBP
+N
+DP∇2P. (3.3)
The constant ζ is the rate of progenitor cell differentiation enhanced by the
concentration of BMP present and diminished by the concentration of noggin.
The parameter  may be interpreted as a measure of the sensitivity of the
retardation of the differentiation process to the presence of noggin. We choose
to model the dispersion of the progenitor cell population as a Fickian diffusion
process as a first approximation, recognising that directed migration processes
such as chemotaxis may also play a role here.
The osteoblast population is assumed to only increase due to the differentia-
tion of the progenitor cells. This assumption is made based on the fact that
the proliferation rate of mature osteoblasts is very slow compared to the time
scale of days which is the time scale of interest (Jee 2001). The death of
osteoblasts is modelled as a simple exponential decay, again as a first approx-
imation. This results in the following equation for the rate of change of the
osteoblasts,
∂O
∂t
= −δO + ζBP
+N
+DO∇2O, (3.4)
where the constant δ is the death rate and the central term on the right hand
side represents the differentiation of progenitor cells to osteoblasts as described
previously. As with the progenitor cells we model cell movement as a Fick-
ian diffusion process, with diffusion coefficient DO, as a first approximation.
Although osteoblasts are generally considered to remain stationary after dif-
ferentiation has occurred, we include a diffusion term in order to increase the
stability of our numerical scheme.
We now turn our attention to the modelling of the two chemical species, BMP
and noggin. BMP is produced by both osteoblasts and progenitor cells. It
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is assumed that there is a constant rate of production by the progenitor cells
but that the rate of production by osteoblasts is increased in the presence of
BMP (Chen et al. 1997), and decreased in the presence of noggin (Gazzerro
et al. 1998). Additionally we assume a constant rate of decay for BMP. We
write the equation for BMP as
∂B
∂t
= αP +
βB2O
σ +N
− ρB +DB∇2B. (3.5)
Here the constant α represents the production rate of BMP by the progeni-
tor cells and the constant β is the rate of production of BMP by osteoblasts
enhanced by the concentration of BMP present and reduced by the concen-
tration of noggin. As is the case for , the parameter σ can be interpreted
as a measure of the sensitivity of the inhibition of BMP production by the
presence of noggin. The parameter ρ is the decay rate for BMP. BMPs are
considered diffusible within the extracellular space (Umulis et al. 2009) and
we model this as Fickian diffusion with diffusion coefficient DB.
We assume that the BMP inhibitor noggin is produced only by osteoblasts
and this rate of production is increased by the presence of BMP (Gazzerro
et al. 1998). We also assume a constant rate of decay for noggin. We write
the final equation for our model as
∂N
∂t
= ηB2O − µN +DN∇2N, (3.6)
where η is the rate of production of noggin by the osteoblasts enhanced by the
presence of BMP and µ is the constant decay rate of noggin. Like BMP, noggin
is diffusible in the extracellular space which we model as Fickian diffusion with
diffusion coefficient DN .
Equations (3.3)-(3.6) represent our full system of equations for our model
cellular differentiation. We rewrite the full system of equations here for com-
pleteness,
∂P
∂t
= ξ(P (Pc − P −O))− ζBP
+N
+DP∇2P, (3.7)
∂O
∂t
= −δO + ζBP
+N
+DO∇2O, (3.8)
∂B
∂t
= αP +
βB2O
σ +N
− ρB +DB∇2B, (3.9)
∂N
∂t
= ηB2O − µN +DN∇2N. (3.10)
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With initial conditions
P (x, 0) = P0(x), O(x, 0) = O0(x), (3.11)
B(x, 0) = B0(x), N(x, 0) = N0(x), (3.12)
and appropriate boundary conditions, to be specified later.
As we are considering cellular differentiation as a precursor to intramembra-
nous bone formation during fracture healing the domain of interest is only a
fraction of the entire fracture callus. To determine the appropriate tempo-
ral and spatial domains for our simulations we used the temporal progression
and geometry of a callus that develops following an ovine (sheep) osteotomy
(Manjubala et al. 2009). Within 2 weeks postoperatively new intramembra-
nous bone has formed. For this new bone to form the progenitor cells must
differentiate to become osteoblasts, and then the osteoblasts can create the
new bone by first producing a collagen matrix and then proceeding to min-
eralise this matrix. The production of a mineralised matrix is not a quick
process and thus it is reasonable to assume that the cellular differentiation is
occurring quickly to allow the other processes to occur. Because of this we
used a time domain of 5 days, and at the completion of this time period we
expect to see a patterning in the cell species. For the chemical concentra-
tions we expect to see the patterning evolve in an even shorter time frame
as the chemical pre-pattern must be first established before patterning can
be observed in the cell populations. For the spatial domain we use a domain
that measures 2 mm in length for the 1D simulations and is 2 mm × 2 mm
for the 2D simulations. This domain size was determined from the geome-
try of a sheep’s fracture callus and represents a portion of the callus where
intramembranous bone formation is taking place.
For the initial series of simulations in this chapter, the initial conditions used
for the cell species are a homogeneous distribution of cells across the domain,
P (x, 0) = P0, O(x, 0) = O0. (3.13)
The initial conditions for the chemical species are then set to their steady
state values, which correspond to the initial cell density. However to initiate
pattern formation a small amount of additive white Gaussian noise is added
to the concentration for BMP,
B(x, 0) = B0 + noise, N(x, 0) = N0. (3.14)
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In this chapter we use zero-flux boundary conditions for all species as a starting
point for analysis of the model. In Chapter 4 we incorporate more physically
realistic boundary conditions.
3.2.1 Non-Dimensionalisation
To non-dimensionalise the system we introduce dimensionless variables
P¯ =
P
Pˆ
, O¯ =
O
Oˆ
, B¯ =
B
Bˆ
, N¯ =
N
Nˆ
, t¯ =
t
tˆ
, x¯ =
x
xˆ
, (3.15)
where the hatted values, Pˆ , Oˆ etc., are to be determined. We substitute these
variables to give,
∂P¯
∂t¯
=
(
ξtˆPˆ
)
P¯
((
Pc
Pˆ
)
− P¯ − Oˆ
Pˆ
O¯
)
−
(
ζtˆBˆ
Nˆ
)
B¯P¯(

Nˆ
)
+ N¯
+
(
DP tˆ
xˆ2
)
∂2P¯
∂x¯2
,
(3.16)
∂O¯
∂t¯
= −(δtˆ)O¯ +(ζBˆPˆ tˆ
OˆNˆ
)
B¯P¯(

Nˆ
)
+ N¯
+
(
DO tˆ
xˆ2
)
∂2O¯
∂x¯2
, (3.17)
∂B¯
∂t¯
=
(
αPˆ tˆ
Bˆ
)
P¯ +
(
βBˆOˆtˆ
Nˆ
)
B¯2O¯(
σ
Nˆ
)
+ N¯
− (ρtˆ)B¯ + (DB tˆ
xˆ2
)
∂2B¯
∂x¯2
, (3.18)
∂N¯
∂t¯
=
(
ηBˆ2Oˆtˆ
Nˆ
)
B¯2O¯ − (µtˆ)N¯ + (DN tˆ
xˆ2
)
∂2N¯
∂x¯2
. (3.19)
Further, we let Pˆ = Pc, Oˆ = Pc, tˆ = 1/(ξPc) and xˆ
2 = tˆDP , and let Bˆ = Bc
and Nˆ = ζBc/(ξPc) where Bc is some value representing the expected magni-
tude of the concentration of B (Geris et al. 2008). We introduce dimensionless
parameters
¯ =
ξPc
ζBc
, δˆ =
δ
ξPc
, α¯ =
α
ξBc
, β¯ =
βPc
ζ
σ¯ =
σξPc
ζBc
, ρ¯ =
ρ
ξPc
, η¯ =
ηBcPc
ζ
, µ¯ =
µ
ξPc
,
D¯O =
DO
DP
, D¯B =
DB
DP
, D¯N =
DN
DP
,
(3.20)
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Parameter Dimensional Units Dimensionless
Value Value
Pc 10
6 cells ml−1
Bc 10
−7 g ml−1
ξ 10−7 ml cell−1 day−1
ζ 0.1 day−1
 10−10 g ml−1 10−3
δ 6× 10−3 day−1 6× 10−2
α 10−11 g cell−1 day−1 1000
β 2× 10−4 ml cell−1 day−1 2000
σ 10−10 g ml−1 10−3
ρ 100 day−1 1000
η 103 ml2 g−1 cell−1 day−1 1000
µ 100 day−1 1000
DP 4× 10−8 cm2 day−1
DO 4× 10−8 cm2 day−1 1
DB 7× 10−4 cm2 day−1 2× 104
DN 2.1× 10−2 cm2 day−1 6× 105
Table 3.1: Table of parameter values used to simulate Equations (3.21)-(3.24). See text for
derivations and references. Non-dimensional values were found using the rela-
tionships presented in Equation (3.20).
and apply these to obtain
∂P¯
∂t¯
= P¯
(
1− P¯ − O¯)− B¯P¯
¯+ N¯
+
∂2P¯
∂x¯2
, (3.21)
∂O¯
∂t¯
= −δ¯O¯ + B¯P¯
¯+ N¯
+ D¯O
∂2O¯
∂x¯2
, (3.22)
∂B¯
∂t¯
= α¯P¯ + β¯
B¯2O¯
σ¯ + N¯
− ρ¯B¯ + D¯B ∂
2B¯
∂x¯2
, (3.23)
∂N¯
∂t¯
= η¯B¯2O¯ − µ¯N¯ + D¯N ∂
2N¯
∂x¯2
. (3.24)
3.2.2 Parameters
The parameters used are listed in Table 3.1. Where possible the parameters
have been based on information from experimental evidence or other mathe-
matical models of fracture healing. However for many of the parameters where
suitable values in the literature are not available the values used are based on
order of magnitude estimates.
The limiting cell density, Pc = 10
6 cells ml−1, was determined based on an
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assumption of a cell volume of 10−6 ml as used in Bailo´n-Plaza & van der
Meulen (2001). To determine the proliferation rate of the progenitor cells we
fitted a logistic growth curve to the data presented in Pratap et al. (2003)
to get ξ = 10−7 ml cell−1 day−1. As it is difficult to quantify the rate of
differentiation of progenitor cells to osteoblasts, ζ = 0.1 day−1 was chosen as
an order of magnitude estimate.
Reported values for the active lifespan of osteoblasts vary between species,
from 12 days in mice (Jilka et al. 1998) to 3 months in humans (Manolagas
2000). However these numbers account for changes in cell numbers due to
differentiation of osteoblasts into osteocytes and bone lining cells, as well as
cell death due to apoptosis. Since our model is focused on the early stages
of intramembranous bone formation, before mineralisation has begun, it is
unlikely that osteoblasts will be lost due to further differentiation. It has,
however, been shown that apoptosis occurs in the periosteal callus during
the early stages of fracture healing (Li et al. 2002), so we assume that all
cell losses are due to apoptosis. To calculate the rate of apoptosis, we use
the prevalence rates observed in histological slices. These prevalence rates
are 0.6% in mice and 0.05% in humans (Jilka et al. 2007). The duration of
apoptosis is approximately 2 hrs, so we take δ = 2.5× 10−4 hr−1 for humans.
One of the key features of this model is that heterogeneities in cellular dis-
tributions can arise due to a difference in the rate of cellular differentiation
at different spatial locations and are not due to cell migration effects such as
chemotaxis. Thus we assume for the purposes of this model that both cell
species move at the same rate and that this cell movement is occurring slowly
with DP = DO = 4× 10−8 cm2 day−1
The typical concentrations of growth factors, like BMP, in serum are around
100×10−9 g ml−1 (Geris et al. 2008). Based on this we take Bc = 10−7 g ml−1.
The half-life for growth factors like BMP are typically short, around 10 mins
(Zhao et al. 2006, Kirsch, Nickel & Sebald 2000), giving ρ = 100 day−1. The
half-life for noggin is similarly short (reported < 30 mins (Glaser et al. 2003))
so we assume that it also has a decay rate of µ = 100 day−1. There are
no reported quantified rates of BMP or noggin production by cells. So we
determine these rate parameters for the chemical species as order of magnitude
estimates. We take α = 10−11 g cell−1 day−1 and β = 2×10−4 ml cell−1 day−1.
The diffusion coefficients for the chemical species BMP and noggin in vivo are
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not well known. Young et al. (1980) adapted the Stokes-Einstein equation so
that diffusion coefficients of a protein in water could be related to the mass
of that protein. BMP has a molecular mass of 26 kDa, using their formula a
value ofDB = 7×10−2 cm2 day−1 was obtained. However diffusion through the
extracellular space is much slower then diffusion through water. Additionally
experimental evidence indicates that BMP 4 has only a short range of action,
within a few cell widths, so we decrease the diffusion coefficient by 2 orders
of magnitude and use DB = 7× 10−4 cm2 day−1. The short range of BMP is
due to its molecular structure which allows it to bind to the ECM restricting
its diffusion through the extracellular space. Noggin has a similar molecular
weight of 25 kDa, however it has been shown to act over a much longer range
than BMP (Jones & Smith 1998). Based on the larger range of action we
make the diffusion coefficient 30 times larger then that for BMP, giving DN =
2.1× 10−3 cm2 day−1.
3.3 Fast Time Scales
One of our underlying hypothesises of this model is that cellular differenti-
ation is driven by a chemical pre-pattern. For spatial patterning in the cell
population it must be that a spatial pattern evolves in the chemical species.
As described in Appendix B, for a Turing pattern to evolve certain conditions
must be satisfied. It is difficult to analyse the full system of four coupled PDEs,
however we observe that the parameters relating to the chemical species are
3 orders of magnitude larger than those for the cellular species. This suggests
that there are two time scales for this problem. A fast time scale that the
chemicals are reacting on and a slow time scale for the cells. From a biological
perspective it would also be reasonable to expect this two time scale behaviour
to exist. Cellular processes such as proliferation and differentiation take place
over days, whereas proteins such as BMP and noggin have half-lives measured
in minutes.
By applying a time rescaling to obtain the fast time system, we can effec-
tively reduce our system to two coupled PDEs for the chemical species, BMP
and noggin, making it much easier to analyse the pattern forming abilities of
our model. Indeed our reduced system bears resemblance to the well-studied
Gierer-Meinhardt kinetics, which are known to produce Turing patterns.
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We perform the time rescaling by letting t¯ = τt∗ with
τ =
ζ
βPc
=
1
β¯
. (3.25)
Noting that τ = O(10−3), and further that δ¯ = O(101), D¯O = O(100),
α¯, β¯, ρ¯, η¯, µ¯ = O(103), D¯B = O(104) and D¯N = O(106). By applying this
rescaling to the non-dimensionalised equations and taking the limit as τ → 0
we get
∂P¯
∂t∗
= 0, (3.26)
∂O¯
∂t∗
= 0, (3.27)
∂B¯
∂t∗
= τ
(
α¯P¯ + β¯
B¯2O¯
σ¯ + N¯
− ρ¯B¯ + D¯B ∂
2B¯
∂x¯2
)
, (3.28)
∂N¯
∂t∗
= τ
(
η¯B¯2O¯ − µ¯N¯ + D¯N ∂
2N¯
∂x¯2
)
. (3.29)
In this reduced fast time system the cell species appear to be at steady state,
however the chemical species are still diffusing and reacting which could lead
to possible pattern formation.
3.3.1 Fast Time Results
We can take the reduced fast time system and solve it numerically to show
that spatial patterns can arise in the chemical concentrations. For these sim-
ulations we used the parameters as listed in Table 3.1. We assumed that the
cell densities of the progenitor cells and the osteoblasts were spatially homo-
geneous. The boundary conditions used were zero flux for all boundaries. By
using these boundary conditions we can isolate the domain from other exter-
nal factors which are typically present and instead focus on understanding the
underlying processes that are occurring. For the initial conditions the steady
state solution to the kinetics without diffusion and with σ¯ = 0 was used. These
initial conditions were used as they are easy to find analytically, furthermore
because σ¯ is small compared to N¯ the error introduced by the assumption
that σ¯ = 0 is small. To initiate the pattern formation a small amount of ad-
ditive white Gaussian noise was added to the initial BMP concentration. The
simulations were carried out on a 1D domain using the MATLAB (Release
2012b) function pdepe with 200 spatial mesh points.
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Figure 3.2: Concentration profiles of (a) BMP and (b) noggin as the solutions to the fast
time system in Equations (3.28) and (3.29). For these simulations the cell density
of progenitor cells and osteoblasts were held constant at P¯ (x, t) = 0.8, O¯(x, t) =
0.2 and all other parameters were as in Table 3.1. Initially (light blue) the
concentrations were almost spatially homogeneous, with B¯(x, 0) = 2.8+noise and
N¯(x, 0) = 1.56. After 3 days (orange dashes) a pattern with a dominant wave
length of 0.4 mm has become apparent. By 4 days (green solid) the amplitude of
the pattern has increased however the dominant wave length has not changed.
By 5 days (dark blue dot dashed) the pattern appears to have become steady.
The first simulation conducted was with P¯ (x, t) = 0.8 and O¯(x, t) = 0.2 chosen
as the steady state values. This gave initial conditions for the concentrations
of BMP and noggin as B¯(x, 0) = 2.8 + noise and N¯(x, 0) = 1.56. The re-
sults for this simulation are shown in Figure 3.2. We observe that by day 3 a
regular pattern has begun to appear in the concentration levels of BMP and
noggin. The patterns for BMP and noggin are in phase, which is an expected
result of the Gierer-Meinhardt equations (Murray 2003). As time progresses
the amplitude of the pattern increases, and after 5 days appears to have be-
come steady, which is illustrated below. We see that the final pattern has a
wavelength of 400µm.
To demonstrate the stability of this steady state we calculated the absolute
change in the solution from time step to time step as
∆B =
∑
i
|B¯(xi, tn+1)− B¯(xi, tn)|, (3.30)
∆N =
∑
i
|N¯(xi, tn+1)− N¯(xi, tn)|. (3.31)
A plot of these changes over time is shown in Figure 3.3. We see that after
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Figure 3.3: Plot showing the total absolute difference between solutions at each time step
for the solution shown in Figure 3.2. The large spike indicates the period in
which the pattern is evolving and hence there is a large change in the solution
at every time step. We see that once this spike has diminished the amount of
change continues to decrease indicating the the steady state found is stable.
the establishment of the pattern, the amount of change in B and N continues
to decrease over time indicating the stability of the pattern.
3.3.2 Turing Parameter Analysis
We can see that our fast time model produces Turing patterns. In Appendix
B we derived a set of conditions that must be satisfied for Turing patterns to
evolve. In this section we use these conditions to provide some analysis on the
range of parameters that will give rise to patterns for the fast time system in
Equations (3.28) and (3.29).
To begin with we briefly repeat the conditions here. For a non-dimensional
reaction-diffusion equation
∂u
∂t
= γf(u, v) +
∂2u
∂x2
, (3.32)
∂v
∂t
= γg(u, v) + d
∂2v
∂x2
, (3.33)
with d > 1, it is possible for Turing patterns to evolve if the following condi-
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tions are true
fu(u¯, v¯) + gv(u¯, v¯) < 0, (3.34)
fu(u¯, v¯)gv(u¯, v¯)− fv(u¯, v¯)gu(u¯, v¯) > 0, (3.35)
dfu(u¯, v¯) + gv(u¯, v¯) > 0, (3.36)
(dfu(u¯, v¯) + gv(u¯, v¯))
2 > 4d(fu(u¯, v¯)gv(u¯, v¯)− fv(u¯, v¯)gu(u¯, v¯)), (3.37)
where u¯, v¯ are the steady state values of u, v for the reaction terms in the
absence of diffusion, i.e. f(u¯, v¯) = 0, g(u¯, v¯) = 0. In addition for physically
realistic solutions to exist the kinetics f and g must have a confined set in the
positive domain.
In our analysis of the pattern forming capabilities of Equations (3.28) and
(3.29) we make some simplifying assumptions. Firstly we assume that the cell
populations are constant with P¯ (x, t) = P¯0 and O¯(x, t) = O¯0. The second
assumption is that σ¯ = 0, since σ¯ is much less then the value of N¯ at the
steady state.
In order to apply the conditions above (Equations (3.34)–(3.35)) we need to
further non-dimensionalise Equations (3.28) and (3.29) to reduce the number
of variables. To do this we rescale the variables as
u =
η¯
β¯
B¯, v =
µ¯η¯
β¯2O¯0
N¯ , t˜ =
τD¯B
L2
t∗, x˜ =
x
L
, (3.38)
where L is the length of the domain. We introduce new parameters
a =
α¯η¯P¯0
µ¯β¯
, b =
ρ¯
µ¯
, γ =
µ¯L2
D¯B
, d =
D¯N
D¯B
. (3.39)
Using these we can rewrite Equations (3.28) and (3.29) as
∂u
∂t˜
= γ
(
a− bu+ u
2
v
)
+
∂2u
∂x˜2
, (3.40)
∂v
∂t˜
= γ(u2 − v) + d∂
2v
∂x˜2
. (3.41)
This is the non-dimensional form identical to that in Equations (3.32) and
(3.33), with
f(u, v) = a− bu+ u
2
v
, (3.42)
g(u, v) = u2 − v, (3.43)
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and it should be noted that this is a non-dimensional form of the standard
Gierer-Meinhardt activator-inhibitor system (Gierer & Meinhardt 1972).
We find the steady state to be
(u¯, v¯) =
(
a+ 1
b
,
(a+ 1)2
b2
)
, (3.44)
and evaluate the partial derivatives of the kinetics at this steady state to give
fu(u¯, v¯) =
b(1− a)
a+ 1
, fv(u¯, v¯) = − b
2
(a+ 1)2
,
gu(u¯, v¯) =
2(a+ 1)
b
, gv(u¯, v¯) = −1.
(3.45)
Since by definition u is the activator of the system and must be self-activating,
it must be that fu(u¯, v¯) > 0 and hence that 0 < a < 1. We can substitute these
partial derivatives into Equations (3.34)–(3.37). The first condition gives the
constraint
b <
a+ 1
1− a. (3.46)
Applying the second condition yields b > 0 which must always be true since
both ρ¯ and µ¯ are positive constants. Applying the third condition gives
b >
a+ 1
d(1− a) . (3.47)
Applying the fourth condition results in the following quadratic in b
d2(1− a)2b2 − 2d(1 + a)(3 + a)b+ (1− a)2 > 0, (3.48)
with roots given by
b1, b2 =
1 + a
d(1− a)2
(
a+ 3±
√
8(a+ 1)
)
. (3.49)
For Equation (3.48) to be true, it must be that b > b1 and b > b2, or b < b1
and b < b2. If we consider the latter case then
b <
1 + a
d(1− a)2
(
a+ 3−
√
8(a+ 1)
)
, (3.50)
which combined with Equation (3.47) gives
a+ 1
d(1− a) <
1 + a
d(1− a)2
(
a+ 3−
√
8(a+ 1)
)
, (3.51)
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Figure 3.4: Parameter space for the possible evolution of patterns for the kinetics given by
Equations (3.32) and (3.33). For it to be possible for patterns to evolve our
parameter choices must lie in a region below the thick solid line and above the
dashed line for the known parameter d.
which can be rearranged and simplified to
1 + a > 2. (3.52)
Clearly this cannot be the case when 0 < a < 1 so it must be that to satisfy
the fourth condition
b >
1 + a
d(1− a)2
(
a+ 3 +
√
8(a+ 1)
)
, (3.53)
and we can see that if this condition is satisfied then the condition given in
Equation (3.47) will also be satisfied.
Thus for it to be possible for a Turing pattern to evolve the following con-
straints on parameters a, b and d must be satisfied
0 < a < 1, (3.54)
1 + a
d(1− a)2
(
a+ 3 +
√
8(a+ 1)
)
< b <
a+ 1
1− a. (3.55)
This parameter space is illustrated in Figure 3.4 for different values of d.
The existence of a confined set in the positive quadrant (u > 0, v > 0) for
generalised Gierer-Meinhardt kinetics was proven in Huang et al. (2007). Since
48
3.3 Fast Time Scales
a confined set for the kinetics without diffusion is also a confined set once
diffusion has been included (Smoller 1994), this ensures that our solutions for
u and v will remain physically realistic.
Influence of Cell Population Levels
We can also examine how changing the assumed value of the cell populations
influences the pattern formation process. This is of interest as when we con-
sider the full system of equations we expect the cell populations to be changing
due to differentiation. Interestingly, when we perform the further nondimen-
sionalisation to give rise to Equations (3.40) and (3.41), the new parameters
a, b, γ and d have no dependence on the size of the osteoblast population O¯0.
Furthermore, since only the parameter a depends on P¯0 it is possible to con-
struct a bound on P¯0 such that patterns can arise. From Equation (3.54) and
the parameters in Table 3.1 we get a bound of 0 < P¯0 < 2. Given these param-
eters Equation (3.48) yields a tighter upper bound to give 0 < P¯0 < 0.86 and
we call P¯0 = 0.86 the critical value of P¯0 for patterns to arise. Since a value
of P¯0 = 1 corresponds to the progenitor cells being at full carrying capacity,
this bound shows that patterns can arise for most physically realistic values
of P¯0.
Whilst the value of O¯0 has no effect on the pattern forming ability of the
system it will have an effect on the final pattern obtained. The inclusion of
O¯0 in the scaling of N¯ (Equation (3.38)) means that changes in O¯0 will change
both the magnitude and average value of the concentration profile of N¯ when
returning to the original system of equations.
Since P¯0 influences the pattern forming ability of the system it is also of inter-
est to see if changing P¯0 has an influence on the dominant spatial frequency
ν of the final pattern. As shown in Appendix B the solution to the linearised
system is given by
w =
∑
k
cke
λ(k)t cos(kx), (3.56)
where w = (u − u¯, v − v¯)T , k is the wavenumber and corresponds to spatial
frequency ν as k = 2piν and λ(k) is the eigenvalue associated with wavenumber
k and is related to temporal growth. A mode with wavenumber k is unstable
if Re{λ} > 0, and the larger λ is, the faster the instability will grow. This
means that the expected dominant frequency of a Turing pattern corresponds
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Figure 3.5: Re{λ} versus spatial frequency ν for different values of P¯0. For the parameters
b = 1, γ = 5000, d = 30 the value P¯0 = 0.86 represents a critical value, values of
P¯0 above this point will never give rise to patterns, whereas values of P¯0 below
this could give rise to patterns. As P¯0 decreases the dispersion curves rise and
a larger range of frequencies become unstable. However we note that for each
of the curves the frequency at which the maximum value of λ occurs does not
change substantially, meaning that the predicted dominant frequency of the final
pattern will be the same.
to the wavenumber for which λ(k) is a maximum, as it will grow the fastest.
In Figure 3.5 we plot the Re{λ} versus the spatial frequency ν for varying
values of P¯0 using the parameters in Table 3.1. We see that as P¯0 decreases,
the range of unstable modes increases, however the frequency at which the
maximum value of Re{λ} occurs does not change significantly.
This is important when considered in the context of the full model. As pro-
genitor cells differentiate the progenitor density decreases. The fact that this
decrease in density is not likely to induce a change in the pattern frequency
allows the frequency of the chemical pattern to remain stable for longer, thus
allowing the chemical patterning to have a greater effect on the cellular pop-
ulations.
Another factor to consider for the full model is that when the progenitor den-
sity is high i.e. greater than the critical value of P¯0 then cellular differentiation
will occur en masse across the domain. As the progenitor cell population de-
creases due to this differentiation it will eventually become low enough to
allow patterning in the chemical species to occur, which in turn will result in
pattering visible in the cell populations.
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3.4 Full System
Observing that it is possible for patterns to evolve in the fast time system and
providing some analysis on the conditions under which this will occur, we turn
our attention to solving the full system as given by Equations (3.7)-(3.10). As
before the parameters used are those given in Table 3.1. We solve this full
system in 1D and then in 2D.
3.4.1 1D Results
For the 1D simulations the boundary conditions used were zero flux for all
species and the initial conditions used were P¯ = 0.8, O¯ = 0.2, B¯ = 2.8+noise
and N¯ = 1.568. A typical solution is shown in Figure 3.6. The 1D system was
solved numerically using the inbuilt MATLAB (Release 2012b) solver pdepe
with 200 spatial mesh points.
After one day the concentration levels for BMP and noggin start to show a
regular pattern, with a very small magnitude. The population levels of the pro-
genitor cells have decreased due to differentiation and the osteoblasts numbers
have increased. However the cell populations are still spatially homogeneous.
After two days the magnitude of the pattern observed in the concentration of
BMP and noggin has grown substantially. By this stage the profile for BMP
appears to have almost reached steady state. For the cellular populations a
regular pattern has started to develop in response to the chemical pattern. The
peaks of BMP increase the differentiation rate, so the profile for the osteoblasts
is in phase with the chemical pattern. Correspondingly, the population of
progenitor cells is out of phase with the chemical pattern.
The spatial heterogeneity continues to grow in the cellular species and we see
that after 5 days the patterning has become much more pronounced. Also as
differentiation is still occurring across the entire domain, albeit at differing
rates we still see a decrease in the average value of progenitor cells and a
corresponding increase in the average value of the osteoblasts.
Despite the changes in the cellular populations we observe that the BMP
concentration profile appears to be approximately stable. Importantly, as
predicted by the Turing pattern analysis, the frequency of the pattern is not
changing so that the peaks and troughs remain in the same location. This al-
lows the slower reacting cellular species to have time to react and differentiate
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Figure 3.6: Results of numerical simulation for the full system in 1D. We see that after 1 day
a pattern is starting to evolve in the chemical concentrations however the cell
populations remain spatially homogeneous. By 2 days the BMP concentration
has almost stabilised, and the cell populations have begun to respond to the
chemical patterning. As time progresses the spatial heterogeneity in the cell
populations becomes more pronounced.
according to the BMP pattern.
In contrast the noggin concentration profile is both increasing in magnitude
and in average value. Again this is consistent with the Turing parameter
analysis. Where an increase in osteoblast numbers was predicted to result in
an increase in both average value and magnitude of the noggin concentration.
We can compare these simulation results to results reported in biological liter-
ature. These simulations were conducted on a domain that is 2 mm long. This
gives a wave length of our pattern of 0.4 mm. This appears to be consistent
with the periodicity of the mineralisation observed in histology (Manjubala
et al. 2009). Whilst our model is not for the mineralisation we would expect
the pattern of cellular differentiation to match the periodicity of the mineral-
isation.
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It is difficult to find experimental data on fracture healing for the very short
time periods for which we are interested. In vitro studies on the effects of
BMP on progenitor cell differentiation show that 3 days after the application of
BMP-2,-6 and -9 there had been a substantial amount of cellular differentiation
to osteoblasts (Cheng et al. 2003). Histology of rat fractures show that cellular
differentiation has occurred by day 2 (Yoshimura et al. 2001). The exact
speed of cellular differentiation in response to BMP signalling is unknown
but it would appear that the results of our model are consistent with the
time frames observed experimentally. Additionally, if we consider the sheep
osteotomy model (see for example (Manjubala et al. 2009)) after 2 weeks
mineralised callus is observable. Cellular differentiation is the first process to
occur and is followed by other processes to give rise to mineralised bone. This
means that for the BMP pre-pattern to be responsible for a cellular pattern,
which then influences the appearance of the new mineralised bone, it must be
that the cellular species are responding to the chemical pre-pattern quickly.
Thus the appearance of patterning in the cell species after 2 days, and growing
stronger quickly as time goes on, supports our hypothesis that an underlying
chemical pre-pattern gives rise to patterning in the cellular species which in
turn effects the structure of new intramembranous bone.
3.4.2 2D Results
Using the same kinetics we also solved the full system on a 2D domain. To find
the 2D numerical solutions a finite volume approach was used for the spatial
discretisation. The time integration was done using the MATLAB (Release
2012b) function ode15s. The results presented in Figure 3.6 were obtained
using 100 mesh points in each dimension. As in the above simulations, zero
flux boundary conditions were used and the initial conditions were P¯ = 0.8,
O¯ = 0.2, B¯ = 2.8+noise and N¯ = 1.568.
There are two noticeable difference between the 1D and 2D results. The first
difference is that in 1D the concentration levels formed a uniform pattern
across the domain, however in the 2D results the peaks are more randomly
scattered rather then forming a uniform pattern. There is still a degree of
patterning in the 2D results. There appears to be a maximum and minimum
distance between peaks, as usually occurs in spot forming Turing patterns.
The final distribution of these peaks is determined by the initial conditions
53
3 A Regulatory Model for Osteoblast Progenitor Differentiation
0 0.05 0.1 0.15 0.2
0
0.05
0.1
0.15
0.2
x (cm)
y
(c
m
)
2 4 6 8 10 12
B (×10−7 gml−1)
(a)
0 0.05 0.1 0.15
0
0.05
0.1
0.15
x (cm)
y
(c
m
)
0.2 0.3 0.4 0.5 0.6
O (×106 cellsml−1)
(b)
0 0.05 0.1 0.15 0.2
0
0.05
0.1
0.15
0.2
x (cm)
y
(c
m
)
(c)
0 0.05 0.1 0.15 0.2
0
0.05
0.1
0.15
0.2
x (cm)
y
(c
m
)
(d)
0 0.05 0.1 0.15 0.2
0
0.05
0.1
0.15
0.2
x (cm)
y
(c
m
)
(e)
0 0.05 0.1 0.15 0.2
0
0.05
0.1
0.15
0.2
x (cm)
y
(c
m
)
(f)
Figure 3.7: Continued on next page.
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Figure 3.6: 2D simulation results showing concentration and cell population profiles for BMP
and osteoblasts. The left column shows the evolution of the BMP concentration
profile and the right column shows the osteoblast profile. The profiles are shown
for t = 0 (top row, previous page), t = 1 day (2nd row, previous page), t = 2 days
(3rd row, previous page) and t = 4 days (this page).
and parameters used. The other major difference between the 1D and 2D
results is the magnitude of the peaks for both BMP and noggin, with the 2D
simulations producing results where the peaks are much larger.
The temporal progression occurs in much the same fashion as for the 1D case.
After 1 day the beginnings of a pattern is detectable in the concentration
levels of BMP and noggin, however at this point the pattern appears to have
a more labyrinth like appearance compared to the spotted patterns appar-
ent at the later time steps. The cell species appear to have mostly changed
homogeneously to this point.
By 2 days the BMP concentration levels appear to have almost reached steady
state and there is a distinct spotted pattern. By this stage the cell population
levels have started to react to the chemical patterning giving rise to an obvious
spatial heterogeneity to the cell populations. As before, the regions of high
BMP, have a faster differentiation rate of cells which gives rise to regions of
high numbers of osteoblasts.
We see that as time continues the overall numbers of osteoblasts continues
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Image removed due to copyright.
Please see Manjubala et al. (2009)
Figure 1(a).
Figure 3.7: Histological section of an ovine tibial osteotomy 2 weeks post surgery showing
the structure of newly formed intramembranous bone (Manjubala et al. 2009).
The black rectangular regions are the pre-existing cortical bone, the irregularly
patterned black material in the regions adjacent to the cortical bone is the new
intramembranous bone. The white region is bone marrow and the pink regions
are fibrous tissue. The spatial frequency of the structure of the new intramem-
branous bone is consistent with the spatial frequency of our simulation results.
to increase, as well as this the difference between the values at the top of
the peaks and the bottom of the troughs is increasing. Like the 1D results
the BMP concentration profile seems to reach a steady state, but the noggin
concentration levels continue to grow due to the changes in the osteoblast
population.
Though difficult, we can make some comparisons between the spatial and
temporal appearance of our results and the appearance of new intramembra-
nous bone seen in histology (see for example Figure 3.7 taken from Manjubala
et al. (2009) or the histological images in Epari et al. (2006)). Our hypothesis
is that the spatially heterogeneous distribution of osteoblasts across the do-
main is a contributing factor to the appearance of the new intramembranous
bone. The spatial frequency observed in our simulation results is consistent
with the spatial frequency observed in the histological sections, supporting
this hypothesis. We also note that like the 1D case the temporal development
of the heterogeneity would appear to be consistent with the experimental re-
sults, with rapid evolution of the spatial patterning allowing time for slower
processes like mineralisation to occur.
We note that our model is only capable of forming spotted patterns and not the
labyrinth like patterns that are sometimes observed in Turing patterns. This
is due to the underlying kinetics of BMP and noggin. The Gierer-Meinhardt
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kinetics will only give rise to labyrinth patterns when activator saturation is
included in the model (Koch & Meinhardt 1994). For our purposes the spotted
formation is sufficient evidence that cellular differentiation could be caused
due to an underlying pattern in BMP and noggin and that the spatial and
temporal appearance of the spots are consistent with histological observations.
However, it may be of interest in future models to include saturation to obtain
labyrinth patterns which may better replicate the structure of new bone.
If we consider the extension of the model to a 3D domain, we would expect
that the spotted pattern observed in 2D would become a pattern of spheres in
3D. This is in agreement with numerical results obtained for Turing pattern
formation using different kinetics (Leppa¨nen et al. 2002). Again if we wished
to recover a interconnected labyrinth like arrangement of osteoblasts then a
change needs to be made to the kinetics of our model. As discussed above
the inclusion of BMP (activator) saturation gives rise to labyrinth patterns
in 2D and it would be expected that upon extension to 3D the labyrinth like
behaviour would persist.
The use of the finite volume method and the lack of advection in our model
means that the implementation of the model in 3D should be a relatively
straightforward task. However the introduction of an additional dimension
will substantially increase the number of nodes in the simulation. This means
that care will need to be taken to ensure that the numerical scheme is efficient
and that memory is managed appropriately.
3.5 Summary
In this chapter we have presented a new model for cellular differentiation as it
occurs during intramembranous bone formation in fracture healing. We began
with the hypothesis that cellular differentiation is guided by a chemical pre-
pattern. From this starting point we built a model with biologically relevant
terms for cellular differentiation of osteoblast progenitor cells to osteoblasts,
where differentiation was dependent on a chemical pre-pattern established
through the kinetics of BMP and noggin.
When considering the fast time dynamics of our system of equations, we
demonstrated that a simplified version of our kinetics for BMP and noggin
is the same as the well studied Gierer-Meinhardt kinetics. In this form it is
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easy to apply standard analysis of Turing patterning processes to define ranges
of parameters for patterning to evolve. This analysis also allowed us some in-
sight into the expected patterning that will result. An important result from
this analysis was that the frequency of patterns in BMP and noggin is not
strongly dependent on the cell density of progenitor or osteoblast cells. This
means that the chemical pattern will be stable even as the cell populations
are changing.
When we consider the full problem we achieved results that appeared to be
consistent with our interpretation of the relevant biology, both spatially and
temporally. Our 2D model indicated that patterning in the cellular species
was apparent after 2 days and a strong pattern was observable after 4 days.
Within the biological context it is important that the cells react quickly to
the chemical pre-pattern, as this would then allow time for the other processes
required for mineralised bone to form. Spatially the distribution of pools of
osteoblasts appeared consistent the spatial frequency observed in the struc-
ture of new intramembranous bone. Thus, our model appears to support our
hypothesis that a chemical pre-pattern gives rise to a heterogeneous distribu-
tion of differentiated osteoblasts and that this distribution could give rise to
the structural appearance of new intramembranous bone.
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Previously we built a model for cellular differentiation of osteoblast progenitor
cells into osteoblasts. We modelled this differentiation process as being de-
pendent on the concentration of two diffusible agents, BMP and its inhibitor
noggin. The underlying reactions of BMP and noggin, along with diffusion,
allowed the evolution of temporally stable, spatially non-homogeneous pat-
terns in their concentration. These patterns in the chemical species induced a
spatial structure in the distribution of cellular differentiation events. Our pro-
ceeding work with this model was confined to a fixed 2D domain. This allowed
us to determine some of the critical reaction parameters, given the appropri-
ate length and time scales. However the simplified domain and boundary
conditions do not provide a good representation of the growing callus during
fracture repair.
During fracture healing the callus grows in a outward direction from the ex-
isting cortical bone. Thus in order for our model to more accurately represent
a fracture healing context we must consider the model on a growing domain.
It is well known that pattern forming mechanisms can be influenced by length
(and time) scales. It is therefore possible that the growth of the callus (and
hence the domain of our model) will have an impact on the pattern forming
ability of our model. Changes in the chemical pre-patterns would influence
the predicted distribution of osteoblasts, which, whilst not part of our model,
would influence the subsequent mineralisation.
As a first step towards simulating our model on a growing domain, we impose
boundary conditions that are more consistent with the context of fracture re-
pair whilst considering a non-growing domain. In this context one boundary
represents the intact cortical bone and the opposite boundary represents the
periosteum. Within this set-up we can observe a moving front of pattern for-
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Figure 4.1: Schematic of the domain between x = 0 and x = Lx, and y = 0 and y = Ly.
The left boundary is adjacent to the pre-existing cortical bone and the right
boundary represents the periosteum. There is a source of BMP released by the
damaged bone surface.
mation, and it is possible to determine the speed of the front of differentiation.
Having established a speed of propagation of the patterning front we then
consider a growing domain. To create a growing domain we then let the
boundary representing the periosteum expand away from the cortical bone,
to simulate the growth of the callus during fracture healing. This allows us to
explore the effect of the domain growth on the cellular differentiation.
4.1 Determining the Wave Speed of Cellular
Differentiation
We begin our exploration of the model on a non-growing domain, however
we introduce boundary conditions which are relevant to the fracture healing
context. We now consider a domain such as that illustrated in Figure 4.1,
where one boundary of the domain represents the intact cortical bone and the
opposite boundary represents the periosteum. It is believed that when the
bone is damaged, BMP stored in the extracellular matrix is released, and that
this release of BMP from the bone helps initiate the fracture healing cascade.
In these simulations we observe that cellular differentiation first begins at the
existing bone surface, and then as time progresses differentiation begins to
occur further and further away from the bone surface. This could be viewed
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as a wave of cellular differentiation across the domain. These simulations,
where the domain is non-growing, allow us to view the natural wave speed of
this front of differentiation. Knowing this wave speed will provide additional
information about the time and length scales involved as we move towards a
model with callus growth.
In this section we continue to use the model described in Chapter 3, however
make appropriate changes to the boundary conditions to better represent the
fracture callus region. For completeness we repeat the non-dimensional form
of the equations here,
∂P¯
∂t¯
= P¯
(
1− P¯ − O¯)− B¯P¯
¯+ N¯
+∇2P¯ , (4.1)
∂O¯
∂t¯
= −δ¯O¯ + B¯P¯
¯+ N¯
+ D¯O∇2O¯, (4.2)
∂B¯
∂t¯
= α¯P¯ + β¯
B¯2O¯
σ¯ + N¯
− ρ¯B¯ + D¯B∇2B¯, (4.3)
∂N¯
∂t¯
= η¯B¯2O¯ − µ¯N¯ + D¯N∇2N¯ . (4.4)
Our domain now describes a region which is bounded by the existing bone
surface on the left and the periosteum on the right. When bone is damaged
it triggers a release of BMP. We model this as a source of BMP at the left
boundary. In addition, we assume that the existing bone is a solid and that
cells cannot migrate into this region nor can noggin diffuse across this bound-
ary. The right boundary represents the periosteum, a membranous material
that normally lies on the surface of bone, however during fracture healing the
periosteum separates from the bone and healing occurs in the region between
it and the bone surface. We assume that cells cannot cross the periosteum and
that it is impermeable to BMP and noggin. We make this choice to highlight
the interior process. It may indeed be possible for these species to cross the
periosteum, however we assume that such flux is not significant. By setting
these boundaries to be no flux we remove any potential exterior influences on
our theoretical study. Similarly, on the top and bottom boundaries we also
use zero flux conditions. We are mostly interested in the behaviour in the
direction of the callus growth and by using these zero flux conditions we can
isolate our domain from further external influences. We assume that the do-
main represents a region that is somewhat removed from the fracture gap and
hence ignore the influence of chemical signals that may be diffusing from the
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haematoma. Thus the boundary conditions used are zero flux for all species
on all boundaries with the exception of
B(0, y, t) = 5× 10−7 g ml−1, (4.5)
on the left boundary x = 0. This concentration of BMP at the boundary
was chosen as it represented a value greater than the initial concentration of
BMP, yet was still within the range of BMP values obtained in the simulations
in Chapter 3. We also note that these boundary conditions are identical to
those used in Chapter 3, with the exception of this source of BMP at the bone
surface.
The initial conditions include a uniform distribution of progenitors across the
domain, with no differentiated osteoblasts. This gives the initial condition for
the cells as
P (x, y, 0) = 0.8× 106 cells ml−1, O(x, y, 0) = 0 cells ml−1. (4.6)
Previously to find the initial conditions for the chemical species we used the
steady state value for the concentrations given the cell density of progenitor
cells and osteoblasts. However there is a degeneracy in Equations (4.3) and
(4.4) when O = 0. To overcome this we take to initial condition for the
chemical species to be the steady state when P = 0.8 × 106 cells ml−1 and
O = 0.01 cells ml−1. This gives the following uniform initial conditions for the
chemical species
B(x, y, 0) = 2.77× 10−7 g ml−1, N(x, y, 0) = 0.077× 10−7 g ml−1. (4.7)
We note that unlike in the previous simulations in Chapter 3 we include no
noise in our initial condition. Instead the BMP source on the left boundary
is sufficient to initiate pattern formation.
4.1.1 Finding the Wave speed in 1D
In the first instance we attempted to measure the wave speed for a 1D domain.
We solved Equations (4.1)-(4.4) with zero flux boundaries for all species except
for BMP, where we introduced a source on the left boundary B¯(0, t) = 5. The
initial conditions were as in Equations (4.6) and (4.7) and all other parameters
used were as listed in table Table 3.1. In order to view the propagation of
the wave over a longer time period, so that the wave speed could be more
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accurately measured, we extended the spatial domain to a length of Lx = 1 cm.
As in Chapter 3, the numerical approach used to solve these equations was the
MATLAB (Release 2012b) function pdepe, a numerical solver for parabolic or
elliptical PDEs in one spatial dimension.
In this chapter we consider a specific set of parameters that we have previ-
ously shown could give rise to patterns across the domain. This is not the
only parameter choice that could give rise to patterning, and in Chapter 3
we discussed some of the factors relating to the parameter space for pattern
formation and the implications of this parameter space on our model. It is
reasonable to expect that a different choice of parameters will give rise to a
pattern formation front with a different wave speed. However we are not in-
terested in establishing the wave speed as a function of these parameters or
in conducting a sensitivity analysis. Rather we wish to determine the wave
speed as a precursor to establishing the phenomenological effect of a growing
domain on our model.
Figure 4.2 shows the evolution of the pattern for the BMP concentration and
osteoblast populations. Initially there is a spatially homogeneous distribu-
tion of all species. The source of BMP at the boundary x = 0 initiates the
formation of a Turing patterning process in the chemical species. As time
progresses the patterning spreads across the domain. We observe that indi-
vidual peaks and troughs remain static and are not moving across the domain,
rather the propagating front represents the division of the domain between a
region where patterning has occurred and a spatially homogeneous region. In
Figure 4.2(b) we see the evolution of the pattern for BMP across space and
time. We see that the velocity of the front appears to remain at a relatively
constant speed of 0.37 cm day−1, and that the frequency of the evolved pat-
tern appears to remain constant. We note that after about 2 days the front of
pattern formation disappears and the pattern evolves uniformly across the re-
mainder of the domain. We remind ourselves that the spatially homogeneous
initial conditions are unstable, due to the Turing-like kinetics for BMP and
noggin. The timing of the appearance of patterning in this region is consistent
with the timing of the evolution of pattern observed in the case of zero flux
boundary conditions and spatially homogeneous initial conditions, such as the
simulations in the previous chapter. Thus the patterning in this region does
not evolve as part of the patterning front, rather in this region the patterns
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Figure 4.2: Concentration and cell density over time for BMP and osteoblasts showing the
front of pattern initiation. (a) Concentration profiles for BMP over time. (b)
Space-time evolution of BMP concentration, the orange line represents the po-
sition of a front moving with speed 0.37 cm day−1. (c) Cell Density profiles for
the osteoblast population over time, as expected we see that osteoblast differen-
tiation lags the BMP patterning process. (d) Space-time evolution of osteoblast
cell density, the orange line represents the position of a front moving with speed
0.37 cm day−1.
simply emerge due to the instability of the initial conditions.
We see that the differentiation of the progenitor cells into osteoblasts follows
the chemical pre-pattern. As expected, the appearance of patterning in the
cells lags that of the chemical species. As the cellular species differentiate at
a slower speed compared to the chemical reactions the front is less defined,
however it seems to travel at a similar speed to the chemical pattern front. We
see that the magnitude of the pattern is larger and that the troughs are lower
near the left hand boundary then near the wave front. Indeed this effect is
apparent even after the patterning has evolved across the entire domain. There
are two causes for this. Firstly, the cells on the left have been exposed to the
chemical pre-pattern for longer, resulting in the larger magnitude. The second,
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is that over time the osteoblast population is increasing due to differentiation,
even in the non-patterned region. The longer it takes for the chemical pre-
pattern to reach a point, the higher the osteoblast population will be at the
commencement of patterning. This, in particular, affects the height of the
trough. Over the course of the simulation the differentiation of progenitors to
osteoblasts always exceeds the death of osteoblasts, thus even in the troughs
the population is still increasing. This means that in regions where there is a
higher level of osteoblasts at the onset of patterning the troughs will naturally
start at a greater height then those to the left.
4.1.2 Finding the Wave Speed in 2D
Having determined the wave speed for the 1D case we now turn to a 2D
domain as illustrated in Figure 4.1. As in Chapter 3 we used the finite volume
method to solve Equations (4.1)–(4.4) numerically. The boundary conditions
used are zero flux for all species on all boundaries except for BMP on the left
boundary, where the condition was B(0, y, t) = 5× 10−7 g ml−1 and the initial
conditions were as in Equations (4.6) and (4.7). A domain size of Lx = 0.2 cm
and Ly = 0.2 cm was used.
In Figure 4.3 we show the distribution of BMP concentration and osteoblast
density at times t = 0.5, 1.2 and 2 days. Looking first at BMP we see that
there are now two fronts of patterning. Initially the BMP source across the left
boundary drives the emergent pattern to appear in vertical stripes. However
these stripes are unstable and over time further evolve to become spots, giving
a second front of patterning. This effect is much more apparent in the profiles
for BMP, however we see for the osteoblasts that by day 2 the stripes are
starting to evolve into spots. We see that this progression from stripes to
spots results in a final pattern where the spots are aligned vertically and
staggered horizontally in adjacent columns.
To determine the wave speed we use a similar approach as for the 1D results.
We took a cross-section of the solution across y = 0.1 cm and used this to form
the images shown in Figure 4.4. This image allows us to clearly see both the
front of the stripe pattern formation as well as the front for the development
of spots in the BMP concentration. We see that the stripe formation spreads
quickly across the domain at a speed similar to that of the 1D case. The spot
formation lags the stripe formation by about a day but the front appears to
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Figure 4.3: Concentration profiles for BMP (left column) and osteoblasts (right column)
showing propagation of the differentiation front. Profiles are shown at times
t = 0.5 days (top row), t = 1.2 days (middle row) and t = 2 days (bottom row).
The pattern first spreads across the domain as a series of stripes, and then further
evolves to a spotted pattern.
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Figure 4.4: Space-time evolution along the line y = 0.1 cm for (a) BMP and (b) osteoblasts.
The orange line indicates the position of a front corresponding to a speed of
0.37 cm day−1. For BMP we see that both fronts appear to travel at this speed.
For the osteoblasts the fronts are less clear, however they appear to also be
travelling at the this speed.
travel at the same speed. For the osteoblasts the stripe formation is clearly
apparent, however the subsequent development of spots is less clear. As was
the case with the 1D simulations the front of cellular differentiation lags the
mineralisation front but still appears to move at roughly the same speed.
Both the 1D and 2D simulations have predicted a speed of the front of dif-
ferentiation of around 0.37 cm day−1. Based on the measurements of an ovine
fracture callus after 2 weeks the callus has grown to a width of approximately
0.5 cm (Manjubala et al. 2009). Thus the speed of the differentiation front is
much faster then the speed at which the callus is growing.
4.1.3 Effect of Partial BMP Source at the Bone Surface
Having established an approximate wave speed of pattern formation we take
a slight detour and turn our attention to a variation of the previous 2D simu-
lations. When bone is damaged BMP is released from the bone extra cellular
matrix into the fracture callus. It is likely that only the bone nearest the
fracture gap sustains enough damage to act as a BMP source.
To include this effect in our model we designate the top of our domain to
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Figure 4.5: Schematic of the domain with a BMP source on the top half of the left boundary.
be nearest to the fracture gap, such that our domain could be considered a
simplified view of the fracture callus as shown in Figure 1.2. We then change
the left hand boundary condition so that only the top half of the boundary
acts as a BMP source, as illustrated in Figure 4.5. The boundary condition
for BMP on the left boundary can be written as
B(0, y, t) = 5× 10−7 g ml−1,
∂B(0, y, t)
∂x
= 0 g ml−1 cm−1,
y > 0.1 cm,
y ≤ 0.1 cm.
(4.8)
All other boundary and initial conditions were as in Section 4.1.2.
The results for these simulations are seen in Figure 4.6. We see that the
initial front has a stripe like appearance but that this very quickly evolves
into a spotted pattern. The initial stripes propagate horizontally along the
top half of the domain but spread in a radial fashion in the bottom half of the
domain. This affects the eventual pattern of the spots. In the top half of the
domain the spots appear to be more regularly distributed in the horizontal
direction, whereas in the lower half the spots are less aligned. The spots of
high osteoblastic differentiation are sites where new bone would be expected
to appear, and the distribution of these spots would influence the spicule
growth that occurs in new intramembranous bone. The distribution of spots
that emerges reflects an aspect of the appearance of new intramembranous
bone in the fracture callus, such as that seen in Figure 4.7. In the regions of
the callus closest to the fracture gap many of the bony spicules appear to be
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Figure 4.6: Concentration profiles for BMP (left column) and osteoblasts (right column)
showing the effect of a source of BMP across the top half of the left boundary.
Profiles are shown at times t = 0.4 days (top row), t = 0.6 days (middle row) and
t = 1 days (bottom row). The pattern no longer emerges with an initial stripe
formation.
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Image removed due to copyright.
Please see Schell et al. (2006) Figure
3.
Figure 4.7: Histological section showing new intramembranous bone formation. The section
is from a sheep, taken two weeks after a tibial osteotomy (Schell et al. 2006).
The black rectangular regions are the pre-existing cortical bone, the irregularly
patterned black material in the regions adjacent to the cortical bone is the new
intramembranous bone. The white region is bone marrow and the pink regions
are fibrous tissue. We can observe that near the fracture gap the spicules are
aligned perpendicular to the existing cortical bone surface, but removed from
the gap they appear to be aligned parallel to the bone surface.
aligned perpendicular to the existing bone surface. Removed from the gap the
spicules align parallel with the bone surface. In between there is a transition
zone where the spicules are not so clearly aligned.
4.2 Extension to Growing Domain
During fracture healing the callus region grows. We now incorporate this
callus growth into the model. In this section we consider that the growth
of the domain is solely due to the proliferation of progenitor cells located at
the periosteum. Our new growing domain is illustrated in Figure 4.8. As
a first approximation we assume that the cells present in the periosteum on
the boundary of the callus are proliferating at a constant rate. Following this
assumption, we model the growth of the callus as occurring at a constant rate
as,
dLx
dt
= ρ. (4.9)
As before on the left boundary, we have a source of BMP and all other species
are zero-flux. On the top and bottom boundaries we have zero flux for all
species. However on the right boundary we change the conditions to reflect
that this boundary represents the periosteum. We assume that at the perios-
teum there is a constant density of progenitor cells, and that there are no
osteoblasts. We also assume that the periosteum is impermeable to BMP and
noggin and model this as zero-flux and the specific form of these boundary
conditions is derived from a conservation of mass argument. This gives the
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Figure 4.8: Schematic of the domain when a moving boundary is considered. The right
boundary at Lx(t), representing the periosteum, moves to the right due to the
proliferation of progenitor cells present at the periosteum.
boundary condition at x = Lx as
P = 0.8× 106, O = 0,
∂B
∂x
= − ρ
DB
B,
∂N
∂x
= − ρ
DN
N.
(4.10)
Converting these boundary conditions to non-dimensional forms using the
relationships in Chapter 3 gives
P¯ = 0.8, O¯ = 0,
∂B¯
∂x¯
=
ρ¯
D¯B
B¯,
∂N¯
∂x¯
=
ρ¯
D¯N
N¯ ,
(4.11)
and the speed of the boundary becomes
dL¯x
dt¯
= ρ¯, (4.12)
where ρ¯ = tˆρ/xˆ.
We use initial conditions as in Equations (4.6) and (4.7) and take an initial
domain width of Lx(0) = 0.02 cm.
4.2.1 Numerical Methods
The inclusion of a moving boundary introduces new challenges in obtaining
a numerical solution. The full details of the numerical scheme are provided
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in Appendix C, but we will provide a short description here. The domain
is rescaled spatially to transform it to a static domain. We then take the
rescaled equations and rewrite them in conservative form. This allows us to
use the finite volume method to perform the spatial discretisation. We note
that the rescaling introduces an advective flux into our system of equations
and we use van Leer flux-limiting to compute the advective terms. We then
use the inbuilt MATLAB (Release 2012b) solver ode15i to perform the time
integration.
4.2.2 Results
The speed of the front of differentiation was previously computed as approx-
imately 0.37 cm day−1, which is much faster than the rate of callus growth.
We initially took the callus growth rate to be a tenth of the speed of the
differentiation front ρ = 0.037 cm day−1. This would result in a total callus
width 0.518 cm after 2 weeks which would seem reasonably consistent with
callus geometry observed in sheep at this time point (Manjubala et al. 2009).
We show the profiles for BMP concentration and osteoblast density at times
t = 1, 3, and 5 days in Figure 4.9. We observe that a Turing pattern does
indeed evolve over time as the domain grows and the resulting pattern fea-
tures rows of spots that are roughly vertically aligned, and that the spots
are staggered in adjacent rows. In Turing patterning processes the domain
size has an influence on the final pattern achieved and in our results we see
that the domain length is the key determinant in the number of rows of spots
apparent.
As usual the patterning in the osteoblasts lags the patterning in the BMP.
This allows the spotted pattern in the BMP to become well established before
significant cellular differentiation can occur. The result of this is that the spots
of high osteoblastic differentiation are well defined, compared to our previous
results with a BMP source on a static domain. This well defined spotted
patterning may help define the form of the new intramembranous bone. New
bone is produced by osteoblasts, so it would be expected that patterning in
the osteoblast population would affect the location and direction of new bony
spicule growth, and hence define the appearance of the new woven bone.
Observing the progression of the BMP concentration we see that in the early
stages the domain is not large enough in the horizontal direction to accommo-
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Figure 4.9: Concentration profiles for BMP (left column) and osteoblasts (right column)
showing the effect of domain growth on cellular differentiation. Profiles are
shown at times t = 1 days (top row), t = 3 days (middle row) and t = 5 days
(bottom row). We see the emergence of well defined spots of osteoblastic differ-
entiation.
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Figure 4.10: Concentration of BMP at times t= 2, 2.1 and 2.2 days demonstrating the evo-
lution of the second column of spots. We see the transient stripe-like structure
which quickly breaks down into individual spots.
date any patterning. Once the domain grows to a sufficient size we see the first
signs of a pattern evolve. As before, the initial patterning appears as a tran-
sient vertical stripe, before evolving into a series of spots. It would perhaps
be reasonable to expect that this is how the rest of the pattern evolution oc-
curred, with a new stripe appearing as the domain grows long enough for it to
fit before further breaking into spots, however this is not what occurs. Instead
the spatial conditions have a further influence of the form of the patterning.
We turn our attention to how the second row of spots evolves, illustrated in
Figure 4.10. Examining the progression along the lower boundary, we note
that the first row of spots does not have a spot on the boundary. As the
domain grows there becomes enough room for a spot to begin to appear in
the lower right corner, before the domain becomes long enough to fit another
stripe. This prevents a second stripe from evolving, instead the second row of
spots forms with the appearance of some shortened stripe-like structures that
are highly unstable and quickly become spots.
As the domain continues to grow each new row of spots evolves in a similar
fashion. An individual spot may evolve if the patterning in the previous row
provides a suitable gap or short stripe-like structures appear and quickly evolve
to become spots. As the stripe like structures are only apparent for a short
period of time, they have little effect on the observed cell differentiation. This
gives rise to the well defined spots in Figure 4.9.
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Effect of Increasing the Rate of Growth of the Domain
Within our modelling framework the growth rate of the domain is related to
the rate of proliferation of the progenitor cells present in the periosteum. It
is of interest to determine how a faster domain growth, due to say increased
cell proliferation would influence the patterning of our model.
To do this we take an extreme case, increasing the rate of domain growth
to match the approximate speed of the patterning front. We set the rate
of domain growth to ρ = 0.37 cm day−1 and all parameters, boundary and
initial conditions were kept the same as in the previous simulations. The
results are shown in Figure 4.11. We observe that with the faster speed of
domain growth the initial pattern again becomes a stripe formation, with the
evolution of spots following. Comparing the final form of the pattern with that
observed in the previous simulations we observe that the horizontal frequency
of the spots appears to be slightly increased with the increased growth rate.
We also observe that with the greater growth rate the spots are now aligned
horizontally rather then the staggered nature seen with the slower growth rate.
4.3 Summary
We have presented a model of cellular differentiation in which we assumed that
the differentiation was due to a underlying chemical pre-pattern. This pre-
pattern was generated through a Turing pattern mechanism. It is well known
that domain size and boundary conditions have a strong influence on the
appearance of Turing patterns, and hence it was of interest to determine the
influence of more physically realistic domain information had on the evolution
of patterning in the cellular species.
By first introducing a source of BMP on the left boundary representing a
release of BMP from the damaged bone we determined that the speed of the
front of differentiation was around 0.37 cm day−1. This speed is much faster
then the expected growth of the callus region.
When our model was then simulated on a growing domain with a growth rate
consistent to that observed experimentally, we observed that a well defined
pattern of spots evolved in the osteoblast population. This was due to the fast
speed of pattern propagation compared to the domain growth rate. As the
chemical patterning spreads quickly throughout the domain it allows for well
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Figure 4.11: Concentration profiles for BMP (left column) and osteoblasts (right column)
showing the effect of an increased rate of domain growth on cellular differenti-
ation. Profiles are shown at times t = 0.5 days (top row), t = 1 days (second
row), t = 1.5 days (third row) and t = 2 days (bottom row). We see that the
stripe formation is again apparent and that the spots are aligned horizontally,
as opposed to the slower domain growth where the spots where staggered.
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defined patterning in the osteoblast population. As osteoblasts are directly
responsible for creating new bone tissue, this patterning in the osteoblast
population could have an effect on the resultant structure of the newly formed
intramembranous bone.
Another interesting result was observed when a source of BMP was only ap-
plied to half of the left boundary. The resultant distribution of the spotted
patterning in the cellular species was in some ways similar to the structural
patterning observed in the new intramembranous bone. This indicates that
the chemical signals released from the bone during trauma, as well as signals
originating from the fracture gap may play an important role in the hetero-
geneity of the structure of the new intramembranous bone.
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5A Mathematical Model for the Mineralisation
of New Bone Tissue
In our overall view of the process of intramembranous bone formation during
fracture healing we consider three separate regions: a proliferative region near
the periosteum were new osteoblast progenitor cells proliferate; a region of cel-
lular differentiation where the progenitor cells differentiate to become mature
osteoblasts in response to a chemical signal; and a mineralisation region where
the newly differentiated osteoblasts act to produce new mineralised bone. In
the previous chapters we have created a model for the cellular differentiation
region and included the impact of the proliferative region, modelled as domain
growth. This model led to a patterned distribution of pools of differentiated
osteoblasts amongst less differentiated cells. The underlying assumption was
that in regions with a high osteoblast population density mineralisation will
occur, and that the spatial distribution of these pools of osteoblasts would
influence the structural form of the new intramembranous bone in the callus.
We now turn our attention to building a mathematical model to examine how
this mineralisation process is regulated.
A common approach used in the bioregulatory models of fracture healing
by Bailo´n-Plaza & van der Meulen (2001) and Geris et al. (2006) is that
the rate of formation of new mineralised bone tissue is modelled as being
proportional to the osteoblast population density, with the rate decreasing
as the local tissue density increases. A similar concept is used in a model
of the bone multicellular unit (BMU) during remodelling, where the rate of
bone formation decreases as the radius of the osteon (Buenzli et al. 2014).
Other similar models take an even simpler approach and model the rate of
bone formation as simply proportional to the osteoblast cell density (Ryser
et al. 2009, Pivonka et al. 2008).
79
5 A Mathematical Model for the Mineralisation of New Bone Tissue
In our modelling of the new bone formation process we aim to take a different
approach. We aim to explore what additional factors may act to be regulating
osteoblast production of new bone. In a model by Moreo et al. (2009) for bone
ingrowth into implants new bone formation was influenced by the presence
of two generic growth factors. They also explicitly tracked the movement
of the bone surface. We take this approach of explicitly modelling the bone
surface, but instead create a mathematical model for bone mineralisation that
considers the influence of the regulatory loop between alkaline phosphatase
and pyrophosphate on mineralisation.
In our model for mineralisation we assume a homogeneous distribution of cells
across the domain. This is in contrast to our previous models for cell differen-
tiation where we demonstrated the potential for heterogenous cell populations
to develop. In this work we simplify to a homogeneous cell population in order
to decouple the development and analysis of the mineralisation model from
the additional complexities that would arise from the inclusion of a hetero-
geneous domain. We recognise that a heterogeneos cell population would be
more physically realistic and discuss some of the difficulties that could arise
and potential approaches to solve them in the Future Work section of this
thesis (Section 6.2).
5.1 Mineralisation of Bone Tissue
Mineralised tissues such as bone and teeth consist of an organic matrix, mostly
formed from collagen, and inorganic mineral crystals which form around the
collagen fibrils. The deposition of the minerals onto the collagen matrix is
known as mineralisation, or sometimes as calcification, because of the high
content of calcium in the mineral. In healthy individuals mineralisation is
confined to bone and teeth and this desired mineralisation is referred to as
being physiological. It is also possible for pathological mineralisation to occur
in other soft tissues such as osteoarthritis where the cartilage present in joints
calcifies, or the calcification of arterial walls. Whilst the mechanisms that
control physiological and pathological mineralisations may not be identical
it is likely that there are some common processes that allow mineralisation
to occur. Thus insights into physiological mineralisation could also provide
insights to pathological mineralisation and vice versa. Whilst we focus on the
mineralisation of bone during fracture healing, many of the ideas discussed
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could be applied to mineralisation as it occurs during bone remodelling or
tooth formation, or even pathological mineralisation.
Bone tissue consists of an organic matrix of mostly collagen that has been
mineralised with crystalline hydroxyapatite. As a composite material bone is
both rigid, due to the presence of mineral, and resistant to fracture, due to
the collagen matrix which increases the toughness (Fratzl et al. 2004). The
organic component of bone is about 90% collagen I, and the rest is other non-
collagenous proteins. These non-collagenous proteins play many roles, includ-
ing assisting in the regulation of the deposition of mineral onto the matrix
(Boskey & Robey 2013). Hydroxyapatite (Ca10(PO4)6(OH)2) crystals form
the mineral component of bone however it contains many mineral impurities
such as magnesium, fluoride and carbonate. As well as providing the stiffness
of the bone, it provides the body with a store of calcium and phosphate that
can be accessed if required (Boskey 2001).
In humans, mineralisation is restricted to bone and teeth. It is commonly
stated that mineral concentrations of calcium and inorganic phosphate (Pi)
are sufficiently high in the extracellular fluid for mineral crystals to form. This
helps explain why bone and teeth don’t spontaneously dissolve but it raises
another question about why our bodies aren’t calcified statues. One contribut-
ing factor to this, that is supported by both in vivo and in vitro experiments,
is that the presence of mineralisation inhibitors prevent pathological mineral-
isation from occurring. For example in mice models, mice without the genes
associated with known mineralisation inhibitors exhibit excessive pathologi-
cal mineralisation, often with fatal results (Murshed et al. 2005). It has also
been observed in humans that mutations in genes related to known inhibitors
can lead to arterial calcification (Rutsch et al. 2003) and osteoarthritis (Suk
et al. 2005). The presence of these mineralisation inhibitors throughout the
extracellular space means that mineral forming cells such as osteoblasts and
odontoblasts (tooth forming cells) must possess mechanisms for removing the
inhibitors from the local environment.
5.1.1 The Role of Osteoblasts in Mineralisation
Osteoblasts, and the osteoblast derived cell type osteocytes, play many im-
portant roles in the initiation and regulation of bone tissue formation and
mineralisation. These include producing the collagen matrix, producing ma-
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trix vesicles to initiate crystal formation and producing enzymes that can
remove mineralisation inhibitors.
Osteoblasts produce and arrange the extracellular collagen matrix of bone.
As the collagen matrix is formed some of the osteoblasts become trapped in
the matrix and become osteocytes. Osteocytes help control and regulate the
subsequent mineralisation of the collagen (Franz-Odendaal et al. 2006).
As the collagen fibres are produced they are arranged in a staggered array.
This array structure is particularly conducive to mineralisation. The gaps
between fibres, known as the hole zones, contain proteins that help attract
and bind mineral ions to the matrix. These hole zones are the first sites
where mineralisation appears, and from here it propagates along the fibres
(Nudelman et al. 2010, Mann 2001).
The deposition of hydroxyapatite crystals in the hole zones of the collagen
matrix is facilitated by extracellular organelles known as matrix vesicles, al-
though the precise nature by which this occurs is unknown. Matrix vesicles
are produced by osteoblasts and immature osteocytes by a budding process
of the plasma membrane (Xiao et al. 2007, Golub 2009). The membrane of
the vesicle contains a high number of calcium pumps, such as annexin II,V,VI
(Kirsch, Harrison, Golub & Nah 2000), which act to increase the local cal-
cium concentration inside the vesicle. At the same time the concentration of
phosphate ions is also increased inside the vesicle via sodium/phosphate co-
transporters (Montessuit et al. 1991, Kirsch 2006). The high concentrations
of calcium and Pi ions inside the vesicle allow small hydroxyapatite crystals
to nucleate and quickly grow. As the crystals grow even larger they even-
tually protrude from the vesicle into the extracellular space and continue to
propagate there.
How the hydroxyapatite crystals contained within the vesicles become at-
tached to the collagen matrix is still unknown. One theory is that when the
vesicles break down, the crystal dissolves and the local extracellular concen-
tration of ions is increased. These ions bind at specific points on the colla-
gen fibres which creates new nucleation points for mineral crystal formation
(Mann 2001). Another hypothesis is that when the crystals are released from
the vesicle they get stuck in the grooves in the collagen fibres, and that pro-
teins present in the collagen and on the vesicle membrane help facilitate this
process (Golub 2010).
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5.1.2 Inhibition of Mineralisation
There is good evidence to suggest that mineralisation throughout the entire
body is prevented by mineralisation inhibitors. In murine studies it has been
shown that the removal of the genes related to known inhibitors results in
excessive pathological mineralisation. Similarly, mice where the osteoblasts
lack the ability to remove these inhibitors have insufficient mineralisation of
bone tissue (Hessle et al. 2002, Harmey et al. 2004).
Two known strong mineralisation inhibitors are pyrophosphate (PPi) and Ma-
trix GLA protein (MGP). MGP is produced by vascular smooth muscle cells
and chondrocytes. It has been shown that mice lacking MGP develop excessive
arterial calcification and mineralisation of cartilage tissues shortly after birth
leading to their death (Luo et al. 1997). MGP is not expressed by osteoblasts
and hence is not likely to be influencing the mineralisation that occurs during
intramembranous bone formation.
The potent mineralisation inhibitor PPi is present in the extracellular fluid
throughout the body (Fleisch & Bisaz 1962, Russell et al. 1971). The proteins
related to the production of PPi are produced by virtually every cell type in
the body, but it is interesting to note that osteoblasts express high levels of
these proteins (Murshed et al. 2005). PPi inhibits mineralisation via at least
2 different mechanisms. One mechanism is that PPi induces osteoblasts to
express osteopontin, a late stage mineralisation inhibitor (Cowles et al. 1998,
Harmey et al. 2004, Johnson et al. 2003, Addison et al. 2007). The other
mechanism is that it binds to sites in the crystal lattice of the hydroxyapatite
that should be occupied by an phosphate ion, which prevents further crystal
growth (Addison et al. 2007). It is for this reason that it is believed that the
ratio of PPi to Pi is a more important determinant of whether mineralisation
will occur rather then the absolute concentrations of either species (Murshed
et al. 2005, Sapir-Koren & Livshits 2011, Terkeltaub 2001). This hypothesis
is further supported by murine models which demonstrate that mice missing
both the genes for PPi expression and proper phosphate regulation have an
almost normal level of mineralisation, whereas mice missing just one of these
genes suffer severe mineralisation defects (Murshed et al. 2005).
83
5 A Mathematical Model for the Mineralisation of New Bone Tissue
5.1.3 Alkaline Phosphatase
Alkaline Phosphatase (ALP) is an enzyme that removes the phosphate group
from molecules (Milla´n 2006). As the name suggests ALP is most effective in
an alkaline environment (Fernley & Walker 1967, Holtz & Kantrowitz 1999).
Substrates of ALP include adenosine triphosphate (ATP) and PPi, although
there are many others (Rezende et al. 1994). In humans there are four isozymes
of ALP, however only one of these is relevant to bone repair. Osteoblasts pro-
duce the tissue non-specific form of ALP. Tissue non-specific ALP (TNAP) is
also expressed in other tissues including the liver and kidneys (Milla´n 2006).
TNAP exists in forms that are either bound to cell membranes or freely cir-
culating. During bone formation the majority of TNAP is bound to the cell
membrane of osteoblasts (and mineralising chondrocytes) and their matrix
vesicles. Whilst free circulating TNAP will be present during bone repair,
in healthy individuals the membrane bound TNAP is the main influence on
mineralisation (Murshed et al. 2005).
The role of TNAP in mineralisation is to remove the mineralisation inhibitor
PPi. It has been demonstrated that osteoblasts that have been exposed to
PPi express higher levels of TNAP indicating a regulatory loop exists to keep
PPi levels in check (Addison et al. 2007). A beneficial side effect of this is
that when TNAP acts on PPi, it also raises the local Pi concentration. This
new Pi can then be incorporated into the growing HA crystals.
5.2 A Model for Mineralisation
The regulatory loop between TNAP and PPi during the mineralisation of
tissue has been well studied in both in vitro cell assays and in vivo animal
models. This has led to widely stated theory that the removal of PPi by TNAP
is a large contributing factor to bone mineralisation occurring. Furthermore
to the best of our knowledge there has been no mathematical modelling of
this system. For this reason we choose to build a mathematical model that
examines the relationship between TNAP and PPi. It has also been indicated
that the concentration of PPi in the extracellular fluid is of a lesser importance
than its ratio with Pi. Thus we have included the concentration of Pi in our
model as well.
The model that we present focuses on a particular aspect of new bone forma-
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tion specifically how TNAP, PPi and Pi interact to form an environment that
is conducive to new mineral formation. At this stage in the development of
the model we choose to ignore changes in cell populations, including the dif-
ferentiation of osteoblasts to osteocytes, but are aware that these populations
would have an effect on the speed at which mineralisation occurs, following
from this we refer to all mineralising cells as osteoblasts for simplicity. In
addition, we ignore the production of the collagen matrix and instead assume
that the osteoblasts have produced a suitable collagen matrix that can be
mineralised.
Furthermore, we ignore the effects of calcium in driving mineralisation. Cal-
cium forms a major part of the mineral component of bone and as such plays
an important role in mineral formation. However calcium homeostasis is also
very important to many other systems within the body and hence is very
tightly regulated through a series of mechanisms (Peacock 2010). This makes
it very difficult to experimentally determine the effect of circulating calcium
levels on mineralisation. Instead the influence of Pi on mineralisation has
been far more widely studied both in vivo and in vitro due to the availability
of suitable mouse models. Indeed it is curious to note that mineralisation is
achieved in vitro by the addition of a phosphate source to the medium, rather
than additional calcium (Birch & Wright 2013). We also note that the effect
of calcium ion concentration was considered by Carlier et al. (2011), where the
authors presented a modified version of the bioregulatory model for fracture
healing presented in Geris et al. (2006).
In Figure 5.1 a diagram of the relationship between TNAP, PPi and Pi is
shown. In this figure we illustrate the key processes occurring that we aim
to model. The mineralisation inhibitor PPi is produced by the osteoblast.
The osteoblast also produces the enzyme TNAP bound to its cell membrane.
The TNAP cleaves the PPi removing the inhibitor. Additionally as the PPi
is cleaved it results in two new Pi ions. Thus the cleaving action of TNAP
both lowers the levels of inhibitor and raises the levels of Pi ions. A further
description of these mechanisms is given below.
The mineralisation inhibitor PPi is present in the extracellular fluid. Its pres-
ence in the extracellular space is regulated via two separate mechanisms within
the osteoblasts. It is created internally within the cell and exported into the
extracellular space via the ANK protein. It is also produced externally of the
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Osteoblast
PPi produced inside
the osteoblast and
exported into the
extracellular space
PPi is cleaved
by TNAP giving
rise to Pi
Figure 5.1: Illustration of the relationship of PPi and TNAP. The mineralisation inhibitor
PPi (orange circles) is produced by osteoblasts and deposited into the extra-
cellular space. The membrane bound protein TNAP (blue squares) cleaves the
inhibitor PPi, giving rise to extra Pi (green triangles). This additional Pi can
be incorporated into the new hydroxyapatite crystals.
cell via the NPP1 protein embedded in the osteoblast cell membrane (Harmey
et al. 2004, Terkeltaub 2001).
In order for mineralisation to proceed the PPi needs to be removed from
the extracellular fluid. In bone formation this occurs through the actions of
TNAP which cleaves the PPi. TNAP is found both freely circulating in the
extracellular fluid and bound to the cell membrane of osteoblasts, however
in the context of bone formation in healthy individuals the membrane bound
TNAP is believed to play the dominant role (Murshed et al. 2005).
The removal of PPi by TNAP plays another important role other than the
removal of an inhibitor. As the PPi is cleaved it gives rise to Pi. This raises
the local concentration of Pi which can be incorporated into the growing hy-
droxyapatite crystal.
5.3 Kinetic Equations
We begin by constructing a set of kinetic equations to describe the relation-
ship between TNAP, PPi and Pi. We introduce the variables A for TNAP
(tissue non-specific Alkaline phosphatase), P for PPi (Pyrophosphate – the
mineralisation inhibitor) and I for Pi (Inorganic phosphate). At this stage of
the modelling process we are interested in establishing the kinetic equations
that describe the relationship between our three chemical species. We ignore
spatial effects, such as diffusion and the influx or outflux of PPi and Pi as they
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freely circulate through the extracellular fluid. Doing this allows us to focus
on the osteoblastic regulation of TNAP,PPi and Pi concentration levels.
TNAP is produced by osteoblasts and remains bound to the cell membrane.
There is evidence that cells cultured with increased PPi have an increase in
TNAP gene expression and activity (Addison et al. 2007). In addition we
assume that TNAP has a constant rate of decay. Based on this we write an
equation for TNAP mass concentration as
dA
dt
= αO + βAPO − δA. (5.1)
Here O represents the cell density of osteoblasts, and for this model we assume
that the osteoblast population is not changing and hence that O is a constant.
The parameter α is the baseline rate of production of TNAP by the osteoblasts,
β is the rate of production of TNAP by the osteoblasts as increased by the
presence of TNAP and PPi and δ is the decay rate of TNAP.
Pyrophosphate is produced by all cells in the body as a by-product of res-
piration and through other processes. Interestingly mineralising osteoblasts
produce PPi at a rate greater then other cell types (Murshed et al. 2005). We
model the production of PPi by cells as a constant production by osteoblasts.
It is widely assumed that ALP is a Michaelis-Menten like enzyme (Ciancaglini
et al. 2010), thus we use a Michaelis-Menten type reaction to model the en-
zymatic cleaving of PPi by ALP. In addition there is evidence that Pi is also
a competitive inhibitor for this reaction (Cyboron et al. 1982). We write the
equation for the molar concentration of PPi as
dP
dt
= ηO − kcatAP
KM
(
1 + IKI
)
+ P
, (5.2)
where η is the production rate of PPi by osteoblasts. The remaining parame-
ters kcat,KM ,KI follow the standard definitions of Michaelis-Menten kinetics.
The turnover number kcat is the maximum number of substrate molecules
cleaved per enzyme molecule per second. The Michaelis constant KM is the
concentration of substrate at which the reaction rate is half the maximum rate
in the absence of inhibitor. The final parameter is the inhibition constant KI .
For the phosphate equation we simply model the concentration changes due to
the cleaving action of ALP. As the PPi is cleaved two Pi ions are created. In
this model we assume that the effect of cell phosphate consumption or produc-
tion, and the removal of Pi as it becomes incorporated in the hydroxyapatite
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Parameter Value Units Dimensionless Value
O 106 cells ml−1
δ 0.36 day−1 0.36
kcat 51.84× 10−3 mol g−1 day−1 518.4
KM 150× 10−9 mol ml−1 150
KI 23× 10−9 mol ml−1 0.023
A0 30× 10−6 g ml−1 3
P0 1.8× 10−9 mol ml−1 1.8
I0 1.15× 10−6 mol ml−1 1.15
Table 5.1: Table of parameters for mineralisation model.
crystal is negligible. Thus the equation for the molar concentration of Pi was
given as
dI
dt
= 2
kcatAP
KM
(
1 + IKI
)
+ P
. (5.3)
The initial conditions are
A(0) = A0, P (0) = P0, I(0) = I0. (5.4)
Here we choose A0, P0, I0 to be values within the normal serum range for these
species. We assume that before t = 0 the cells are not mineralising and all
species are at there normal levels. At t = 0 the cells become mineralising cells
and begin producing high levels of ALP and PPi as observed in mineralising
cell cultures.
5.4 Parameter Values for Kinetic Model
Like many biological problems to which mathematical modelling is applied,
some of the parameters can be found or estimated from the literature whereas
for others this was not possible. In this model we were able to find or esti-
mate all of our parameters from the literature except for three, α, β and η,
which relate to the production of TNAP and PPi by the cells. The remaining
parameters are listed in Table 5.1 and we detail below how they were obtained.
As with our model for cellular differentiation, we assume a carrying capacity
for the cells of 106 cells ml−1 (Bailo´n-Plaza & van der Meulen 2001), and fur-
ther assume that the cells are densely packed with O = 106 cells ml−1. The
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decay rate δ was found from the half-life of the protein. TNAP is reported to
have a half-life of 2 days, this corresponds to δ = 0.35 day−1 (Milla´n 2006).
Next we determine the parameters for the equations for PPi and Pi. The
Michaelis-Menten kinetic parameters were found in the literature for puri-
fied mouse TNAP at physiological pH and temperature (7.4 and 37◦C). The
values reported were kcat = 51.91 ± 0.65 × 10−3 mols (g protein)−1 day−1
and KM = 0.15 ± 0.4 × 10−6 mol ml−1 (Ciancaglini et al. 2010). Thus in
our simulations we take kcat = 51.91 × 10−3 mols (g protein)−1 day−1 and
KM = 0.15 × 10−6 mol ml−1. The inhibition constant is reported to have
values in the range KI = 18− 26.6× 10−9 mol ml−1 (Cyboron et al. 1982). In
our simulations we use a mid-range value of KI = 23× 10−9 mol ml−1.
Finally we are left to determine the initial conditions for our model. As
stated previously, it is intended that the initial conditions be representative of
normal serum conditions experienced by non-mineralising cells. This allows
us to observe the changes in the concentrations as induced by the mineral-
ising cells. Standard serum concentrations of PPi and Pi are readily avail-
able in the literature. The serum concentration of PPi in healthy humans is
within the range 0.64-2.96×10−9 mol ml−1 (Psychogios et al. 2011). The serum
concentration of Pi is 0.8-1.5×10−6 mol ml−1 (Boron & Boulpaep 2003). Us-
ing this data we choose the initial conditions P0 = 1.8 × 10−9mol ml−1 and
I0 = 1.15× 10−6mol ml−1.
The concentration levels of TNAP were far harder to estimate. From the
parameter kcat we know the rate at which a mole of substrate is cleaved per
minute per gram of enzyme. Since we model PPi as a molar concentration
(mol ml−1), we choose to model TNAP as a mass concentration (g ml−1).
Unfortunately in experimental models TNAP concentration is not measured.
Instead it is common to measure the TNAP activity level, i.e. the rate at
which a substrate (typically pNPP) is cleaved by the TNAP present. Another
common measure is the TNAP mRNA expression. Using the data in Chang
et al. (2006) human MSCs that were cultured in a mineralisation medium
had an average TNAP activity of 1.15×10−13 mol pNPP cell−1 min−1 after 9
days of culture. The control cells which were not cultured in a mineralisa-
tion medium and hence did not produce a mineralised matrix had a TNAP
expression of 0.36×10−13 mol pNPP cell−1 min−1. The rate at which pNPP
is cleaved by purified TNAP was found to be 1.2× 10−3 mol pNPP min−1 g−1
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(Sima˜o et al. 2007). Furthermore we make the assumption that our cells are at
a density of 106 cells ml−1. This gives an approximate TNAP concentration of
95.8×10−6 g ml−1 for a population of mineralising cells and 30×10−6 g ml−1 for
a population of control cells. It is desired that our initial conditions reflect a
population of non-mineralising cells, and hence we take A0 = 30×10−6 g ml−1.
We note however that the level of TNAP for the mineralising cells is useful
for comparison to our results.
At this stage there are still 3 unknown parameters, α, β and η. We use the
known parameters to rescale Equations (5.1)–(5.3) and make some simplifying
assumptions based on the magnitude of some of the terms. This leads to a
reduced system that is easier to analyse and allows us to determine some
approximate bounds on the unknown parameters.
5.5 Rescaling the Kinetic Equations
Observing the initial conditions we see that there is a large difference in the
magnitude of the different species. The sensible approach at this stage is to
rescale our equations so that the variables have a magnitude of O(1).
We introduce new dimensionless variables
A¯ =
A
Aˆ
, P¯ =
P
Pˆ
, I¯ =
I
Iˆ
, t¯ =
t
tˆ
, (5.5)
and let Aˆ = 10−5, Pˆ = 10−9, Iˆ = 10−6 and tˆ = 1. Substituting these new
variables into Equations (5.1)–(5.3), leads us to introduce new dimensionless
parameters
α¯ =
αOtˆ
Aˆ
, β¯ =βOPˆ tˆ, δ¯ = δtˆ,
η¯ =
ηOtˆ
Pˆ
, k¯cat =
kcatAˆtˆ
Pˆ
, K¯M =
KM
Pˆ
, K¯I =
KI
Iˆ
.
(5.6)
The non-dimensionalised values for these parameters is given in Table 5.1.
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Using these dimensionless parameters we can rewrite Equations (5.1)–(5.3) as
dA¯
dt¯
= α¯+ β¯A¯P¯ − δ¯A¯, (5.7)
dP¯
dt¯
= η¯ − k¯catA¯P¯
K¯M
(
1 + I¯
K¯I
)
+ P¯
, (5.8)
dI¯
dt¯
= 2× 10−3 k¯catA¯P¯
K¯M
(
1 + I¯
K¯I
)
+ P¯
. (5.9)
With rescaled initial conditions
A¯(0) = A¯0, P¯ (0) = P¯0, I¯(0) = I¯0. (5.10)
From this point we can make two observations. The first is that the rate of
change of Pi is at least three orders of magnitude smaller than the rate of
change of PPi or less obviously TNAP. The second relates to the denominator
in the Michaelis-Menten term. The rescaled parameter K¯M = O(102) and
the term I¯/K¯I = O(102). Thus in the denominator K¯M
(
1 + I¯/K¯I
)  P¯
and we neglect the term P¯ in the denominator and can rewrite the system of
equations as
dA¯
dt¯
= α¯+ β¯A¯P¯ − δ¯A¯, (5.11)
dP¯
dt¯
= η¯ − k¯catA¯P¯
K¯M
(
1 + I¯
K¯I
) , (5.12)
dI¯
dt¯
= 2× 10−3 k¯catA¯P¯
K¯M
(
1 + I¯
K¯I
) . (5.13)
This reduction now leaves the Michaelis-Menten term in the form typically
used in the biological literature when discussing the action of TNAP on PPi.
5.6 Determining the Unknown Parameters
The parameters α¯, β¯ and η¯ are still yet to be determined. To determine
these parameters we make some assumptions about the expected behaviour
of our system under different circumstances. We consider the difference be-
tween osteoblasts that are actively involved in producing mineralised bone
and osteoblasts that are not producing bone tissue. In the latter case we as-
sume that the osteoblast population can be characterised by having a value
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of β¯ = 0. This could represent a pool of immature osteoblasts that are not
yet capable of producing mineralised bone. In this case the osteoblasts are
only producing the baseline levels of TNAP, but are not producing the extra
TNAP required to reduce PPi levels so mineralisation can occur. We remind
ourselves that the initial conditions to be used in our model were determined
to represent a population of non-mineralising cells. So we would expect that
when β¯ = 0 the behaviour seen in our system is that the stable concentration
levels for TNAP and PPi do not vary wildly from the values determined as
the initial conditions. We would also expect that this steady state would be
recovered even if different initial conditions were used. In particular, if a low
initial condition was used for the PPi concentration that it would recover to
relatively high steady state value and inhibit mineral formation.
In the case of actively mineralising osteoblasts we assume that this cell pop-
ulation has a non-zero value of β¯. In these cell populations we expect that
the concentration of TNAP will increase and stabilise at a high level and that
the concentration of PPi will decrease and stabilise at a low level so that min-
eralisation will no longer be inhibited. Importantly this behaviour needs to
be able to occur from an initial condition where TNAP is relatively low and
PPi is relatively high, representing the commencement of mineralisation in a
region where mineralisation was previously not occurring.
To begin our analysis to determine the unknown parameters we simplify our
model to two species. As mentioned previously, in Equations (5.11)–(5.13) the
rate of change of Pi is much smaller then the rate of change of TNAP and PPi.
Thus we make the assumption that Pi has a constant value of I¯ = I¯0. We can
further non-dimensionalise this system to reduce the number of parameters.
We introduce new variables,
u =
δ¯
α¯
A¯, v =
δ¯
η¯
P¯ , τ = δ¯t¯, (5.14)
and introduce parameters
a =
β¯η¯
δ¯2
, b =
α¯k¯cat
δ¯2K¯M
(
1 + I¯0
K¯I
) . (5.15)
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du
dτ = 0
dv
dτ = 0
v
u
(1, 1b )
Figure 5.2: Phase plane for the Equations (5.18)–(5.19). The steady state at (u, v) = (1, 1/b)
is a stable node.
This gives the following non-dimensional equations for u and v
du
dτ
= 1 + auv − u, (5.16)
dv
dτ
= 1− buv. (5.17)
5.6.1 Non-Mineralising Osteoblasts
In the case of non-mineralising osteoblasts we make the assumption that β¯ = 0.
In our non-dimensionalised model this gives a = 0 and Equations (5.16) and
(5.17) reduce to
du
dτ
= 1− u, (5.18)
dv
dτ
= 1− buv. (5.19)
We can draw a phase plane for this system and this is illustrated in Figure 5.2.
By inspection of the phase plane we see that there exists only one steady state
and that this steady state will always be in the positive quadrant. The steady
state occurs at (u, v) = (1, 1/b) and can be shown to be a stable node.
Based on the behaviour observed in non-mineralising cells we want the kinet-
ics for β¯ = 0 to have a steady state where TNAP is low and PPi is high.
To determine appropriate bounds on α¯, β¯ and η¯ we need to introduce some
approximate quantitative bounds on TNAP and PPi concentrations. We de-
fine a low range of TNAP to be 1 < A¯ < 5 and a high range for PPi to be
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η¯
α¯
δ¯ 5δ¯
14k¯
0.8k¯
Figure 5.3: Parameter space for α¯ and η¯. The shaded range of values should give results
that replicate the behaviour of non-mineralising cells.
0.8 < P¯ < 2.8, this range of concentration for PPi is essentially the range of
concentration observed in normal human serum.
Working backwards from the steady state u = 1, we have that the correspond-
ing steady state in the original system is A¯ = α¯/δ¯. Thus the range of values
for α¯ that will give rise to a low concentration of TNAP is
δ¯ < α¯ < 5δ¯. (5.20)
We can use a similar process to determine the range of acceptable values for
η¯. To achieve a high steady state value of PPi it must be that
0.8
k¯α¯
δ¯
< η¯ < 2.8
k¯α¯
δ¯
, (5.21)
where
k¯ =
k¯cat
K¯M
(
1 + I¯0
K¯I
) . (5.22)
We illustrate this region for the parameter values given in Table 5.1 in Fig-
ure 5.3.
5.6.2 Mineralising Cells
We now extend this process to consider cells that have responded to an ap-
propriate biological signal and are producing mineralised bone. We model
this by setting the parameter β¯ 6= 0 or equivalently a 6= 0. The phase plane
for Equations (5.16) and (5.17) is given in Figure 5.4. The phase plane shows
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du
dτ = 0
dv
dτ = 0
v
u
(a+bb ,
1
a+b)
1
a
Figure 5.4: Phase plane for the Equations (5.16)–(5.17). There is a single stable steady state
at (u, v) = ((a+ b)/b, 1/(a+ b)).
again there is only one steady state and that this steady state is in the positive
quadrant. This steady state is located at
(u, v) =
(
a+ b
b
,
1
a+ b
)
, (5.23)
and is always stable but may be a node or a spiral dependent on the values of
a and b.
For mineralising cells we expect that the concentration of TNAP will be high
and that the concentration of PPi will be low. Again we define some threshold
values to determine an appropriate range for the parameter β¯. For TNAP to
be high we want a steady state value of 6 < A¯ < 10 and for low PPi we want
a steady state value of P¯ < 0.5.
Following the same process used to determine α¯ and η¯ we can find the following
constraints on β, (
6δ¯ − α¯)k¯
η¯
< β¯ <
(
10δ¯ − α¯)k¯
η¯
, (5.24)
and
β¯ >
η¯δ¯ − 0.5α¯k¯
0.5η¯
. (5.25)
The lower and upper bound on β¯ for the parameters given in Table 5.1 is
shown in Figure 5.5.
An interesting observation that can be made is that above the line η¯ = 5k¯
the estimated upper bound on β¯ is lower then the lower bound. This intro-
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Figure 5.5: Parameter space for β¯. The lower bound is in (a) and the upper bound is in (b).
The dashed orange line represents the bound η¯ = 5k¯
duces an additional constraint on the parameter choices, η¯ < 5k¯. We also
observe through experimentation with differing parameter choices that pa-
rameter choices from the lower left hand corner of the parameter space tend
to have unrealistic properties. The behaviour of the TNAP concentration, for
example, rises then falls rapidly to form a very tall sharp peak.
We can take the information above as well as the constraints in Equations
(5.20)–(5.21) to come up with some possible ranges for the parameters α¯ and
η¯. Using the parameter values given in Table 5.1 we estimate that
0.36 <α¯ < 1.8, (5.26)
0.1 <η¯ < 0.34. (5.27)
It is much harder to define even an approximate range of potential values
for β¯, as this parameter is highly dependent on the choice of α¯ and β¯. For
example with α¯ = 0.36 and η¯ = 0.1 the range of potential β¯ values is 1.2 <
β¯ < 2.1, however with α¯ = 1.8 and η¯ = 0.33 the range of potential β¯ values is
0.35 < β¯ < 0.37.
For the simulations in the following sections we choose to use mid-range values
for α¯, η¯ and β¯. Thus we choose α¯ = 1.08, with this choice of α¯ then the range
of potential η¯ values is 0.16 < η¯ < 0.33. Again taking the mid-point we obtain
η¯ = 0.25. Finally using these values of α¯ and η¯ gives a potential range for β¯
of 0.43 < β¯ < 0.68. Once again we take the midpoint giving β¯ = 0.56. These
parameter ranges and values are summarised in Table 5.2.
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Parameter Range Value Used
α¯ 0.36–1.8 1.08
η¯ 0.16–0.33 0.25
β¯ 0.43–0.68 0.56
Table 5.2: Non-dimensional values for parameters α¯,η¯ and β¯ as used in simulations.
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Figure 5.6: Concentration profiles for (a) TNAP, (b) PPi, (c) Pi and (d) the ratio of PPi to
Pi. The parameters used in these simulations were as listed in Tables 5.1 and
5.2
5.7 Results and Discussion
Using the rescaled Equations (5.7)–(5.9) we simulated our model. The pa-
rameters and initial conditions were as given in Table 5.1 and Table 5.2. We
used the inbuilt MATLAB (Release 2012b) solver ode45 to solve the equations
numerically. The concentration profiles for each of the 3 species are shown in
Figure 5.6, as well as the ratio of the concentrations of PPi to Pi.
We see that initially the TNAP concentration increases sharply with a peak
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of 130 × 10−6 g ml−1 occurring just before 3.5 days have elapsed. This peak
represents a 4.3 fold increase in the amount of TNAP present. After this the
concentration declines at a slower rate and appears to be tending towards
a steady state. The concentration for the PPi initially decreases as PPi is
cleaved by the TNAP. The lowest concentration of PPi is 3.37×10−10 mol ml−1.
This is below the lower bound of physiological serum values for PPi which
is 0.64 × 10−9 mol ml−1. This minimum occurs after 6.2 days so the PPi
minimum lags the ALP peak by 2.7 days. The concentration profile for Pi
shows that Pi concentration values are only changing minimally, and we note
that these changes are much smaller then the daily fluctuations in serum
Pi concentrations (Jubiz et al. 1972). This result should not be surprising
if we consider the concentrations of both of these species in serum. The
concentration of PPi is in the order of 10
−9 mol ml−1 whereas Pi concentrations
are in the order of 10−6 mol ml−1, three orders of magnitude larger. Given that
the enzymatic reaction that cleaves PPi creates two Pi from one PPi we expect
that to make a significant change in the Pi concentration a large amount of
PPi would need to be cleaved. It is often mentioned in the literature that
the role of TNAP is to both decrease PPi and increase Pi, however further
research has indicated that the former of these is the dominant role (Hessle
et al. 2002, Murshed et al. 2005). Our model further supports this theory that
the most important role of TNAP is to remove PPi.
Our model only considers the influence of the cleaving of PPi on the con-
centration level of Pi. The observation that the cleaving of PPi does not
significantly change the Pi concentration levels is of interest in understanding
the role played by PPi and Pi in mineralisation. It has been hypothesised that
the ratio of PPi to Pi is more important in driving mineralisation rather then
the actual concentrations of the species individually (Murshed et al. 2005).
The ratio P/I over time for our simulation is shown in Figure 5.6(d). We see
that because of the small changes in Pi concentration the profile of the ratio
follows that of the concentration of PPi. Thus from our results it appears that,
for a person with a normal healthy metabolism of phosphate, the changes in
this ratio in order for mineralisation to occur are much more related to the
removal of the inhibitor PPi then the associated increase in Pi levels (however
in the instance where phosphate metabolism is impaired then it may still be
playing an important role in raising serum concentration).
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Due to the wide ranging experimental protocols apparent in the biological
community it is difficult to quantitatively match our TNAP concentration
profile to those presented in the literature. We can however match our profiles
qualitatively to plots of TNAP activity in cell cultures. In Figure 5.7 we
show the TNAP expression for human osteoblasts treated with BMP 2 at
100 ng ml−1 (Lecanda et al. 1998). The qualitative behaviour in this plot
is typical of TNAP activity of mineralising cells in culture (see for example
(Korkalainen et al. 2009, Choi et al. 1996, Kristensen et al. 2012, Delhanty
et al. 2006)). The TNAP activity levels increase, hit a peak, then decrease
slightly to a level that is still much higher than the initial condition, the exact
timing and magnitude of the curves depends on a variety of factors including
the cell type and mineralisation medium used. In the data shown here the peak
is achieved at 5 days. At this peak the increase in TNAP activity compared
to the control experiment (data not shown) is approximately 3.7 fold. The
activity rate then decreases to be a 3.3 increase on the control value. These
results are similar to those presented in Chang et al. (2006) and discussed
in Section 5.4. There mineralising cells had a 3.2 fold increase in TNAP
activity after 9 days of culture compared to the rate of TNAP activity in
non-mineralising cells.
If we compare our simulation results for TNAP concentration to those for
TNAP activity we see our concentration profile follows the general shape seen
in cell culture experiments, with an increase to a peak followed by a small
decrease. However in our simulations the peak occurs earlier then observed in
the experimental results. One possible explanation for this discrepancy is that
our model fails to account for the time required for cellular differentiation to
occur. The parameters in our model were chosen to represent the parameters
in mineralising cells whereas our initial conditions were chosen to represent
a situation were no cells were mineralising. Thus an interpretation of this is
that at t = 0 all the non-mineralising cells (possibly osteoblast progenitors)
suddenly differentiate into osteoblasts. In reality cell-differentiation is non-
discrete and changes in cell production rates of proteins. for example TNAP,
change gradually over time as the cells differentiate. Indeed increased TNAP
expression is typically used as a marker that osteoblastic differentiation has
occurred.
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Figure 5.7: Comparison of experimental results for TNAP expression with simulation re-
sults for TNAP concentration. The blue curve shows experimentally determined
TNAP activity in human osteoblasts treated with BMP-2 (Data from (Lecanda
et al. 1998)). The green curve shows TNAP concentration as predicted by our
model. We see that the curves have a similar characteristic shape but that there
are differences in the timing of the peaks.
5.7.1 Influence of the rate of TNAP expression on the system
In our discussion of the appropriate choice of parameters α¯, η¯ and β¯ we
examined the behaviour that we would expect to occur in a population of
non-mineralising cells. As no mineralisation is occurring we expect that the
concentration levels of the mineralisation inhibitor PPi will not be reduced
below the known physiological serum concentration.
Non-mineralising osteoblast progenitors express TNAP at a much lower rate
than mineralising cells. In our model we represent this by setting β¯ = 0. We
interpret this as the non-mineralising cells are still producing baseline levels of
TNAP (as defined by the parameter α¯) but are not producing any additional
TNAP in response to the local TNAP or PPi concentration.
We now observe the behaviour of our model when used to simulate a popu-
lation of non-mineralising cells. To do this we set β¯ = 0 and keep all other
parameters as given in Table 5.1 and Table 5.2. The concentration profiles
from these simulations are shown in Figure 5.8.
In these results we see a slightly different qualitative behaviour to that ob-
served in Figure 5.6. The TNAP concentration levels stay constant. This
100
5.8 Extension to Moving Boundary
0 5 10 15 20
2.5
3
3.5
t (days)
A
(×
1
0−
5
g
m
l−
1
)
(a)
0 5 10 15 20
1.2
1.4
1.6
1.8
t (days)
P
(×
1
0
−
9
m
ol
m
l−
1
)
(b)
0 5 10 15 20
1.15
1.16
1.16
1.17
t (days)
I
(×
10
−
6
m
o
lm
l−
1
)
(c)
0 5 10 15 20
1
1.2
1.4
1.6
t (days)
P
/
I
(×
10
−
3
)
(d)
Figure 5.8: Concentration profiles for (a) TNAP, (b) PPi, (c) Pi and (d) the ratio of PPi to
Pi. The parameters used are given in Tables 5.1 and 5.2, with β¯ = 0. We see
that the ALP concentration remains constant, the PPi concentration decreases
slightly but still remains within physiological serum values.
is a consequence of the parameter choice of α¯ which means that the initial
condition is the steady state. Again we recall that the initial conditions were
chosen to be representative of non-mineralising cells so this result is desirable.
The concentration profile for PPi shows that PPi decreases over time but
importantly the lowest value for PPi concentration is 1.25 × 10−9 mol ml−1
which is still well within the bounds of normal serum concentration (0.64-
2.96×10−9mol ml−1). Since the concentration of PPi is still within the bounds
of normal serum concentration this would indicate that mineralisation would
be unlikely to occur under these circumstances.
5.8 Extension to Moving Boundary
Within our generalised view of the fracture callus formation we consider ap-
position of new bone to be an important factor in driving the growth of the
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Figure 5.9: Schematic of domain for mineralisation model, we assume uniformity in the y
direction and only consider the behaviour in the x direction. On the mineral front
x = L1 new mineralised bone is being created due to the actions of osteoblasts
present on the bone surface. The right boundary at x = L2 represents the
periosteum. In the region between these boundaries exists other osteoblasts and
extracellular matrix. PPi and Pi are free to circulate throughout this region but
TNAP is bound to the cell membrane of the osteoblasts.
callus. To model the movement of the mineralisation front we take our previ-
ously described kinetics for TNAP, PPi and Pi and include appropriate spatial
effects. The behaviour we are aiming to model is the deposition of new bone
onto an existing bone surface, such as that illustrated in Figure 5.9. The
mineralisation occurs through the presence of osteoblasts on the bone surface.
These cells produce the collagen matrix and regulate the deposition of min-
eral onto the matrix. As the mineral forms the osteoblast can become trapped
in the matrix and subsequently differentiate to become osteocytes, which are
believed to play a key role in regulating the remodelling of the bone.
A model for the progression of the mineralisation front is also presented in
(Prokharau et al. 2012). They build a model for osseointegration of an im-
plant. Whilst the the authors consider a different context and model differing
regulatory factors to those we consider here, both models aim to represent the
movement of the mineralisation front during intramembranous bone forma-
tion.
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5.8.1 Model Description
The model that we present here represents an initial attempt at creating a
mathematical model for the deposition of mineral during bone formation as a
response to the ratio of concentrations of PPi and Pi. We consider a 1D domain
where there is an existing bone surface at one end. Adopting the convention
that new bone formation tends to occur adjacent to existing bone we assume
that new bone formation can only occur at this bone surface. The bone
formation occurs when the ratio of PPi to Pi is conducive to mineralisation,
that is when there is a low ratio of PPi to Pi. In our model we only consider
the three species previously explored in the kinetic model, TNAP, PPi and Pi.
In this model we do not explicitly include the effect of either the cellular pop-
ulations or the collagen extracellular matrix. Instead we make some assump-
tions about their behaviour. We assume that across our domain of interest
there is a uniform distribution of osteoblasts, but that mineralisation is con-
fined to only occur on the existing bone surface. In addition we assume that
the osteoblasts have produced sufficient collagen such that mineralisation can
occur.
To describe the rate of change of TNAP, PPi and Pi we use the kinetics given in
Equations (5.1)–(5.3) and include appropriate terms to describe their spatial
movement. We assume that the functional TNAP is bound to the osteoblast
cell membrane (Murshed et al. 2005), whereas the PPi and Pi will be freely
circulating throughout the domain.
We can write an equation for the rate of change of TNAP as
∂A
∂t
= DA
∂2A
∂x2
+ αO + βAPO − δA, (5.28)
the first term represents the spatial movement of the TNAP due to the move-
ment of the osteoblasts. As with our earlier models, we model the osteoblast
movement as Fickian diffusion as a first approximation, where DA is the diffu-
sion coefficient. We note that we are neglecting the influence that the moving
mineralisation front may have on the displacement of the osteoblasts.
The equation for the rate of change of PPi is given as
∂P
∂t
= DP
∂2P
∂x2
+ ηO − kcatAP
KM (1 +
I
KI
)
, (5.29)
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and the equation for the rate of change of Pi as
∂I
∂t
= DI
∂2I
∂x2
+ 2
kcatAP
KM +
I
KI
, (5.30)
where DP and DI are the diffusion coefficients for PPi and Pi respectively.
We now turn our attention to the behaviour at the boundaries. Referring to
the schematic in Figure 5.9 the left boundary represents the moving minerali-
sation front, which we denote as x = L1(t) and the right boundary at x = L2
represents the periosteum. As the new bone tissue is deposited the boundary
x = L1(t) moves to the right. We consider the boundary at x = L2 to be
static, but note that it could be of interest to consider the behaviour of the
model if this boundary could also move, for example representing the growth
of the callus due to proliferation of progenitor cells.
We focus first on the boundary at x = L1(t). We assume that the speed at
which the boundary moves is dependent on the ratio of PPi to Pi. When this
ratio is high mineralisation occurs slowly or not at all, whereas when the ratio
is low mineralisation occurs at a much faster rate. Based on this we model
the movement of the left boundary as a smoothed step function,
dL1
dt
=
λ
2
(
1 + tanh
(
µ
(
γ − P (L1, t)
I(L1, t)
)))
, (5.31)
where λ represents the maximum speed of the boundary, µ determines the
steepness of the front, and γ is the switching point.
In addition we need to define the boundary conditions for the three species
in our model. As the mineralisation front moves we assume that cells on the
bone surface are not displaced by the mineralisation front. Rather as the front
advances these cells become trapped within the new matrix and eventually
become osteocytes. As such the TNAP that is bound to the cell membranes
will also become embedded in the newly formed matrix. We use a similar
boundary condition for the PPi. Here we assume that there is an outward
flux of PPi as the boundary moves due to two factors. Firstly as the mineral
crystal is formed some PPi binds to the mineral. Secondly newly mineralised
bone is porous, so the extracellular fluid containing the PPi can flow through
this space. As a first approximation for the loss of PPi we assume that all
PPi in a region that transforms from non-mineral to mineralised bone is lost.
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Thus, we write the boundary conditions for TNAP and PPi on x = L1 as
∂A
∂x
= 0, (5.32)
∂P
∂x
= 0. (5.33)
We note that within the moving boundary framework that this is not a zero
flux boundary condition. The flux leaving the boundary for TNAP, for exam-
ple, is actually equal to dL1dt A. For more details on this see Section C.4 in the
appendix.
The final condition on the left boundary is for Pi. We assume that there is a
loss of Pi due to Pi being incorporated into the newly forming mineral. From
a conservation of mass argument, as seen in Stefan problems (Gupta 2003),
the boundary condition is
∂I
∂x
=
I − IM
DI
dL1
dt
, (5.34)
where IM is the density of Pi in newly mineralised bone.
Finally, we need to determine the boundary conditions on the right boundary
x = L2. We assume that this right boundary represents the periosteum. As
the TNAP is bound to the cells we assume that these cells cannot cross the
periosteum and hence that on x = L2(t) that
∂A
∂x
= 0. (5.35)
For the PPi we assume that there is some inflow of PPi from the extracellular
space, where the concentration of PPi is P0, through the periosteum, however
this flow is impeded by the membrane and hence use an advective boundary
condition
∂P
∂x
= −σ(P − P0), (5.36)
where σ represents the permeability of the periosteum.
For Pi we assume that at the periosteum Pi concentration levels are at the
serum concentration levels and hence take
I = I0. (5.37)
The initial conditions used were to assume a spatially homogeneous distri-
bution across the domain and that this value was equal to the previously
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Parameter Value Units Dimensionless Value
DA 4× 10−8 cm2 day−1 4× 10−6
DP 285× 10−3 cm2 day−1 28.5
DI 285× 10−3 cm2 day−1 28.5
λ 2.2× 10−4 cm day−1 2.2× 10−3
µ 30× 103 30
γ 0.45× 10−3 0.45
IM 2.9× 10−3 mol ml−1 2.9× 103
σ 0.01 cm−1 1× 10−3
Table 5.3: Table of additional parameters for the extended mineralisation model.
determined serum concentration levels. This gives
A(x, 0) = A0, (5.38)
P (x, 0) = P0, (5.39)
I(x, 0) = I0, (5.40)
and finally we define the initial position of the bone surface as
L1(0) = L10 . (5.41)
5.8.2 Parameters
For the kinetic component of the equations we use the parameters given in
Tables 5.1 and 5.2. The remaining parameter values are discussed here.
We have assumed that the active TNAP is bound to the cell membrane of the
osteoblasts, hence we take the diffusion coefficient for TNAP to be the same
as the diffusion coefficient used for the osteoblast population in our model for
cellular differentiation. This gives DA = 4× 10−8 cm2 day−1.
Measurements of the diffusion of Pi through frog muscle tissue give a diffusion
coefficient of 3.3± 0.4× 10−6 cm2 s−1 (Yoshizaki et al. 1982). We assume that
the diffusion throughout muscle tissue provides a good approximation for dif-
fusion through the fracture callus region and take DI = 285×10−3 cm2 day−1.
In water the diffusion coefficient of PPi is of a similar magnitude as that of
Pi (Flury & Gimmi 2002). Thus as a first approximation we assume that
the diffusion coefficient for PPi is the same as Pi and take DP = 285 ×
10−3 cm2 day−1.
106
5.8 Extension to Moving Boundary
In humans the density of mineral in cancellous bone, which is similar in struc-
ture to new intramembranous bone, is 0.49 g cm−3 (Donnelly et al. 2010).
As a starting point we assume that this is also the density of mineral in
new intramembranous bone. We further assume that this mineral is 100%
pure hydroxyapatite, which gives a molar density for Pi in new bone as
IM = 2.9 × 10−3 mol ml−1. We note that it is likely that this is an overesti-
mation of the parameter IM as newly formed woven bone is generally more
porous than existing bone (Currey 2002).
We have three parameters to determine the speed of the mineralisation front
described in Equation (5.31). The parameter λ describes the maximum speed
at which the mineralisation front moves, the parameter µ determines the steep-
ness of the curve and the parameter γ determines the switching point of the
curve. Considering our results from the kinetic model, we desire almost no
mineralisation for a ratio of P/I > 0.55× 10−3, but full mineralisation occur-
ring for ratios P/I < 0.35 × 10−3. From this we choose γ = 0.45 × 10−3 and
µ = 30 × 103 to give an appropriate switching point and a sufficiently steep
curve. To determine the maximum speed of the mineralisation front we used
the mineral apposition rate, commonly reported in histomorphological studies
of bone. In a goat model of distraction osteogenesis, where healing is assumed
to occur mostly through an intramembranous pathway, the mineral apposition
rate in the mineralising zone was on average 2.2µm day−1 (Welch et al. 1998).
From this we set λ = 2.2 × 10−4 cm day−1. The validity of using the mineral
apposition rate to determine the mineralisation front speed is discussed later
in this chapter.
The parameter σ represents the permeability of the periosteum. Through trial
and error it was taken as σ = 0.01.
5.8.3 Non-Dimensionalisation
As was done with the kinetic equations we rescale our system of PDEs to aid
with the numerical simulations. We use the same non-dimensional variables
as before,
A¯ =
A
Aˆ
, P¯ =
P
Pˆ
, I¯ =
I
Iˆ
, t¯ =
t
tˆ
, (5.42)
and introduce a new non-dimensional spatial variable
x¯ =
x
xˆ
. (5.43)
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As before we let Aˆ = 10−5 g ml−1, Pˆ = 10−9 mol ml−1, Iˆ = 10−6 mol ml−1 and
tˆ = 1 min, and introduce xˆ = 0.1 cm.
We introduce new dimensionless parameters as in Equation (5.6), as well as
D¯A =
DAtˆ
xˆ2
, D¯P =
DP tˆ
xˆ2
, D¯I =
DI tˆ
xˆ2
,
λ¯ =
λtˆ
xˆ
, µ¯ =
µPˆ
Iˆ
, γ¯ =
γIˆ
Pˆ
,
I¯M =
IM
Iˆ
, σ¯ = σxˆ.
(5.44)
Additionally the location of the boundaries are also rescaled to
L¯1(t) =
L1(t)
xˆ
, L¯2 =
L2
xˆ
. (5.45)
Using these dimensionless parameters the system can be written in full as
∂A¯
∂t¯
= D¯A
∂2A¯
∂x¯2
+ α¯+ β¯A¯P¯ − δ¯A¯, (5.46)
∂P¯
∂t¯
= D¯P
∂2P¯
∂x¯2
+ η¯ − k¯catA¯P¯
K¯M
(
1 + I¯
K¯I
) , (5.47)
∂I¯
∂t¯
= D¯I
∂2I¯
∂x¯2
+ 2× 10−3 k¯catA¯P¯
K¯M
(
1 + I¯
K¯I
) , (5.48)
dL¯1
dt¯
=
λ¯
2
(
1 + tanh
(
µ¯
(
γ¯ − P¯ (L¯1, t¯)
I¯(L¯1, t¯)
)))
. (5.49)
(5.50)
With boundary conditions on x¯ = L¯1(t)
∂A¯
∂x¯
= 0, (5.51)
∂P¯
∂x¯
= 0, (5.52)
∂I¯
∂x¯
=
I¯ − I¯M
D¯I
dL¯1
dt¯
, (5.53)
and on x¯ = L¯2,
∂A¯
∂x¯
= 0, (5.54)
∂P¯
∂x¯
= −σ¯(P¯ − P¯0), (5.55)
I¯ = I¯0. (5.56)
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The initial conditions are given as
A¯(x¯, 0) = A¯0, P¯ (x¯, 0) = P¯0, I¯(x¯, 0) = I¯0, L¯1(0) = L¯10 . (5.57)
5.8.4 Numerical Methods
The numerical method used to simulate these results was the same as that
used in Chapter 4. We rescaled the moving domain to a static domain, rewrote
the equation in conservative form and then used the finite volume method
to obtain the spatial discretisation and used the inbuilt MATLAB (Release
2012b) function ode15i to perform the time integration. More details on the
rescaling and the finite volume method is given in Appendix C.
5.8.5 Results and Discussion
In the first set of simulations conducted we considered the periosteum to be
located 0.2 mm away from the original bone surface, that is L¯10 = 0 and
L¯2 = 2. All other parameters were as in Tables 5.1–5.3. In Figure 5.10
we show the concentration profiles over a period of 10 days. We remind
ourselves that within the context of fracture healing these processes need to
occur quickly and hence we are only interested in the behaviour of the system
over a relatively short period of time. In addition we show a magnified version
of the concentration profiles of I near the boundary x = L1(t) to show that the
boundary is indeed moving. We also show the position of the mineralisation
front and its velocity in Figure 5.11.
Spatially the profiles for ALP and PPi appear almost uniform, however the
concentrations on the right boundary, where there is a small influx of PPi are
slightly higher. Temporally the concentration levels follow a similar pattern
to that observed in the purely kinetic models. The ALP starts at the low
initial condition representing the expression of non-mineralising cells. Initially,
it rises rapidly to a maximum of around 13.4 × 10−5 g ml−1 achieved after
3.7 days. It then decreases slightly before reaching a minimum of around
9.3 × 10−5 g ml−1 after 12.3 days. Following this point there is at least one
more small oscillation visible in the solution. As the oscillations decay we note
that over a long time the concentration does not tend to a steady value. This
is not surprising given the changing nature of the domain. There is instead a
very slow increase in TNAP concentration. We are not overly concerned with
the long time behaviour but we note that even after running the simulation to
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Figure 5.10: Concentration profiles over time, the blue lines represent the concentration pro-
files and the orange lines represent the location of the boundary. We show the
profiles at t = 0, 2, 4, 6, 8, 10 days. The initial condition is shown as a dotted line
and the remaining time-steps are the solid lines with a darker shade represent-
ing a later time point. (a) Concentration profile for TNAP, the concentration
rises and then falls. (b) Concentration profiles for PPi, over time the concentra-
tion decreases and then slightly increases. (c) Concentration profiles for Pi over
time. The slope of the profiles increases over time and then slightly decreases.
(d) Magnified image of the concentration profiles for Pi showing the movement
of the right boundary.
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Figure 5.11: (a)Position of the mineralisation front. (b) Velocity of the mineralisation front.
We see that mineralisation does not begin to occur until 3 days have passed.
100 days the final values for the concentration of TNAP due to this increase
were only around 9.8× 10−5 g ml−1.
The PPi starts at a high level and initially decreases rapidly. As before the
minimum of PPi concentration lags the maximum of the TNAP concentration.
The minimum occurs at t = 6.3 days and corresponds to a PPi concentration
of 0.35 × 10−9 mol ml−1. Following this the solution rises to reach a local
maximum of 0.46 × 10−9 mol ml−1 just after 9 days have elapsed. After this,
as with the TNAP concentration, there is another small oscillation visible.
Following the visible decay of the oscillations the concentration has a very
slow increase in value.
The profiles for Pi appear close to linear, with the slope dependent on the
speed of the boundary. We see that the slope is initially zero, and remains
that way until the onset of mineralisation, at about day 3 (see Figure 5.11).
At this point the gradient increases quickly as the speed of mineralisation
increases. The speed of the mineralisation front hits a maximum at day 6 and
correspondingly after this point the gradient of Pi decreases again. If we follow
the long term behaviour of the gradient there are some further oscillations,
but following the decay of these oscillations there is a general slow increase in
the slope of the profile corresponding with the slow increase in the speed of
the boundary that occurs.
In Figure 5.11 the position and velocity of the mineralisation front is shown.
We see that mineralisation does not begin to occur until after 3 days. This
delay is expected and physiologically realistic. These simulations represent
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an artificial problem where a group of uniformly non-mineralising cells are
switched on to become mineralising cells at time t = 0 and begin expressing
high levels of TNAP accordingly (in the context of our model this could be
seen as the switch from β¯ = 0 to β¯ = 0.5). Following this switch there is
a period of time in which the cells act to produce an environment that is
conducive to mineralisation, that is a low ratio of PPi to Pi. This could
be considered as being similar to the circumstances encountered in in vitro
cell cultures. Here cultures of cells are treated with chemicals which induce
mineralisation and the resulting effects on the cells are observed. Whilst
the results from these assays varies with the precise experimental procedure
used, there are experiments where mineralisation was observed in less then
5 days, which is consistent with our results (Maeda et al. 2001, Orimo &
Shimada 2006, Stanford et al. 1995).
5.8.6 Speed of Mineralisation
The speed at which the mineralisation front moves is consistent with the choice
of parameter λ, however, unsurprisingly on the scale of the domain of these
simulations, the mineralisation front appears to barely move. The choice of
a large domain was a deliberate one, based on the geometry of the callus
observed in the sheep osteotomy model. In these experiments after 2 weeks
mineralised bone is visible in a range of 4–5 mm from the pre-existing cortical
bone. Thus the speed of mineralisation observed in our simulations is not
consistent with experimental observations.
In their paper for mineralisation of endosteal implants (Prokharau et al. 2012)
assumed that the new mineral front was advancing at a rate in the order of
10µm day−1. We take this a a more physically realistic value for the minerali-
sation rate and investigate the effect of changing the parameters of our model
in order to achieve this mineralisation rate. In particular we focus on the roles
of λ, the maximum speed, and IM , the mineral density, on the mineralisation
rate. In particular the relationship between the mineral density and the min-
eralisation rate is of interest as bone that is formed rapidly is less dense than
bone that is formed more slowly.
The parameter λ was determined based on the mineral apposition rate (MAR)
measured for goat distraction osteogenesis. Healing during distraction osteo-
genesis is similar to that observed in fracture healing, however a key difference
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is that most new bone is formed through an intramembranous pathway. At
first glance the MAR would appear to be an appropriate measure to use to
build our model. The standard method used to calculate the MAR is to label
the bone with two (or more) different fluorescent labels separated by a pe-
riod of time. These labels bind to calcium and become incorporated into the
newly forming bone. When viewed under an epiflourescent microscope both
labels will be apparent. To find the MAR the distance between the differently
labelled surfaces can be measured and then divided by the time between the
labelling (van Gaalen et al. 2010, Parfitt et al. 1987). The labels are taken up
quickly by the bone and tend to remain in the body for only a short period of
time. Generally the interfaces of the labels are sharp, however when bone is
forming rapidly, such as in fracture healing, they become more diffuse making
measurement more difficult. Additionally there is the risk that newly formed
bone will be turned over due to the commencement of remodelling before a
tissue sample can be made.
Further influencing this is the geometry of the newly formed intramembranous
bone. The new bone has a woven appearance formed by interconnected rods
that resemble trabeculae. The new bone growth starts with bony spicules,
and it is possible that the rate of mineral formation on these spicules is not
uniform. For example mineralisation may be occurring faster at the tip than
the sides of the spicule. We must also remember that the histomorphometric
measurements used to calculate the MAR are taken from 2D slices of a 3D
callus, so we will never be able to see the complete picture.
As a first attempt to achieve a faster mineralisation rate with our model we
increase the parameter λ by a factor of 10, to give λ = 2.2 × 10−3 cm day−1.
We see in Figure 5.12 that the increase in λ has provided a small increase in
the speed of the mineralisation front. Indeed increasing λ by 1000 times to
λ = 2.2× 10−1 cm day−1 less then doubles the maximum speed achieved.
This result tends to indicate that other factors are also influencing the speed
of the front. Examining the boundary conditions for both the speed of the
boundary and Pi reveals that as the boundary moves faster more Pi is lost at
the boundary. This in turn increases the ratio of PPi to Pi slowing down the
bone formation. This suggests that if we considered the newly formed bone to
be less dense, that is we take a lesser value of IM , then the mineralisation speed
will increase. The parameter IM = 0.29× 10−3 cm day−1 was taken based on
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Figure 5.12: Velocity of the mineralisation front for increasing values of λ. We see as λ
increases the speed of the mineralisation front also increases, however this is
not a strong effect.
the density of established cancellous bone, whereas the newly formed woven
bone observed in fracture healing is likely to have a lower density(Currey
2002).
In Figure 5.13 we show the effect of decreasing IM on the speed of the bound-
ary. We see that decreasing the mineral density to IM = 2 × 10−1 mol ml−1
gives a small increase in the mineralisation speed. With a further decrease to
IM = 1× 10−3 mol ml−1 we see that the curve has a flattened top, where the
speed stays at 2.2× 10−4 cm day−1 for a period of days. This is the maximum
speed determined by the parameter λ and shows that for decreased IM the
parameters λ is the limiting factor on the mineralisation speed.
We now observe the effect of changing both the mineral density and maximum
speed of the mineralisation front. Combining both a decrease in the mineral
density to IM = 1×10−3 mol ml−1 and an increase in the maximum front speed
λ = 2.210−3 cm day−1 yields the velocity profile shown in Figure 5.14. We see
that the combined effect of both increasing the maximum mineralisation speed
λ and decreasing the mineral density IM results in a much greater increase
in the speed of the mineralisation front than was achieved when they were
considered individually. The maximum speed achieved is 6.1 × 10 cm day−1,
this is closer to the value 10µm day−1 cited in (Prokharau et al. 2012). A fur-
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Figure 5.13: Velocity of the mineralisation front for decreasing values of IM . We see that as
IM decreases the speed of the boundary increases.
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Figure 5.14: Velocity of the mineralisation front showing effect of both increasing λ and
decreasing IM .
ther decrease of the mineral density to IM = 0.5 mol ml results in a maximum
speed of 11µm day−1.
By varying the parameters λ and IM we were able to significantly increase the
speed at which the mineralisation front moved, to a speed which is likely more
realistic. These alterations that were made to the parameters were justified
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from a biological perspective. Whilst we did not show the concentration pro-
files for the chemical species over time, we note that other then the increased
speed of the mineralisation front, the general behaviour did not vary signifi-
cantly to that described previously (Section 5.8.5). These results suggest that
in our model the availability of Pi is a limiting factor in the movement of the
mineralisation front. This indicates that for new bone mineral to form there
is a requirement for not only a reduction in the concentration of PPi, but also
sufficient Pi available for the new mineral to form.
5.8.7 Effect of Domain Size
We are also interested in the effect of the domain size on the concentration
profiles and movement of the mineralisation front. In our original construction
of the domain the left boundary represents the mineralising surface and the
right boundary the periosteum. At the onset of the fracture healing cascade,
cells in the periosteum begin proliferating, driving the periosteum away from
the bone surface. As healing progresses the mineralised callus approaches
the periosteum once again. Thus during the healing process the distance
between the periosteum and the mineralisation front varies depending on many
different factors. As such we wish to determine the effect changing the domain
size has on our simulation results.
We observe these effects by altering the initial length of the domain by chang-
ing L2. If we halve the initial length of the domain such that L2 = 0.1 cm
and keep all other parameters as in Tables 5.1–5.3 then the results are shown
in Figure 5.15. These results do not appear to differ substantially to those
obtained for an initial domain length of 0.2 cm.
If we further decrease the initial size of the domain we begin to have a greater
influence on the concentration profiles and the speed of mineralisation. We
further decreased the initial length of the boundary to 0.02 cm. In Figure 5.16
we show the concentration profiles for TNAP and PPi over a period of 10 days,
as well as the speed of the mineralisation front over 30 days. We see that this
decrease in domain length has had a significant effect on our results. The
concentration for PPi does not decrease to the levels seen in the original sim-
ulation. This is because the shorter domain combined with the fast diffusion
speed of PPi and the PPi source at the periosteum results in an overall in-
crease in PPi concentration across the domain. We additionally illustrate two
116
5.8 Extension to Moving Boundary
0 0.02 0.04 0.06 0.08 0.1
0
5
10
15
x (cm)
A
(×
1
0−
5
g
m
l−
1
)
(a)
,
0 0.02 0.04 0.06 0.08 0.1
0
0.5
1
1.5
2
x (cm)
P
(×
10
−
9
m
o
lm
l−
1
)
(b)
0 0.02 0.04 0.06 0.08 0.1
0.6
0.8
1
1.2
1.4
x (cm)
I
(×
1
0
−
6
m
ol
m
l−
1
)
(c)
Concentration
t = 0days
t = 2days
t = 4days
t = 6days
t = 8days
t = 10days
Mineral Front
t = 0days
t = 2days
t = 4days
t = 6days
t = 8days
t = 10days
0 2 4 6 8 10
0
2
4
6
8
t (days)
L
1
(×
1
0
−
4
cm
)
(e)
0 2 4 6 8 10
0
0.5
1
1.5
t (days)
d
L
1
d
t
(×
10
−
4
cm
d
ay
−
1
)
(f)
Figure 5.15: Concentration profiles over time for a domain with an initial width of 0.1 cm,
we note that there is no substantial difference in the results seen here and those
for a initial domain length of 0.2 cm as seen in Figures 5.10 and 5.11. The blue
lines represent the concentration profiles and the orange lines represent the
location of the boundary. We show the profiles at t = 0, 2, 4, 6, 8, 10 days. The
initial condition is shown as a dotted line and the remaining time-steps are the
solid lines with a darker shade representing a later time point. We show the
concentration profiles for (a) TNAP, (b) PPi and (c) Pi over time. (e) Position
and (f)velocity of the mineralisation front.
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Figure 5.16: Concentration profiles over time for a domain with an initial width of 0.02 cm.
The blue lines represent the concentration profiles and the orange lines represent
the location of the boundary. We show the profiles at t = 0, 2, 4, 6, 8, 10 days.
The initial condition is shown as a dotted line and the remaining time-steps are
the solid lines with a darker shade representing a later time point. We show the
concentration profiles for (a) TNAP, (b) PPi and in (c) we show the velocity
of the mineralisation front.
consequences of the higher levels of PPi. Firstly the concentration of TNAP
is significantly raised as an increase in PPi increases the production rate of
TNAP by the osteoblasts. We also observe that the temporal behaviour does
not match that shown previously. In the original simulations we observed a
sharp increase in TNAP concentration followed by a slower decrease. However
here we see that TNAP concentration continues to increase over time, initially
rapidly, before then slowing down. Another consequence of the higher con-
centrations for PPi is that the mineralisation speed, shown in Figure 5.16(c)
is reduced compared to the longer domain. We show the mineralisation speed
over a period of 30 days. This illustrates that the onset of mineralisation is
slightly delayed compared to the longer domain and that the maximum min-
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Figure 5.17: Effect of parameter σ on mineralisation. (a) and (b) concentration of ALP and
PPi respectively after 10 days. (c) Speed of the mineralisation front. We see
that decreasing σ to σ = 0.1 significantly impedes mineralisation.
eralisation speed is = 0.13×10−4 cm day−1 and is achieved at around 24 days.
Following this maximum the speed continues to decrease slowly.
5.8.8 Effect of the Parameter σ
The overall higher concentrations achieved in the smaller domain were in part
caused by the source of PPi at the boundary. The boundary condition used at
the periosteum for the concentration of PPi took the form a Newton’s cooling
type condition
∂P
∂x
= σ(P − P0), (5.58)
with the parameter σ representing how permeable the periosteum is to the flow
of PPi. The larger σ is the greater the amount of PPi that diffuses through the
periosteum. In Figure 5.17 we show the effect of varying σ on the concentration
profiles and the speed of the mineralisation front, whilst all other parameters
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were held as in 5.1–5.3. Figures 5.17(a) and (b) show the concentration profiles
of TNAP and PPi after 10 days for varying values of σ and Figure 5.17(c)
shows the effect of varying σ on the speed of the mineralisation front. We
see that decreasing the parameter σ from σ = 0.01 cm−1 to σ = 0.001 cm−1
does not provide much change in either the concentration profiles or the speed
of mineralisation. However an increase to σ = 0.1 cm−1 results in a overall
increase in the concentration of PPi across the domain. As in the case of
the shortened domain this has consequences for the concentration of TNAP
and the mineralisation speed. We see that the concentration of TNAP is
at least twice as large and also that there is a rise in the concentration at
the right boundary. This rise corresponds to the smaller rise visible in the
PPi concentration at the right boundary but is further accentuated in the
TNAP profile due to the low diffusion rate. We also see that the speed of the
mineralisation front is significantly reduced due to the increased concentration
of PPi. These results again demonstrate the importance of the removal of PPi
for mineralisation to occur.
5.9 Summary
The removal of the mineralisation inhibitor PPi due to the cleaving actions
of TNAP has been widely identified in the biological literature as key to the
regulation of new mineral formation. Furthermore as bone is comprised of
hydroxyapatite a sufficient supply of Pi is required to create the new bone
mineral. We developed a simple mathematical model for new mineral forma-
tion based on the relationship of TNAP, PPi and Pi.
Initially we considered a purely kinetic model for TNAP, PPi and Pi with-
out considering spatial effects. This model appeared to qualitatively match
expression of TNAP in mineralising cultures of osteoblasts. The presence of
high levels of TNAP induced a reduction of the concentration of PPi, a known
mineralisation inhibitor. The removal of PPi is seen as a key requirement for
mineralisation to occur. We also considered a case where TNAP expression
due to the presence of PPi had been suppressed. As TNAP is a marker of
osteoblastic differentiation this could be seen as the dynamics when consid-
ering a population of non-mineralising osteoblast progenitor cells. When the
TNAP expression was suppressed the PPi concentration remained within the
range of normal serum concentrations and thus it is reasonable to expect that
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no mineralisation could occur. This model demonstrates the importance of
TNAP as produced by the osteoblasts to the mineralisation process. Further
to this the model supports the hypothesis that the dominant role of TNAP in
fracture healing is to remove PPi rather than to create Pi ions.
Extending the kinetic models, we developed a model for the movement of
a mineralising front across a domain. Again the model was simplistic only
considering the effect of the concentrations of TNAP, PPi and Pi on the speed
of mineralisation. This model reinforced the importance of the removal of
PPi for mineralisation to occur. This was demonstrated through a series of
simulations varying the domain size and the source of PPi at the right hand
boundary.
A key result from this model is the effect of the mineral density on the speed
of mineralisation. Our initial choice of parameters resulted in an extremely
slow speed of mineralisation which was physiologically unrealistic. This led to
an investigation of some of the parameters likely to affect the mineralisation
speed. These investigations revealed that a decrease in the mineral density
of the new bone led to an increase in the mineralisation speed. This would
appear to support a view of the overall healing strategy of bone, where new
less dense bone is produced rapidly to stabilise the gap, but the remodelling
process to restore the bone to its original dense cortical structure takes a much
longer time.
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6Summary and Future Directions
Bone formation during fracture healing is a complex process, that is currently
poorly understood. The speed at which new bone forms and the quality of this
new bone is a key issue for patient outcomes. Increasing human understand-
ing of the fracture healing cascade is a key step towards developing clinical
interventions to improve patient outcomes.
Fracture healing is a multiscale process, that is both spatially and temporally
heterogeneous. Experimental data is difficult to obtain and has many limita-
tions. The nature of fracture healing means that it is difficult to observe the
processes that are occurring in an in vivo experimental model. In these ex-
periments histological sections can be used to observe tissue formation across
the entire callus but to obtain these sections the animal must be sacrificed,
and hence these sections represent a single picture of a callus at a single time
point. On the other hand in vitro experiments such as cell cultures can be used
to understand behaviour on a cellular scale, but there is no guarantee that
the behaviour of cells in a Petri dish resembles the in vivo behaviour of these
cells. Mathematical modelling is a tool that can be used to explore ideas and
hypotheses that would otherwise be difficult to quantify from experimental
work.
There is a fundamental hypothesis of bone formation stemming from the work
of (Pauwels 1980), that cellular differentiation is due to the mechanical stresses
and strains placed on the MSCs present at the fracture gap. This hypothesis is
incomplete as it ignores the effect of bioregulatory factors such as proteins and
growth factors that influence the formation of new bone tissue. Mathematical
models that consider these bioregulatory effects exist but they examine the
callus scale dynamics of fracture healing.
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Instead we have built models for aspects of fracture healing as they occur
at a cellular level. These models are designed to illustrate specific elements
of the healing cascade. In particular we focused on the differentiation of
MSCs to become osteoblasts and the mineralisation of new bone tissue to
better understand the mechanisms that drive these processes to occur. The
outcomes of these models is summarised in this chapter. We also indicate
some future directions to extend the research presented to further increase
the understanding of the biological processes that are occurring.
6.1 Summary
In Chapter 1 we set out two key objectives for this thesis. These objectives
were to build mathematical models for two different processes, cellular differ-
entiation and mineral deposition, that occur during intramembranous bone
formation in fracture healing in order to help increase the knowledge and un-
derstanding of the bioregulatory mechanisms that drive these processes. In the
following we summarise the work presented in the thesis with specific mention
of how this work met the outlined objectives.
In Chapter 2 we presented a brief overview of fracture healing and some of the
biological processes that occur in the callus region, as well as a review of exist-
ing mathematical models of fracture healing and bone formation. Examining
the biology of fracture healing revealed that intramembranous bone formation
occurs in regions of the callus that have a high mechanical stability. This in-
dicates that bioregulatory factors are strong driving forces behind the events
that occur during intramembranous bone formation. In our examination of
the biological literature we identified two bioregulatory feedback loops for the
regulation of cellular differentiation and mineralisation. The differentiation of
osteoblast progenitor cells to become mature osteoblasts is enhanced by the
presence of BMP ad inhibited in the presence of noggin. For mineralisation
to occur it is required that the mineralisation inhibitor PPi is removed, this
is facilitated by the osteoblasts through the production of the enzyme TNAP.
Both of these bioregulatory loops are well established as playing a role in bone
formation but to the best of our knowledge they have yet to be fully explored
through mathematical modelling.
Our review of the existing models of fracture healing revealed that these mod-
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els focus on modelling the entire callus as fracture healing occurs. These
models consider a variety of stimuli for driving fracture healing, from mechan-
ical stresses or strains, to growth factor concentrations to hybrid models that
consider both mechanical and biological factors. Because of the complexity
of callus growth and the many complex and coupled processes that are oc-
curring these models tend to be phenomenological instead of focusing on the
underlying mechanisms that are driving the healing to occur. In line with our
aims established in Chapter 1, to gain insight into the bioregulatory factors
affecting two key processes, cellular differentiation and mineralisation, as they
occur during intramembranous bone formation, we decided to take a different
approach in our modelling of intramembranous bone formation. In our mod-
elling approach we focused on building models that explored the regulation of
a specific aspect of intramembranous bone formation, either cellular differen-
tiation or mineralisation, as a result of bioregulatory factors that we identified
from the biological literature.
In Chapters 3 and 4 we addressed the first objective and presented our model
for cellular differentiation. In Chapter 3 we described a model where cellular
differentiation of progenitor cells to osteoblasts was regulated by a chemi-
cal pre-pattern established by BMP and noggin, two proteins that have been
implicated with cell differentiation during intramembranous bone formation.
Following the development of the model we reduced the underlying relation-
ship between BMP and noggin to a Turing pattern problem which allowed for
analysis of the patterning ability of the model. This analysis revealed that as
the cells populations changed due to differentiation that the chemical pattern
in BMP should remain at the same frequency. This is an important result
when we consider the model in its biological context. We also observed that
when simulating our model that the spatial and temporal appearance of the
patterning seemed to be consistent with our expectations based on histological
observations of the callus region.
We further extended this model to more accurately represent the callus domain
in Chapter 4. In particular we investigated the influence of a BMP source at
the boundary representing the cortical bone, and the effect of domain growth
on the patterning that is apparent in our model. We first considered a static
domain with a source of BMP at the cortical bone surface. These simula-
tions allowed us to predict the speed of the front of differentiation. Using
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this method the front of differentiation predicted by our model was found to
move at speed much greater then the expected growth rate of the callus. Also
problematic in these simulations was that the resultant patterning in the cell
species appeared to be more stripe-like, which is not consistent with our view
of the callus region. However as we moved to a growing domain, where we
assumed that the domain grew due to progenitor proliferation at the perios-
teum, we again recovered a spotted pattern. When we considered domain
growth to be similar to that observed in a sheep callus (i.e. much slower then
the speed of the differentiation front), a well defined spotted pattern appeared
with only transient strip-like features. Another interesting result identified in
Chapter 4 was the effect of a BMP source on only half of the left boundary.
This simulation demonstrated how specific boundary conditions can influence
the eventual distribution of spots. This indicates that growth factors that are
released from the damaged bone or other signalling molecules that diffuse from
the fracture gap are likely to influence the structure of the intramembranous
bone.
Our original hypothesis for objective one was that cellular differentiation oc-
curred in a non-uniform fashion across the callus region in response to a chemi-
cal pre-pattern and that the heterogeneities in the osteoblast population would
guide and shape the appearance of the new woven bone. Whilst we did not
explicitly model the new bone formation we would expect that the pools of
osteoblasts observed in our model would present as the first sites where min-
eralisation would occur, and as the mineral structure grew that these pools
would shape the new bone. Our model indicates that the regulation of the dif-
ferentiation by BMP and noggin gives rise to patterns that appear consistent
with the structure of intramembranous bone observed in histology, further in-
creasing the evidence for the role these species play in intramembranous bone
formation.
In Chapter 5 we addressed the second objective of developing a model for
mineralisation. The relationship between TNAP and PPi has been widely
identified in the literature as playing an important role in the regulation of
mineral deposition onto the collagen matrix. We used this relationship as the
basis for a new model of mineralisation. In addition we focused on the effect
of Pi rather calcium on the formation of new mineral.
Initially we examined a simple kinetic model for TNAP, PPi and Pi. Having
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determined appropriate parameters, when simulated, the system went from
an initial condition of low TNAP and high PPi to a state where TNAP was
high and PPi was low. The low level of PPi is important as this is what
creates an environment that is conducive to mineralisation. Furthermore we
note that TNAP concentration levels qualitatively match experimentally de-
termined profiles for TNAP activity in cell cultures. It has been proposed that
the role of TNAP during mineralisation is to both decrease the levels of PPi
and increase the local Pi concentration, with most recent research indicating
that the first of these is the dominant role. Our results lend support to this
theory.
We further extended this model to include spatial effects and explicitly model
the movement of the mineralisation front. For this model the choice of ap-
propriate parameters and boundary conditions became difficult and this had
a significant effect on the behaviour of the model. There are two outcomes
from this model that are relevant to the biological context. The first was
that decreasing the mineral density of the new bone increased the speed of
the mineralisation rate. The second was that the model demonstrated that a
sufficient supply of Pi was required for mineralisation to occur.
6.2 Future Work
There are many additions, improvements and extensions that could be made
to the models presented in this thesis.
Our model for cellular differentiation is only capable of producing a spotted
distribution of cellular differentiation. Inclusion of BMP saturation could
give rise to a labyrinth like patterns that are commonly observed in Turing
patterns. These labyrinth patterns could bear a closer resemblance to the
appearance of the new intramembranous bone.
It would also be of interest to include some form of new bone tissue formation
to observe how the heterogeneities in the osteoblast population help shape
the structure of the new intramembranous bone. This does not necessarily
have to use the mineralisation model we presented in this thesis, although
this is discussed below. A more simple description of new bone formation
being proportional to the osteoblast density such as is seen in other fracture
healing models would suffice.
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If we consider the model for mineralisation, whilst the kinetics for TNAP, PPi
and Pi seemed to give realistic results when considered without spatial effects,
our attempts to include the spatial effects were less successful. Future work
should be conducted to improve this model, in particular the determination of
appropriate parameters and boundary conditions. Further to this relevant cell
species, osteoblasts and progenitor cells, and even the collagen matrix could
be included in the model. Initially the cells could be included with a spatially
heterogeneous distribution across the domain with more osteoblasts closer the
bone surface and more progenitors at the periosteum.
Taking this further, we could consider the incorporation of the mineralisation
model with the cellular differentiation. Implementing this in 2D would in-
troduce several numerical difficulties in the simulation of the model. Ideally
this hybrid model would be capable of replicating the woven appearance of
new intramembranous bone. However this new bone has a complex, chang-
ing topology which would pose difficulties for many front tracking numerical
schemes.
One numerical method that may be ideally suited to this problem is the level
set method. Developed by Osher & Sethian (1988), the level set method is
an interface tracking method that works by embedding the interface into a
higher dimensional surface and evolving the surface and tracking the level
curves (sets). One of the big advantages of the level set method is that it
handles changes in topology with ease, which is important in the context of
new intramembranous bone formation.
Along with the tracking of the bone surface, another potential difficulty would
be the numerical treatment of the boundary conditions at the bone surface. If
the finite volume method was used in conjunction with the level set method,
the control volumes intersected by the bone surface would become irregular
in shape. Appropriate numerical methods would then need to be used to
approximate the area of the irregular cell and the flux lost through the bone
surface.
It would also be of interest to further verify our models with experimental
data. This could be done through the use of ex vivo models of bone growth
and formation, where the mechanical and biochemical environment are con-
trolled. In particular the hypothesis of chemical pattern formation leading
to heterogeneities in the cell population could be further tested through the
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collection of data regarding the spatial distribution of biochemicals such as
BMP and noggin as the bone tissue forms.
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AAn Overview of Bone Biology
Bones play many important roles in the body from structural support to
maintaining calcium homeostasis. Bone fractures impede the bones ability
to perform many of these functions. Thus the ability of the fracture repair
process to restore the original function of the bone is important. In this
appendix we provide some background information about the structure and
biology of bone and its formation.
A.1 Bone Function
Bone has many functions within the body. Perhaps the most obvious that they
form the skeleton which provides structural support for muscles and organs,
as well as protection for important organs. In addition to these mechanical
roles bones also play an important role in maintaining calcium homeostasis
in the body. The bone mineral acts as a pool of calcium that can be accedes
in times of calcium depletion. Bone also houses bone marrow in its interior,
which produces new blood cells.
A.2 Bone Classification
Human bones are often classified based on there shape and structure. They
are typically described as belonging to one of the following categories: long,
short, flat, irregular and sesamoid (Rizzo 2011, Gosling et al. 2008).
Long Bones These are the long thin bones that form most of the bones in
the limbs. They have a well defined structure and consist of a long
thin hollow shaft comprised of cortical bone, with wider ends where the
cortical bone thins surrounds cancellous bone.
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Flat Bones These bones are flat and platelike. They consist of a cancellous
bone sandwiched between two sheets of cortical bone. Bones such as the
cranium (skull) and scapula (shoulder blade) are flat bones.
Short Bones These bones are as long as they are wide and are often roughly
cuboidal in shape. They have a thin outer layer of cortical bone sur-
rounding cancellous bone. The tarsals and carpals in the ankle and wrist
are examples of short bones.
Sesamoid Bones These are bones that are embedded in a tendon. They are
similar in structure to short bones. They act to increase the mechanical
effect of the tendon and reduce the amount of wear on the tendon. In
humans the patella (knee bone) is an example of a sesamoid bone.
Irregular Bones These are bones that do not fit into any of the above cate-
gories, such as the vertebrae. They often have complicated and irregular
geometries. Structurally they consist of cancellous bone in a thin shell
of cortical bone.
A.3 Bone Structure
Based on the descriptions above bones can be broadly classified into two cat-
egories, those that are long bones and have a well defined structure and those
that are not long bones. These bones have irregular geometries and struc-
turally are composed of a thin cortical shell surrounding cancellous bone.
Most models (both biological and mathematical) of fracture healing focus on
mid shaft fractures of long bones. Within this thesis we continue that trend,
and will focus on these types of fractures.
A.3.1 Long Bone Structure
The structure of long bones is well defined. A typical schematic is shown in
A.1. The general structure can be described as a long, thin shaft, known as
the diaphysis, connecting two wider ends, known as the epiphysis or heads of
the bone.
The boney material that makes up the diaphysis is known as compact or
cortical bone. This cortical bone is dense and well structured giving strength
to the bone. The cortical bone forms a hollow cylindrical shape. The hollow
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Image removed due to copyright.
Please see Aspinall et al. (2004).
Figure A.1: Typical schematic of a long bone, (Aspinall et al. 2004).
inside the diaphysis is known as the medullary cavity and contains the bone
marrow. The cortical bone is surrounded by two membranes. The first on
the exterior of the bone is known as the periosteum. This fibrous membrane
contains many potential bone cells for required for bone repair or remodelling.
The other membrane is the endosteum which separates the cortical bone from
the marrow.
The epiphysis has a different structure. Here the cortical bone shell is much
thinner and the interior space is filled with cancellous bone, also known as
spongy bone due to its appearance. The epiphysis also contains the growth
plates. As an immature individual grows the cartilage in the growth plate
also grows and becomes mineralised bone via a process known as endochondral
ossification. As the individual matures, the cartilage becomes fully mineralised
and the bone growth is halted. In addition the ends of long bone are also
covered in articular cartilage. This cartilage allows the bone to move smoothly
during movement and provides some shock absorption for the bone. It is the
degradation of this articular cartilage that leads to osteoarthritis.
A.3.2 Cortical and Cancellous Bone
Cortical bone is the hard, dense bone that comprises the majority of bone
mass and is responsible for most of the bones structural strength (Jee 2001).
Mature cortical bone is comprised of many microscopic layers, laid together
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Image removed due to copyright.
Please see Arnett (2008).
Figure A.2: Transverse section through cortical bone showing the osteon structure (Arnett
2008).
like plywood. These layers are known as lamellae and are 3-7µm thick. Within
these lamellae the collagen fibres and mineral crystal lattice are well aligned,
however there is a difference in alignment between adjacent lamellae Most of
these lamellae form in concentric circles surrounding a channel known as the
Haversian canal which contains the blood vessels and nerves of the bone. A
group of lamellae surrounding a Haversian canal is known as a osteon.
An illustration of a osteon structure is shown in Figure A.2. This figure
is representative of a transverse section taken through cortical bone. The
concentric nature of the lamellae can be seen. Osteons are cylindrically shaped
and run longitudinally with the bone. They are typically around 200-250µm
in diameter (Jee 2001).
Cancellous bone, has a much less defined structure. It is constructed from a
network of rods and plates known as trabeculae. This network of trabeculae
gives the cancellous bone a very porous structure. These interconnected pores
contain red bone marrow, which is responsible for the production of red and
white blood cells and platelets (Scanlon & Sanders 2011, Doblare´ et al. 2004).
Due to its structure cortical bone has a much larger surface area to volume
ratio. This allows the cancellous bone to be formed or resorbed quickly to
help maintain calcium and other mineral homeostasis (Clarke 2008).
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A.3.3 Important Cells
There are many different cell types that are present during different stages of
bone development, maintenance and reparation. The key bone cells include
osteoblasts, osteoclasts and osteocytes. Other cells which play important roles
during bone formation include chondrocytes, mesenchymal stem cells (MSC)s
and endothelial cells.
Osteoblasts Osteoblasts are the bone forming cells. They differentiate from
MSCs through a progression of stages, from MSC to committed os-
teoblast precursor to pre-osteoblast to mature osteoblast (Majeska 2001).
They are polarised, cuboidal in shape and about 15-30µm thick. Mature
osteoblasts rarely proliferate (Jee 2001).
Mature osteoblasts produce the collagen matrix of bone tissue and con-
trol is alignment, and regulate the mineralisation of this matrix. The
functions of osteoblasts are known to be controlled by the presence of
many different growth factors present during bone formation (Barnes
et al. 1999).
Quiescent osteoblasts are present on the surface of bone tissue. These
cells are sometimes referred to as bone lining cells. it is believed that
these cells help maintain a separate region of bone fluid from the ex-
tracellular fluid. In this bone fluid the concentrations of calcium and
phosphate ions can be more closely controlled, which in turn will regu-
late bone crystal growth (Jee 2001).
Osteocytes As the osteoblasts produce the bone matrix some may become
trapped in the new matrix and turn into osteocytes. Osteocytes have
small bodies but posses long cell processes spread through the bone ma-
trix. This allows the osteocytes to sense changes in the bones mechanical
loading, detect microdamage to the bone and signal other osteocytes or
cells (Majeska 2001).
Osteoclasts Osteoclasts are giant multinucleated cells that are able to re-
sorb bone. They attach tightly to the bone forming an impermeable
barrier, this gives rise to a sealed compartment between the cell and the
existing bone surface. Within this compartment the osteoclasts create
a highly acidic local environment. The acidic environment dissolves the
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bone mineral releasing calcium and phosphate ions. The osteoclasts also
secrete a range of proteases that digest the collagen matrix. By possess-
ing the ability to free minerals from the bone matrix osteoclasts play a
key role in maintaining calcium homeostasis (Jee 2001, Clarke 2008)
Mesenchymal Stem Cells Mesenchymal stem cells are multiplurent stem
cells that have the ability to differentiate to form many different tis-
sue types including bone, cartilage, bone marrow, muscle, tendons and
ligaments. They can thus be found in all of these tissue types. The dif-
ferentiation of these cells is controlled by different physical and chemical
stimuli (Prendergast & van der Meulen 2001).
Chondrocytes These are cartilage forming cells. During endochondral bone
formation a cartilage matrix is formed by chondrocytes and is then min-
eralised to form mineralised bone (Einhorn 1998).
Endothelial Cells These cells form the new blood vessels throughout the
bone. Vascularisation occurs early during fracture healing in the same
region as intramembranous bone is forming. The blood vessels spread
toward the fracture gap and help to convert cartilage tissue into miner-
alised bone (Glowacki 1998). If insufficient vascularisation occurs during
healing then it is likely that the fracture will not fully heal, resulting in
a non-union (Augat et al. 2005).
A.3.4 Collagen and Mineral Structure
The noncellular component of bone is a matrix of collagen fibres that have
been mineralised. The mineral is hard but brittle whereas the collagen matrix
is soft and tough(resistant to fracture). The composite nature of bone tissue
has the advantages of both of these material types to create bone tissue that
is stiff and resistant to fracture (Fratzl et al. 2004, Ashby et al. 1995).
Bone mineral is typically described as an impure form of hydroxyapatite
(Ca5(PO4)3(OH)), other ions that are present in the mineral phase include
magnesium, sodium and carbonate. As well as providing strength to bones,
the mineral component of bone provides a pool of calcium and phosphate that
can be accessed by the body when required (Boskey 2001).
Collagen I is the main organic component of bone and is expressed by os-
teoblasts. It is also the main collagen type found in skin and arterial walls. In
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bone, the collagen molecules align themselves to form fibrils The molecules in
these fibrils are aligned in staggered parallel lines. As part of this staggered
structure between the end of adjacent molecule there is a 40 nm gap, known
as a hole zone. These hole zones play an important role in mineralisation as
they provide the first nucleation points for crystal growth (Mann 2001). The
collagen matrix also contains many other non-collagenous proteins. Some of
these proteins help aid mineralisation by attracting calcium or phosphate ions
and acting as nucleation points for the hydroxyapatite growth (Boskey 2001).
A.4 Mechanism of Bone Formation
Bone can be formed by two different mechanisms, endochondral or intramem-
branous ossification. During endochondral ossification bone is formed through
an intermediary cartilage stage, whereas in intramembranous ossification the
new bone forms directly.
During development and growth endochondral ossification is responsible for
the formation and lengthening of long bones. It also plays an important
role in fracture healing. During fracture healing endochondral ossification oc-
curs across the fracture gap, where there is little mechanical stability. Chon-
drocytes present form a cartilage matrix which stabilises the fracture gap.
Through the process of endochondral ossification this cartilage matrix even-
tually becomes a boney matrix allowing the fracture gap to be bridged by
bone.
Intramembranous ossification is where bone is formed directly by osteoblasts
without an intermediary cartilage stage. Intramembranous ossification is re-
sponsible for the formation of flat bones such as the bones in the skull. In
fracture healing intramembranous ossification occurs in regions of high me-
chanical stability. Here the new bone is formed appositionally on existing
bone near the fracture gap.
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BIntroduction to Turing pattern formation
From the spots on a leopard’s skin to the skeletal structure of limbs, patterns
are widely evident across nature. The development of form and structure in an
organism is termed morphogenesis. Morphogenesis is most readily associated
with the developing embryo however it can also occur during growth or tissue
repair.
Turing pattern formation is one mechanism that has been proposed as a math-
ematical description of morphogenesis. Mathematical models for Turing pat-
tern formation are well studied and there exists a series of known conditions
that must be satisfied for patterning to occur. Through the work of Segel
& Jackson (1972) and Gierer & Meinhardt (1972) it has been established
that patterning only occurs in a two species system when there is local self-
enhancement and long-range inhibition.
We can further derive a set of more rigorous conditions to determine whether
patterning will arise. In the process of this we will also reveal other aspects
of Turing patterning that influence the form of the final pattern.
B.1 Diffusion Driven Instability
These days Turing patterns are generally described as forming due to a dif-
fusion driven instability. This occurs when a steady state for a system of
equations is stable in the absence of diffusion, however when diffusion is in-
cluded the steady state becomes unstable. A pattern is then formed as a new
spatially heterogeneous stable steady state evolves (see Figure B.1(c)).
The idea that the inclusion of diffusion could give rise to spatial patterns is
counter-intuitive as diffusion is typically seen as a stabilizing process. During
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t = t0
t = t1
(a) (b) (c)
Figure B.1: Plots showing instability introduced by diffusion. When (a) diffusion or (b)
reaction terms only are considered the solution tends to a spatially homogeneous
state. When (c) both reaction and diffusion terms are considered the system
tends to a spatially non-homogeneous steady state.
diffusion, matter moves from areas of high concentration to areas of low con-
centration. This results in a smoothing process and the entire region will, as
t→∞, all be at the same concentration as illustrated in Figure B.1(a). Sim-
ilarly perturbations from a homogeneous stable steady state for some given
reaction will eventually return to the homogeneous steady state as in Fig-
ure B.1(b).
B.2 Turing Mechanisms
The following equations describe a general reaction diffusion system involving
two species.
∂A
∂t
= DA∇2A+ F (A,B) (B.1)
∂B
∂t
= DB∇2B +G(A,B) (B.2)
where A, B are the concentrations of two different chemicals, DA, DB are
the diffusion coefficients of A, B respectively and F , G are the (non-linear)
kinetics of the system. A and B are chosen such that A represents the slower
diffusing chemical (DA < DB). The kinetics of the system describe the inter-
action between A and B. Some common kinetics that produce Turing pat-
terns are Schnackenberg (Schnackenberg 1979) and Gierer-Meinhardt (Gierer
& Meinhardt 1972).
Equations (B.1) and (B.2) can be nondimensionalised by setting x∗ = x/L,
t∗ = t/tˆ and d∗ = DB/DA, where L is the typical length scale and tˆ = L2/DA.
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We also set u∗ = A/Aˆ and v∗ = B/Bˆ as the dimensionless concentrations.
The appropriate choice of Aˆ, Bˆ is determined by the kinetics. This gives the
general form
∂u∗
∂t∗
= ∇2u∗ + γf(u∗, v∗), (B.3)
∂v∗
∂t∗
= d∗∇2v∗ + γg(u∗, v∗), (B.4)
where f(u∗, v∗), g(u∗, v∗) are the dimensionless kinetics and γ is a constant
proportional to L2/DA, the exact form of which depends on the kinetics.
B.3 Conditions for Diffusion Driven Instability
Diffusion driven instability occurs when a steady state that is stable in the
absence of diffusion becomes unstable when diffusion is present. As such it is
possible to derive a set of conditions on the parameters in Equation (B.3) and
Equation (B.4) such that this instability can occur. The following derivation
of the conditions required for diffusion driven instability to occur is based
mostly upon the approach presented in Murray (2003).
We start by determining the conditions for stability of the steady state in the
absence of diffusion. Removing diffusion the system becomes, with the *’s
dropped for convenience
∂u
∂t
= γf(u, v), (B.5)
∂v
∂t
= γg(u, v). (B.6)
The stability of the steady state (u¯, v¯) = (u0, v0) can be determined by lin-
earising about the steady state,
ut = γ(fu(u0, v0)(u− u0) + fv(u0, v0)(v − v0)) (B.7)
vt = γ(gu(u0, v0)(u− u0) + gv(u0, v0)(v − v0)). (B.8)
From here on it will be assumed that fu, fv, gu, gv are the respective functions
evaluated at u0, v0. By setting
w =
(
u− u0
v − v0
)
, A =
[
fv fu
gu gv
]
, (B.9)
we can rewrite Equation (B.7) and Equation (B.8) as
wt = γAw. (B.10)
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The steady state is stable if the real part of both the eigenvalues of A are
negative. For a 2× 2 matrix, M , the eigenvalues, λ, are the solution to
λ2 − tr(M)λ+ |M | = 0, (B.11)
i.e. the eigenvalues are given by
λ =
tr(M)±√tr(M)2 + 4|M |
2
. (B.12)
From this we see that for Re{λ} < 0, we must have tr(M) < 0 and |M | > 0.
Thus for our steady state (u¯, v¯) = (u0, v0) we are guaranteed stability if
tr(γA) = γ(fu + gv) < 0 ⇒ fu + gv < 0 (B.13)
|γA| = γ2(fugv − fvgu) > 0 ⇒ fugv − fvgu > 0. (B.14)
These are the first two conditions that must be satisfied for diffusion driven
instability to occur.
We now consider the full reaction diffusion system given by equations (B.3)
and (B.4). Linearising about the steady state gives
wt = γAw +D∇2w (B.15)
where
D =
[
1 0
0 d
]
. (B.16)
This is a partial differential equation (PDE) which can be solved using sepa-
ration of variables. We set
w(x, t) = W(x)T (t), (B.17)
and by following the standard process we obtain
∇2W = −k2W, (B.18)
where k is an eigenvalue of the PDE, also referred to as the wavenumber.
From separation of variables we also expect that our time solution will take
the form
T (t) = ceλt. (B.19)
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Since the problem is linear we expect a superposition of solutions such that
our final solution has the form
w =
∑
k
cke
λtWk(x), (B.20)
where ck are coefficients which can be determined from a Fourier expansion
of the initial conditions.
We can substitute Equation (B.18) and Equation (B.20) into Equation (B.15).
Our system, for each k, is now
λcke
λtWk(x) = γcke
λtAWk(x)− k2ckeλtDWk(x), (B.21)
which can be rearranged as
cke
λtWk(λI − γA+Dk2)(x) = 0. (B.22)
For a matrix equation Bx = 0 a non-trivial solution for x only exists if |B| = 0.
This means that
|λI − γA+Dk2| = 0. (B.23)
This is equivalent to finding the eigenvalues λ of the matrix
M = γA−Dk2 (B.24)
=
[
γfu − k2 γfv
γgu γgv − dk2
]
. (B.25)
These eigenvalues determine the stability of the steady state. For diffusion
driven instability to occur the steady state must now be unstable. For the
steady state to be unstable the real part of at least one eigenvalue must be
positive. From Equation (B.12) we see that this will occur if tr(M) > 0 or
|M | < 0.
The tr(M) is given by
tr(M) = γ(fu + gv)− (1 + d)k2. (B.26)
From the condition given in Equation (B.13) we know that fu + gv < 0, and
also by definition d > 0 and γ > 0. From this we see that tr(M) < 0 and that
for a diffusion driven instability to occur |M | < 0. The |M | is given by
|M | = γ2(fugv − fvgu)− k2γ(dfu + gv) + dk4. (B.27)
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Since fugv − fvgu > 0 from the condition in Equation (B.14) it must be that
dfu + gv > 0, (B.28)
in order to have |M | < 0. However fu + gv < 0, so d 6= 1 is required.
Equation (B.28) is the third condition for diffusion driven instability. It is
necessary but not sufficient for |M | < 0.
To get the final condition we consider that Equation (B.27) is a quadratic in
terms of k2. For |M | < 0 for some values of k2, it follows that the minimum
value of |M | must be negative. |M |min occurs at
k2 =
γdfu + gv
2d
(B.29)
and is given by
|M |min = −γ
2(dfu + gv)
2
4d
+ γ2(fugv − fvgu). (B.30)
By solving for |M |min < 0, we get the final condition
(dfu + gv)
2 > 4d(fugv − fvgu). (B.31)
For given reaction kinetics there exists a critical value of the diffusion ratio
d = dc for instability to occur. The critical value occurs when |M |min = 0.
Remembering that the equations were set up such that d > 1, dc is found as
the appropriate root of
f2ud
2
c − 2(fugv − 2fvgu)dc + g2v = 0 (B.32)
Given this, a critical wavenumber, k2c can also be found as
k2c =
γ(dcfu + gv)
2dc
(B.33)
Figures (B.2a) and (B.2b) show |M | and Re{λ}, respectively, as functions of
k2 for different d. As can be seen when d < dc there are no values of k
2
for which |M | < 0 and equivalently Re{λ} > 0 and so no diffusion driven
instability will occur. When d > dc there is a range of k
2 values that give
|M | < 0 and Re{λ} > 0. In this case the value of k2 that corresponds to
the maximum value of Re{λ} will be the dominant wavenumber in the final
pattern.
The four conditions for diffusion driven instability to occur are given by Equa-
tions (B.13), (B.14), (B.28) and (B.31) and are summarised in Table B.1.
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Figure B.2: Effect of diffusion coefficient on |M | and Re{λ} for Schnackenberg kinetics with
a=0.2, b=2.
Conditions for Diffusion Driven Instability
fu + gv < 0
fugv − fvgu > 0
dfu + gv > 0
(dfu + gv)
2 > 4d(fugv − fvgu)
Table B.1: Conditions for diffusion driven instability.
B.3.1 Physical solutions
The above conditions must be satisfied for diffusion driven instability to occur
on an infinite domain. To ensure that the patterns are biologically realistic
it must be that neither u nor v become negative or grow infinitly large. This
introduces an extra constraint that is often overlooked. The kinetics must
have a confined set in the positive quadrant
A confined set (also known as a bounded domain) exists if a closed curve
can be found in the (u, v) domain where all phase trajectories on the curve
point into the enclosed domain. This means that once a trajectory enters the
domain it cannot leave the domain, since if the trajectory were ever to reach
the boundary, it would move back into the domain. For a confined set to exist,
we must have that for all points on the boundary
n.
(
du
dt
,
dv
dt
)
≤ 0, (B.34)
where n is the outward pointing normal to the boundary. It can be shown that
a confined set for the non-diffusive kinetics is also a confined set when diffusion
is included (Smoller 1994). The important implication of this is that if a
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confined set in the positive quadrant exists, then the solution obtained when
diffusion is included will have finite amplitude and solutions will never become
negative. If no such confined set exists then the solutions obtained with the
inclusion of diffusion will tend toward infinity and/or become negative, which
would both result in unrealistic solutions.
B.4 Finite Domains
A further consideration in a biological context is that we are restricted to
a finite domain and both domain size and boundary conditions effect the
appearance of the final pattern. For example for a given domain size it may
not be possible for any of the patterns associated unstable wavenumbers to fit,
and hence no pattern will be observable. We demonstrate this by considering
a 1D domain of length 1 unit, with the parameters set such that unstable
wavenumbers are associated with patterns with wavelengths between 8–10
units. Because the domain is much shorter then the wavelength of the possible
patterns we do not expect to observe any patterns across the domain. This
behaviour is also influenced by the boundary conditions.
Another example of this demonstrates the importance of the boundary condi-
tions. Consider the case of of a 1D domain 0 ≤ x ≤ p, with zero flux boundary
conditions. These boundary conditions imply that the slope of the curve will
be zero at the endpoint so the domain and hence that concentrations will be at
either the maximum or minimum value. This means that for a pattern to fit it
must be that the domain length is an integer multiple of half its wavelength.
The following provides a mathematical derivation of this.
If we consider the spatial eigenvalue problem in Equation (B.18) with our
imposed zero flux boundary conditions we get the following system of ODEs,
d2W
dx2
+ k2W = 0,
dW
dx
∣∣∣∣∣
x=0
=
dW
dx
∣∣∣∣∣
x=p
= 0.c (B.35)
Solving this gives
Wn = An cos(kx), n = 0, 1, 2, ... (B.36)
where
k =
npi
p
. (B.37)
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For each k the resultant pattern will have a wavelength of
l =
2pi
k
=
2p
n
, (B.38)
that is domain length p is an integer multiple of half the wavelength l, as
described above.
Equation (B.37) gives the allowable values of k for this domain. For a diffusion
driven instability to occur it must be that not only the conditions given in
Table B.1 are satisfied but that the eigenvalue λ associated with at least 1
admissible wave number k as given by Equation (B.37) has Re{λ} > 0.
It is possible that their exists multiple values of k which satisfy Re{λ} > 0.
Remembering that the linear solution is given by
w =
∑
k
cke
λt cos(kx), (B.39)
we see that the solution is a superposition of all unstable modes. We would
expect that the dominant mode of our solution would be that corresponding to
the largest value of λ. This is because this mode would be the fastest growing
mode when the system is perturbed from the steady state.
In reality this is only true for patterns with a low dominant mode. For larger
modes the nonlinearities present in the equations have an increased effect and
the expected dominant mode from the linear analysis may not be the dominant
mode present in the ultimate pattern (Murray 2003).
Thus the appearance of Turing patterns is shaped by both the parameters
of the model and the domain conditions. The parameters must satisfy the
conditions given in Table B.1. In addition to this the domain size and bound-
ary conditions need to be appropriate given the choice of parameters to allow
patterning to be observed.
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C.1 Introduction
Throughout this thesis a variety of numerical methods have been used to solve
the PDEs and ODEs that formed our model equations. These methods were
implemented in MATLAB (Release 2012b), a software package/high level cod-
ing language that is designed for solving complex mathematical problems. As
part of this it contains a suite of highly efficient and optimised ODE solvers.
Because of this, as much as possible we utilised the tools and functions already
available within MATLAB (Release 2012b). One of the potential disadvan-
tages with MATLAB (Release 2012b) is that because it is an interpreted lan-
guage the runtimes in MATLAB (Release 2012b) will always be slower than
for a similar script in a complied language such as C++. This can cause prob-
lems for large complex systems which end up with huge runtimes. However
in the simulations we conducted we did not encounter any excessively long
runtimes.
MATLAB (Release 2012b) has functions available to solve both systems of
ODEs (the ode family of functions) and parabolic and elliptic PDEs with one
spatial dimension (pdepe) and we used these to solve our model equations as
appropriate. However MATLAB (Release 2012b) does not have the function-
ality to solve PDEs with more then one spatial dimension. Instead, for our
simulations of a two dimensional domain we used a methods of lines approach.
This meant that we first performed a spatial discretisation of our domain us-
ing the finite volume method. This gives a system of ODEs which we could
then be solved using a suitable ODE solver in MATLAB (Release 2012b).
As we moved to more complex problems with growing and shrinking domains
the above approach needed to be adapted. Two methods were explored to
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handle these changing domains. Firstly we followed the approach in Illing-
worth & Golosnoy (2005) and rescaled to a fixed domain, and then rewrote
the equations in such a way to give new conservative PDEs which we could
then solve using the previously described approach. The second approach im-
plemented but ultimately not used in any of the simulations presented in this
thesis was the level set method.
C.2 Finite Volume Method
The finite volume method (FVM), also known as the control volume method
is a numerical method used to discretise PDEs. It is popular in the fields
of computational fluid dynamics, numerical heat transfer and transport in
porous medium. An important reason for this popularity is that the FVM
results in a conservative discretisation of the PDE, this allows the solution to
retain the conservation present in the original equation.
We present here a basic introduction to the finite volume method. Initially
we focus on a 1D discretisation discuss and demonstrate the process. We
then take the 1D discretisation and use this as a basis to extend to a 2D
discretisation. For a more detailed derivation of the finite volume method the
reader is directed towards the many texts that can be found on the subject
including Patankar (1980) and Versteeg (1995).
C.2.1 Mesh Grids
The domain on which we wish to solve our PDE is divided up using a mesh
structure. The mesh is constructed from a series of nodes, which are connected
to form elements. Node points can be regularly or irregularly spaced. In two
dimensions elements are rectangles for a regular grid of nodes or typically
triangles or quadrilaterals for an irregular grid. In three dimensions elements
are typically tetrahedrons or hexahedrons.
The mesh is used to construct control volumes. This can be done using either
a cell-centred or vertex-centred approach. In the cell-centred approach the
control volumes are the elements and the discrete values of the solution are
stored at the centroid of the cell. In a vertex-centred approach the solutions
are stored at the nodes and the control volume is constructed to surround the
node.
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Boundary CV Interior CV
Figure C.1: Diagram of node distribution for a 1D problem, nodes are indicated by black
dots and cell faces as dashed lines. We note that in this image the nodes are
all separated by the same distance, this type of mesh is often referred to as a
uniformly spaced mesh. A useful feature of the finite volume method is that it
is not a requirement that the mesh be uniformly spaced. Instead the mesh can
be designed to suit the particular problem and domain.
C.2.2 Discretisation in 1D
We start by illustrating the discretisation for a vertex centred finite volume
discretisation in 1D. This discretisation is valid for a generalised advection
diffusion equation
∂φ
∂t
+
∂
∂x
(
vxφ−Dxx∂φ
∂x
)
= S. (C.1)
Here vx is the advection velocity and Dxx is the diffusion coefficient, these
coefficients are not necessarily constant and instead could depend on φ, x or
t. The term S is the source term, a function of φ, x and t. This equation is
often written as
∂φ
∂t
+
∂
∂x
(J) = S, (C.2)
where
J = vxφ−Dxx∂φ
∂x
, (C.3)
and is the flux due to both advection and diffusion. The boundary conditions
are given by
vxφ−Dxx∂φ
∂x
= k(φ∞ − φ) at x = 0, (C.4)
vxφ−Dxx∂φ
∂x
= −k(φ∞ − φ) at x = L. (C.5)
We note that in the limit k →∞ the generalised boundary conditions become
Dirichlet conditions. The initial condition is
φ(0, x) = φ0(x). (C.6)
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xW xP xE
∆xp
δxw δxe
xw xe
Figure C.2: Diagram of an interior node, demonstrating the notations used in this section.
The following conventions are used, capital subscripts refer to values at the
node points, for example P refers to the current point, and E and W refer
to the points to the east and west respectively. Lower case subscripts refer to
values at the faces, again the subscripts e and w referring to the east and west
face, relative to the current node. When describing the spatial properties of the
grid an upper-case ∆x refers to a individual cells width, whereas a lower-case
δx refers to the distance between cells, again the subscripts e and w to denote
between the east and west.
A regularly spaced vertex centred mesh is illustrated in Figure C.1. An indi-
vidual interior node is illustrated in Figure C.2. This figure also provides an
illustration of the notation used in the following discretisation.
In the following we are only deriving a spatial discretisation. The temporal
integration can then be completed numerically by a variety of methods includ-
ing the use of the many widely available numerical integrators available (such
as ode45 or any of the other ODE solvers available with MATLAB (Release
2012b), or the sundials package).
Taking Equation (C.2) and integrating over the control volume we get∫ xe
xw
∂φ
∂t
dx+
∫ xe
xw
∂
∂x
(J) dx =
∫ xe
xw
S dx. (C.7)
We introduce control volume averages
φ¯P =
1
∆xP
∫ xe
xw
φ dx, (C.8)
and
S¯P =
1
∆xP
∫ xe
xw
S dx, (C.9)
to get
∂φ¯P
∂t
+
1
∆xP
(Je − Jw) = S¯P . (C.10)
Here Je and Jw is the flux evaluated at the east and west face respectively.
We can approximate the control volume averages as the value at the node P
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and write
∂φP
∂t
+
1
∆xP
(Je − Jw) ≈ SP . (C.11)
We note that for a uniformly spaced grid this approximation will be second
order accurate. All that is left now is to approximate the flux at the faces, Je
and Jw.
C.2.3 Treatement of the Diffusion Term
In the case where vx = 0 then there is no advection and flow is purely diffusive.
The expression for the east flux becomes,
Je =
(
−Dxx∂φ
∂x
)
e
, (C.12)
= −Dxxe
(
∂φ
∂x
)
e
. (C.13)
Here Dxxe is the diffusion coefficient evaluated at the east face. In the case of
a non-constant diffusion coefficient care must be taken in the approximation
of Dxxe , however this level of detail is beyond the level required in this thesis.
The remaining term
(
∂φ
∂x
)
e
is the x derivative of φ evaluated at the east face.
A natural approximation of this derivative is to use(
∂φ
∂x
)
e
≈ φE − φP
δxe
. (C.14)
This gives the east flux as
Je ≈ −Dxxe
φE − φP
δxe
, (C.15)
and simiarly we find the west flux as
Jw ≈ −Dxxw
φP − φW
δxw
. (C.16)
These flux approximations are second order accurate for a uniformly spaced
grid.
C.2.4 Treatment of the Advection Term
We now present a method for the discretisation of the advection term. There
are many methods that can be used to implement this discretisation, including
averaging and up-winding. Averaging and up-winding are simple to implement
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xWW xW
φ2up
xP
φup
xE
φdwn
vx
φe
∂φ
∂x 2up
∂φ
∂xup
Figure C.3: Illustration of the labels used in the description fo flux limiting to find the value
of φe, for an advection from left to right.
but have drawbacks. Instead, in this thesis we use an approach known as flux
limiting, and use the van Leer limiter. This method is both second order
accurate in space and will not give spurious oscillations in the solution (van
Leer 1974, Sweby 1984).
With advection the flux on the east face is
Je = vxeφe −Dxxe
(
∂φ
∂x
)
e
. (C.17)
The diffusion component of this equation can be approximated in the same
fashion as before. We assume that the velocity at the face, vxe , can be found
exactly. However we need a way to approximate φe, that is the value of φ at
the east face.
When using flux limiting to approximate φe we introduce a limiter function
σ(r) where r is a sensor to be defined. The value of φe at the face is then
given as
φe ≈ φup + σ
2
(φdwn − φup), (C.18)
where φup is the upstream value of φ and φdwn is the downstream value as
illustrated in Figure C.3. When the velocity is positive, the advective flow
is from left to right. In this case to find φe, the downwind value is φE and
the upwind value is φP . If the velocity was negative (flow from right to left)
these would be reversed. We note that through our choice of σ we can achieve
averaging (σ = 1), up-winding (σ = 0) or down-winding (σ = 2). For van
Leer flux limiting σ is given by
σ(r) =
r + |r|
1 + |r| . (C.19)
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xB
xE
∆xb
δxe
xe
Figure C.4: Diagram illustrating the notation used for boundary nodes. The diagram shows
the boundary at x = 0 and we note the introduction of the subscript B to
illustrate the boundary nodes.
To evaluate σ we use a sensor r defined as
r =
(
∂φ
∂x
)
2up(
∂φ
∂x
)
up
(C.20)
where the subscript 2up indicates the value at the second upwind face and the
subscript up indicates the value at the upwind face.
C.2.5 Boundary Nodes
For the boundary nodes a similar process is followed to obtain the discreti-
sation. The boundary at x = 0 is illustrated in Figure C.4. We note the
introduction of the subscript b to indicate the boundary node, face and con-
trol volume. Integrating across the control volume and introducing the control
volume averages φ¯ and S¯ gives
∂φ¯P
∂t
+
1
∆xb
(Je − Jb) = S¯P . (C.21)
We approximate the cell averages as the value at the boundary and yhe east
flux can be approximated using the methods described above. This leaves
only the flux at the boundary, Jb to be found. Equation (C.4) explicitly states
the flux and hence can simply be substituted into this equation. Thus for the
boundary cell at x = 0 we can write
∂φB
∂t
≈ 1
∆xb
(Je − k(φ∞ − φB)) + SB. (C.22)
Using the same process a similar expression can be formulated for the bound-
ary at x = L.
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Figure C.5: Schematic of a rectangular grip over a 2D domain. The circles are nodes and
the solid lines the cell faces.
C.3 Finite Volume Method in Two Dimensions
In the following section we extend the discretisation presented above to a 2D
mesh. Whilst it is possible to use a irregular mesh, in this section we focus
purely on a discretisation on a regular mesh grid, such as that illustrated in
Figure C.5, as this was the scheme used throughout the thesis. In 2D the
generalised equation to be discretised is
∂φ
∂t
+∇ · (−D∇φ+ vφ) = S, (C.23)
where D is the diffusion tensor and v is the advection velocity. As in the one
dimensional case we can introduce an expression for the flux
J = −D∇φ+ vφ. (C.24)
We consider generic boundary conditions
−D∇φ+ vφ = k(φ∞ − φ), onx ∈ ∂Ω (C.25)
and initial condition
φ(x, y, 0) = φ0(x, y). (C.26)
In Figure C.6 we illustrate a typical interior control volume and its neighbours.
If we integrate over the control volume we get∫
ΩP
∂φ
∂t
dV +
∫
ΩP
∇ · J dV =
∫
ΩP
S dV. (C.27)
We introduce the control volume averages
φ¯P =
1
VP
∫
ΩP
φ dV, (C.28)
S¯P =
1
VP
∫
ΩP
S dV, (C.29)
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φP φEφW
φN
φS
∆xP
∆yP
δxw δxe
δxn
δxs
Figure C.6: Diagram of a typical control volume in 2D demonstrating the notation.
where VP = ∆xP∆yP is the area of the control volume and use these to rewrite
Equation (C.27) as
∂φ¯P
∂t
+
1
VP
∫
ΩP
∇ · J dV = S¯P . (C.30)
We turn our attention now to approximating the second term in this equation.
From Gausses law we can write this term as∫
ΩP
∇ · J dV =
∫
∂ΩP
J · nˆ dS, (C.31)
=
∑
j∈n,e,s,w
∫
∂ΩPj
J · nˆ dSj . (C.32)
for a rectangular cell such as that in Figure C.6. If we consider for example the
east face. Here the normal is defined as nˆ = i. Thus we introduce the notation
Je = J · nˆ as representing the horizontal component of the flux evaluated at
the east face. The total flux lost through the east face is∫
∂ΩPe
Je dSe = J¯e∆yp, (C.33)
where J¯e is the average value of Je along the face. We use a midpoint ap-
proximation for this average value and take J¯e as the value of the flux at the
midpoint of the face (x, y) = (xe, yp). Furthermore we need to approximate
the value of the flux at this point. In the case of pure diffusion we can use the
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same approximation as the one dimensional case and get∫
∂ΩPe
Je dSe ≈ DxxφE − φP
δe
∆yp. (C.34)
Using the same arguments for the north, south and west faces we can write
the following approximation∫
ΩP
∇ · J dV ≈ (Je − Jw)∆yp + (Jn − Js)∆xp (C.35)
≈ Dxx
(
φE − φP
δxe
− φP − φW
δxw
)
∆yp
+Dyy
(
φN − φP
δyn
− φP − φS
δys
)
∆xp
(C.36)
With the inclusion of advection terms the approximation of the flux becomes
more difficult. The use of averaging is the simplest of the methods. Up-
winding and flux limiting can be used however their use introduces additional
complexities, particularly when the velocity field is complex. For example,
consider a velocity field that curves by 90◦ from heading north to heading
east. If we consider a node point just after the bend, is the upwind point to
the west of the node or to the south?
For the purposes of these thesis we do not encounter these problems. In all
of our simulations with advection the velocity vector v = [Vx, 0] only has a
horizontal component. Thus we can safely use flux-limiting to approximate
the flux due to advection in the horizontal direction.
The treatment of the boundaries done in a manner similar to the 1D case.
Again we note that the boundary condition Equation (C.25) explicitly states
the flux at the boundary. We can simply substitute this boundary flux for the
relevant term in Equation (C.35).
C.4 Simulations on a Growing or Shrinking
Domain: A Rescaling Approach
In some of the models we consider there is a need to be able to numerically
solve a moving boundary problem, with both growing and shrinking domains.
One approach that can be used to solve these moving boundary problems is
to rescale the problem to static domain. In order to use the FVM on this
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rescaled problem we need to convert it to conservative form. To do this we
use follow the approach in (Illingworth & Golosnoy 2005). In this section we
consider a 2D domain that is static in the y direction but the boundaries in the
x direction are moving. We enforce no specific directionality on the movement
of these boundaries, rather there direction will be determined by the velocity
function. This formulation can be reuduced to either of the moving boundary
problems in Chapters 4 and 5. Throughout the domain we solve the generic
PDE
∂φ
∂t
= D∇2φ+ S, (C.37)
where D is the diffusion constant and S is the source function, possible de-
pendent on φ, x, y or t. We note that there is no advection considered in this
initial PDE as there was no advection in any of our models. At this stage
we do not define any boundary conditions but will discuss the effect of the
rescaling on the boundary conditions as used in our models later on. We will
however define the velocity of the moving boundaries as
dL1
dt
= v1, (C.38)
dL2
dt
= v2, (C.39)
where v1 and v2 are functions that describe the velocity of the boundary. By
convention if the velocity is positive the boundary moves to the right and if it
is negative it moves to the left. Finally we define the initial condition as
φ(x, y, 0) = φ0. (C.40)
Since the domain is only changing in the x direction this is the only direction
in which we need to apply the scaling. We introduce a new spatial variable,
ζ ∈ [0, 1], and rescale x as
ζ(t) =
x− L1(t)
L2(t)− L1(t) . (C.41)
Applying this scaling to Equation (C.37) gives
∂φ
∂t
+
∂ζ
∂t
∂φ
∂ζ
= D
(
∂ζ
∂x
)2∂2φ
∂ζ2
+D
∂2φ
∂y2
+ S, (C.42)
Evaluating the partial derivatives of ζ and introducing the notation L′1 and
L′2 to represent the temporal derivatives of L1 and L2 we get
∂φ
∂t
+
(ζ − 1)L′1 − ζL′2
L2 − L1
∂φ
∂ζ
=
(
D
L2 − L1
)2∂2φ
∂ζ2
+D
∂2φ
∂y2
+ S. (C.43)
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This can be rewritten in conservative form as
∂µ
∂t
=
∂
∂ζ
(
D
(L2 − L1)2
∂µ
∂ζ
+
ζL′2 + (1− ζ)L′1)
L2 − L1 µ
)
+D
∂2µ
∂y2
+ (L2 − L1)S,
(C.44)
where µ = (L2 − L1)φ. This equation is conservative for the quantity µ =
(L2 −L1)φ, we could write it in the form given in Equation (C.23) and hence
easily solve this PDE numerically using the FVM. We notice that whilst our
original equation had no advection terms the moving boundaries have intro-
duced advection in the x direction. As this artificial velocity is purely in the x
direction and hence we can easily use flux-limiting as our scheme to calculate
the advection fluxes without any of the complexities that can arise for more
complicated velocity fields.
Of course we also have to apply the transform in Equation (C.41) to our
boundary and initial conditions and ensure that they are written in terms of
µ = (L2 − L1)φ. Applying these to the initial condition yeilds
(L2 − L1)φ|t=0 = (L2(0)− L1(0))φ0. (C.45)
In addition to the discretised equations from the FVM we also need to solve
Equations (C.38) and (C.39) to track the position of our boundaries. Because
of the presence of the L′1 and L′2 in Equation (C.44) to solve these equations
in MATLAB (Release 2012b) we need to use the function ode15i.
C.4.1 Transformation As Applied To The Model For Cellular
Differentiation
We conclude this appendix by providing details of the specific equations that
were used to solve the PDE systems giving throughout this thesis. In Chap-
ter 4 we considered a 2D domain where the domain was fixed in the y direction
but the right most boundary in the x direction was growing. We see that this
is a simplification of our general case where L1 = 0 and L
′
1 = 0. Additionally
in this model the right most boundary is denoted as L2 = Lx. The equations
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to be solved are
∂P¯
∂t¯
= P¯
(
1− P¯ − O¯)− B¯P¯
¯+ N¯
+∇2P¯ , (C.46)
∂O¯
∂t¯
= −δ¯O¯ + B¯P¯
¯+ N¯
+ D¯O∇2O¯, (C.47)
∂B¯
∂t¯
= α¯P¯ + β¯
B¯2O¯
σ¯ + N¯
− ρ¯B¯ + D¯B∇2B¯, (C.48)
∂N¯
∂t¯
= η¯B¯2O¯ − µ¯N¯ + D¯N∇2N¯ . (C.49)
with
dL¯x
dt¯
= ρ¯. (C.50)
The boundary conditions on x¯ = 0 are
∂P¯
∂x¯
= 0,
∂O¯
∂x¯
= 0,
B¯ = 5,
∂N¯
∂x¯
= 0,
(C.51)
and on x¯ = L¯x
P¯ = 0.8, O¯ = 0,
∂B¯
∂x¯
= − ρ¯
D¯B
B¯,
∂N¯
∂x¯
= − ρ¯
D¯N
N¯ .
(C.52)
On the top and bottom boundaries, zero flux boundary conditions are applied
for all species. The initial conditions are
P¯ = 0.8, O¯ = 0,
B¯ = 2.77, N¯ = 0.077.
(C.53)
We can apply the above rescaling and transformation in a straight forward
manner to Equations C.46–C.49,
∂L¯xP¯
∂t¯
= L¯x
(
P¯
(
1− P¯ − O¯)− B¯P¯
¯+ N¯
)
+
∂
∂ζ
(
D¯P
L¯2x
∂L¯xP¯
∂ζ
+
ζL′x
Lx
L¯xP¯
)
+ D¯P
∂2L¯xP¯
∂y¯2
,
(C.54)
∂L¯xO¯
∂t¯
= L¯x
(
−δ¯O¯ + B¯P¯
¯+ N¯
)
+
∂
∂ζ
(
D¯O
L¯2x
∂L¯xO¯
∂ζ
+
ζL′x
Lx
L¯xO¯
)
+ D¯O
∂2L¯xO¯
∂y¯2
,
(C.55)
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∂L¯xB¯
∂t¯
= L¯x
(
α¯P¯ + β¯
B¯2O¯
σ¯ + N¯
− ρ¯B¯
)
+
∂
∂ζ
(
D¯B
L¯2x
∂L¯xB¯
∂ζ
+
ζL′x
Lx
L¯xB¯
)
+ D¯B
∂2L¯xB¯
∂y¯2
,
(C.56)
∂L¯xN¯
∂t¯
= L¯x
(
η¯B¯2O¯ − µ¯N¯)+ ∂
∂ζ
(
D¯N
L¯2x
∂L¯xN¯
∂ζ
+
ζL′x
Lx
L¯xN¯
)
+ D¯N
∂2L¯xN¯
∂y¯2
,
(C.57)
(C.58)
The boundary conditions on y¯ = 0 and y¯ = L¯y remain unchanged by the
transformation. The left boundary x¯ = 0 is transformed to ζ = 0. We see that
for ζ = 0 the advection term in the flux disappears and it becomes a simple
task to transform the boundary conditions. On the right boundary x¯ = L¯x
transforms to ζ = 1. Here the Dirichlet boundary conditions for P¯ and O¯
remain unchanged. However for the chemical species the boundary conditions
are zero flux and we demonstrate that this is the case once the transformation
has been applied. Applying the transformation to the boundary condition for
B¯ gives
∂B¯
∂ζ
= − L¯xρ¯
D¯B
B¯, (C.59)
and we see that substituting this into the expression for the horizontal flux of
B¯ gives
D¯B
L¯2x
∂L¯xB¯
∂ζ
+
ζL′x
Lx
L¯xB¯ = 0. (C.60)
Simiarly for N¯
D¯N
L¯2x
∂L¯xN¯
∂ζ
+
ζL′x
Lx
L¯xN¯ = 0. (C.61)
Finally the initial conditions can be simply scaled by the initial domain length
as in Equation (C.45).
C.4.2 Transformation As Applied To The Model For Mineral
Deposition
Finally we turn our attention to the model presented in Chapter 5. In this
model we consider a 1D domain but both the boundaries are able to move.
Again this is a simplified case of the general case given above where we can
simply omit the y dimension. The non-dimensional model equations are given
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by
∂A¯
∂t¯
= D¯A
∂2A¯
∂x¯2
+ α¯+ β¯A¯P¯ − δ¯A¯, (C.62)
∂P¯
∂t¯
= D¯P
∂2P¯
∂x¯2
+ η¯ − k¯catA¯P¯
K¯M
(
1 + I¯
K¯I
) , (C.63)
∂I¯
∂t¯
= D¯I
∂2I¯
∂x¯2
+ 2× 10−3 k¯catA¯P¯
K¯M
(
1 + I¯
K¯I
) , (C.64)
dL¯1
dt¯
=
λ¯
2
(
1 + tanh
(
µ¯
(
γ¯ − P¯ (L¯1, t¯)
I¯(L¯1, t¯)
)))
. (C.65)
(C.66)
With boundary conditions on x¯ = L¯1
∂A¯
∂x¯
= 0, (C.67)
∂P¯
∂x¯
= 0, (C.68)
∂I¯
∂x¯
=
I¯ − I¯M
D¯I
dL¯1
dt¯
, (C.69)
and on x¯ = L¯2,
∂A¯
∂x¯
= 0, (C.70)
∂P¯
∂x¯
= −σ¯(P¯ − P¯0), (C.71)
I¯ = I¯0. (C.72)
The initial conditions are given as
A¯(x¯, 0) = A¯0, P¯ (x¯, 0) = P¯0, I¯(x¯, 0) = I¯0, L¯1(0) = L¯10 (C.73)
We apply the transformation to get
∂(L¯2 − L¯1)A¯
∂t¯
= (L¯2 − L¯1)
(
α¯+ β¯A¯P¯ − δ¯A¯)
+
∂
∂ζ
(
D¯A
(L¯2 − L¯1)2
∂(L¯2 − L¯1)A¯
∂ζ
+
L¯′1(1− ζ)
(L¯2 − L¯1)(L¯2 − L¯1)A¯
)
,
(C.74)
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∂(L¯2 − L¯1)P¯
∂t¯
= (L¯2 − L¯1)
η¯ − k¯catA¯P¯
K¯M
(
1 + I¯
K¯I
)

+
∂
∂ζ
(
D¯P
(L¯2 − L¯1)2
∂(L¯2 − L¯1)P¯
∂ζ
+
L¯′1(1− ζ)
(L¯2 − L¯1)(L¯2 − L¯1)P¯
)
,
(C.75)
∂(L¯2 − L¯1)I¯
∂t¯
= (L¯2 − L¯1)
2× 10−3 k¯catA¯P¯
K¯M
(
1 + I¯
K¯I
)

+
∂
∂ζ
(
D¯I
(L¯2 − L¯1)2
∂(L¯2 − L¯1)I¯
∂ζ
+
L¯′1(1− ζ)
(L¯2 − L¯1)(L¯2 − L¯1)I¯
)
,
(C.76)
dL¯1
dt¯
=
λ¯
2
(
1 + tanh
(
µ¯
(
γ¯ − P¯ (L¯1, t¯)
I¯(L¯1, t¯)
)))
. (C.77)
The boundary x¯ = L¯1 becomes ζ = 0 in the rescaled dimensions. On this
boundary the equations for A¯ and P¯ are such that the only material lost
through the boundary is due to the movement of the boundary. As the bound-
ary moves from left to right the domain shrinks and a region that was once
part of the domain is lost. Additionally any TNAP or PPi in this region is
also lost. In the unscaled version of this problem, the boundary condition ap-
peared to be a zero flux condition, however we see that once the rescaling has
been applied this is not the case. For TNAP and PPi the boundary conditions
on ζ = 0 becomes
D¯A
(L¯2 − L¯1)2
∂(L¯2 − L¯1)A¯
∂ζ
+
L¯′1
(L¯2 − L¯1)(L¯2 − L¯1)A¯ = L¯
′
1A¯ (C.78)
D¯P
(L¯2 − L¯1)2
∂(L¯2 − L¯1)P¯
∂ζ
+
L¯′1
(L¯2 − L¯1)(L¯2 − L¯1)P¯ = L¯
′
1P¯ (C.79)
(C.80)
For Pi on this boundary we had a condition derived from a conservation of
mass argument. Rescaling this equation gives
D¯I
(L¯2 − L¯1)2
∂(L¯2 − L¯1)I¯
∂ζ
+
L¯′1(1− ζ)
(L¯2 − L¯1)(L¯2 − L¯1)I¯ = I¯M L¯
′
1, (C.81)
we see that the amount of Pi lost through the boundary is simply the density of
the new bone mineral times the speed at which the mineralisation is occurring.
On the right boundary the coordinate transformation converts x¯ = L¯1 into
ζ = 1. The advective component of the flux disappears at this boundary and
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the boundary conditions can be simply rewritten as
∂(L¯2 − L¯1)A¯
∂ζ
= 0, (C.82)
∂(L¯2 − L¯1)P¯
∂ζ
= σ¯(L¯2 − L¯1)2(P¯ − P¯0), (C.83)
(L¯2 − L¯1)I¯ = (L¯2 − L¯1)I¯0. (C.84)
As before it is a simple task to rescale the initial conditions by the initial
domain length as in Equation (C.45).
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Glossary
ALP Alkaline phosphatase. An enzyme that breaks down phosphate com-
pounds
BMP Bone morphogenetic protein. The BMP family of proteins are growth
factors that induce the formation of bone and cartilage. BMP 2 and 4
have both been associated with intramembranous bone growth.
Cancellous Bone Bone that has a spongy appearance. In long bones it is
found in the ends of the bone. The plate and rod-like structures that
give its appearance are called trabecula.
Chondrocyte Cartilage cell
Cortical Bone Dense bone tissue that forms the shaft of long bones. The
cortical bone is constructed from well organised layers of bone, known
as lamella.
Hydroxyapatite Mineral component of bone, Ca10(PO4)6(OH)2.
MAR Mineral apposition rate. Measured quantity that describes the rate at
which new mineral is being formed.
MSC Mesenchymal stem cell. Pluripotent stem cell with the capacity to
become osteoblasts. During fracture healing these cells accumulate at
the fracture site and differentiate to drive new tissue formation.
Noggin BMP inhibitor associated with reduced intramembranous bone for-
mation.
Osteoblast Bone forming cells. These cells are responsible for creating new
bone tissue.
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Glossary
Osteoblast Progenitor Partially differentiated cell on the pathway to be-
come an osteoblast. We use this term throughout the thesis to refer to
cells present in the periosteum.
Osteocyte Cells embedding in the bone tissue. Thought to play a role in
sensing damage and regulating remodelling.
Osteoid Unmineralised bone matrix.
Periosteum Membrane like material that surrounds bones. In fracture heal-
ing is a source of progenitor cells.
Pi Inorganic phosphate. Free phosphate found in the extracellular fluid.
PPi Pyrophosphate. Potent inhibitor of mineral formation.
TNAP Tissue non-specific alkaline phosphatase. The specific form of ALP
produced by osteoblasts. Believed to be important for the removal of
PPi.
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